<?xml version="1.0" encoding="utf-8"?>
<rdf:RDF
  xmlns:ns1="http://edrn.nci.nih.gov/rdf/rdfs/bmdb-1.0.0#"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/239">
    <ns1:Description>CXCL8, commonly known as IL8, is a member of the CXC chemokine family.  This chemokine functions as a chemoattractant, or chemotactic factor, that attracts neutrophils, basophils, and T-cells, but not monocytes.  IL8 is one of the major mediators of the inflammatory response, and is involved in neutrophil activation.  It is released from several types of cells in response to an inflammatory stimulus.  IL8 also functions as an angiogenic factor.  The IL8 gene maps to chromosome 4q, and is found in a chemokine gene cluster along with ten other members of the CXC chemokine gene family.
There are several N-terminal processed forms that are produced by proteolytic cleavage after secretion from at least peripheral blood monocytes, leukcocytes and endothelial cells. Among the forms are:  IL-8(1-77), IL-8(5-77), IL-8(6-77), IL-8(7-77), IL-8(8-77), IL-8(9-77).  IL-8(1-77) is generally referred to as interleukin 8. IL-8(6-77) is
the most promiment form.</ns1:Description>
    <ns1:Alias>small inducible cytokine subfamily B, member 8</ns1:Alias>
    <ns1:Alias>T-cell chemotactic factor</ns1:Alias>
    <ns1:Alias>Emoctakin</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:239</ns1:URN>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>GCP-1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000575.1"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>IL8</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/106"/>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:3576"/>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>emoctakin</ns1:Alias>
    <ns1:Alias>interleukin 8</ns1:Alias>
    <ns1:Alias>3-10C</ns1:Alias>
    <ns1:Alias>CXCL8</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>MDNCF</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>IL-8</ns1:Alias>
    <ns1:Alias>GCP1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>NAF</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Alias>lymphocyte-derived neutrophil-activating factor</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>LYNAP</ns1:Alias>
    <ns1:Alias>Neutrophil-activating protein 1</ns1:Alias>
    <ns1:Alias>Protein 3-10C</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6025"/>
    <ns1:Alias>Monocyte-derived neutrophil-activating peptide</ns1:Alias>
    <ns1:Alias>MONAP</ns1:Alias>
    <ns1:Alias>OTTHUMP00000199825</ns1:Alias>
    <ns1:Alias>AMCF-I</ns1:Alias>
    <ns1:Alias>NAP-1</ns1:Alias>
    <ns1:Alias>chemokine (C-X-C motif) ligand 8</ns1:Alias>
    <ns1:Alias>T cell chemotactic factor</ns1:Alias>
    <ns1:Alias>LUCT</ns1:Alias>
    <ns1:Alias>beta-thromboglobulin-like protein</ns1:Alias>
    <ns1:Title>CXCL8</ns1:Title>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>interleukin-8</ns1:Alias>
    <ns1:Alias>NAP1</ns1:Alias>
    <ns1:Alias>Granulocyte chemotactic protein</ns1:Alias>
    <ns1:HgncName>CXCL8</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:Alias>neutrophil-activating peptide 1</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>C-X-C motif chemokine 8</ns1:Alias>
    <ns1:Alias>LECT</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P10145"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1014">
    <ns1:Alias>DEFCAP-L/S</ns1:Alias>
    <ns1:Alias>Nucleotide-Binding Oligomerization Domain</ns1:Alias>
    <ns1:Alias>NAC</ns1:Alias>
    <ns1:Alias>KIAA0926</ns1:Alias>
    <ns1:Alias>Caspase Recruitment Domain-Containing Protein 7</ns1:Alias>
    <ns1:Alias>VAMAS1</ns1:Alias>
    <ns1:Alias>Death Effector Filament-Forming Ced-4-Like Apoptosis Protein</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>CIDED</ns1:Alias>
    <ns1:Alias>NACHT, LRR And PYD Containing Protein 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>CLR17.1</ns1:Alias>
    <ns1:Alias>Caspase Recruitment Domain Protein 7</ns1:Alias>
    <ns1:Alias>Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat And Pyrin Domain Containing 1</ns1:Alias>
    <ns1:Alias>Leucine Rich Repeat And Pyrin Domain Containing 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=14374"/>
    <ns1:Alias>NACHT, LRR And PYD Domains-Containing Protein 1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Nucleotide-Binding Domain And Caspase Recruitment Domain</ns1:Alias>
    <ns1:Alias>NLRP1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Alias>NALP1</ns1:Alias>
    <ns1:Alias>NACHT, Leucine Rich Repeat And PYD (Pyrin Domain) Containing 1</ns1:Alias>
    <ns1:Alias>DEFCAP</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9C000"/>
    <ns1:Alias>CARD7</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>PP1044</ns1:Alias>
    <ns1:HgncName>NLRP1</ns1:HgncName>
    <ns1:Alias>SLEV1</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:1014</ns1:URN>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/606636"/>
    <ns1:Alias>NACHT, Leucine Rich Repeat And PYD Containing 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/22861"/>
    <ns1:Title>NLRP1</ns1:Title>
    <ns1:Description>NLR Family, Pyrin Domain Containing 1</ns1:Description>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/27">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/43"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Alias>Secreted phosphoprotein 1</ns1:Alias>
    <ns1:Alias>Bone sialoprotein 1</ns1:Alias>
    <ns1:Alias>early T-lymphocyte activation 1</ns1:Alias>
    <ns1:AccessGrantedTo>Pass New York University School of Medicine</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/21"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Description>Osteopontin, also known as SPP1 or OPN, a secreted, integrin-binding matrix phosphorylated glycoprotein is involved in bone remodeling by osteoclasts and is overexpressed in many advanced cancers. Osteopontin has been identified as one of the leading genes that promotes the metastasis of hepatocellular carcinoma.</ns1:Description>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>Urinary stone protein</ns1:Alias>
    <ns1:HgncName>SPP1</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://expasy.org/uniprot/P10451"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/18"/>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:6696"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Mor Yale University</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>BSPI</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11255"/>
    <ns1:Alias>BNSP</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/48"/>
    <ns1:Alias>SPP1</ns1:Alias>
    <ns1:Alias>Nephropontin</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/254"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_001238759.1"/>
    <ns1:Alias>Osteopontin</ns1:Alias>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:Title>SPP1</ns1:Title>
    <ns1:Alias>ETA-1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:27</ns1:URN>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>SPP-1</ns1:Alias>
    <ns1:Alias>Uropontin</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>OPN</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/360">
    <ns1:Alias>metallophosphoesterase domain containing 2</ns1:Alias>
    <ns1:HgncName>MPPED2</ns1:HgncName>
    <ns1:Alias>dJ1024C24.1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/744"/>
    <ns1:Alias>Fetal brain protein 239</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:360</ns1:URN>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/212"/>
    <ns1:Alias>Q15777</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MPPED2&amp;search=MPPED2"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Alias>D11S302E</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>fetal brain protein 239</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q15777"/>
    <ns1:Alias>Hs.46638</ns1:Alias>
    <ns1:Title>MPPED2</ns1:Title>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>chromosome 11 open reading frame 8</ns1:Alias>
    <ns1:Alias>C11orf8</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>c11orf8</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Metallophosphoesterase domain-containing protein 2</ns1:Alias>
    <ns1:Alias>metallophosphoesterase MPPED2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=1180"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>metallophosphoesterase domain-containing protein 2</ns1:Alias>
    <ns1:Alias>EC 3.1.-.-</ns1:Alias>
    <ns1:Description>MPPED2 displays low metallophosphoesterase activity (in vitro) and may play a role in the development of the brain and nervous system (by similarity). Alternatively spliced transcript variants have been described.</ns1:Description>
    <ns1:Alias>FAM1B</ns1:Alias>
    <ns1:Alias>dJ873F21.1</ns1:Alias>
    <ns1:Alias>MPPED2</ns1:Alias>
    <ns1:Alias>239FB</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/190">
    <ns1:Alias>Chondroitin sulfate proteoglycan core protein 2</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>CSPG2</ns1:Alias>
    <ns1:Alias>versican proteoglycan</ns1:Alias>
    <ns1:Alias>PG-M</ns1:Alias>
    <ns1:Alias>VCAN</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=VCAN&amp;search=cspg2"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>versican core protein</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:HgncName>VCAN</ns1:HgncName>
    <ns1:Alias>chondroitin sulfate proteoglycan 2</ns1:Alias>
    <ns1:Alias>versican</ns1:Alias>
    <ns1:Alias>ERVR</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>Large fibroblast proteoglycan</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:190</ns1:URN>
    <ns1:Alias>Glial hyaluronate-binding protein</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Zhang Johns Hopkins University School of Medicine</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>WGN1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P13611"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Description>VCAN, or CSPG2, a large chondroitin sulfate proteoglycan, is a major component of the extracellular matrix. This secreted protein is involved in cell adhesion, proliferation, migration and angiogenesis and plays a central role in tissue morphogenesis and maintenance. It is may play a role in intercellular signaling. Mutations in the CSPG2 gene are the cause of Wagner syndrome type 1. Multiple transcript variants encoding different isoforms have been found for this gene.</ns1:Description>
    <ns1:Security>Public</ns1:Security>
    <ns1:Title>VCAN</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Alias>WGN</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>GHAP</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=2464"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1462"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/29">
    <ns1:referencesResource rdf:resource="http://www.expasy.org/uniprot/P14780"/>
    <ns1:Alias>Gelatinase B</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:4318"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/20"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Description>MMP9 is a member of the matrix metalloproteinase (MMP) family.  It is a secreted protein that may play an essential role in local proteolysis of the extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. MMP9 also plays a role in leukocyte migration.  Murine studies suggest a role in tumor-associated tissue remodeling</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:AccessGrantedTo>Pass New York University School of Medicine</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>CLG4B</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:29</ns1:URN>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:HgncName>MMP9</ns1:HgncName>
    <ns1:Alias>92kDa gelatinase</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>metalloproteinase-9 [Precursor]</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=7176"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>MMP9</ns1:Alias>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Instititute</ns1:AccessGrantedTo>
    <ns1:Title>MMP9</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_004985.2"/>
    <ns1:Alias>GELB</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>92 kDa type IV collagenase</ns1:Alias>
    <ns1:Alias>matrix metallopeptidase 9</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/391">
    <ns1:Alias>syndecan 1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>syndecan</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P18827"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>P18827</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:391</ns1:URN>
    <ns1:Description>SDC1 is a transmembrane (type I) heparan sulfate proteoglycan and is a member of the syndecan proteoglycan family.  The SDC1 protein functions as an integral membrane protein and participates in cell proliferation, cell migration and cell-matrix interactions via its receptor for extracellular matrix proteins.</ns1:Description>
    <ns1:Alias>SDC</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:HgncName>SDC1</ns1:HgncName>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>syndecan-1</ns1:Alias>
    <ns1:Title>SDC1</ns1:Title>
    <ns1:Alias>CD138 antigen</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SDC1&amp;search=HUMAN+SDC1"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=10658"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>syndecan proteoglycan 1</ns1:Alias>
    <ns1:Alias>SDC1</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/6382"/>
    <ns1:Alias>heparan sulfate proteoglycan fibroblast growth factor receptor</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>CD138</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/921">
    <ns1:Alias>endoplasmic reticulum-associated amyloid beta-peptide-binding protein</ns1:Alias>
    <ns1:Alias>short chain L-3-hydroxyacyl-CoA dehydrogenase type 2</ns1:Alias>
    <ns1:Alias>short chain type dehydrogenase/reductase XH98G2</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>MRX31</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>MHBD</ns1:Alias>
    <ns1:HgncName>HSD17B10</ns1:HgncName>
    <ns1:Alias>mitochondrial RNase P subunit 2</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>Type II HADH</ns1:Alias>
    <ns1:Alias>mitochondrial ribonuclease P protein 2</ns1:Alias>
    <ns1:Alias>HCD2</ns1:Alias>
    <ns1:Alias>SDR5C1</ns1:Alias>
    <ns1:Alias>17-beta-HSD 10</ns1:Alias>
    <ns1:Alias>short chain dehydrogenase/reductase family 5C, member 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Title>HSD17B10</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/3028"/>
    <ns1:Alias>EC 1.1.1.35,EC 1.1.1.178</ns1:Alias>
    <ns1:Alias>hydroxysteroid (17-beta) dehydrogenase 10</ns1:Alias>
    <ns1:Alias>AB-binding alcohol dehydrogenase</ns1:Alias>
    <ns1:Alias>Endoplasmic reticulum-associated amyloid beta-peptide-binding protein</ns1:Alias>
    <ns1:Alias>3-hydroxyacyl-CoA dehydrogenase type-2</ns1:Alias>
    <ns1:Alias>Mitochondrial ribonuclease P protein 2</ns1:Alias>
    <ns1:Alias>CAMR</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=HSD17B10&amp;search=hsd17b10"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>SCHAD</ns1:Alias>
    <ns1:Alias>amyloid-beta peptide binding alcohol dehydrogenase</ns1:Alias>
    <ns1:Alias>MRXS10</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>XH98G2</ns1:Alias>
    <ns1:Alias>Mitochondrial RNase P protein 2</ns1:Alias>
    <ns1:Alias>HADH2</ns1:Alias>
    <ns1:Alias>ABAD</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=4800"/>
    <ns1:Alias>17-beta-hydroxysteroid dehydrogenase 10</ns1:Alias>
    <ns1:Alias>DUPXp11.22</ns1:Alias>
    <ns1:Alias>hydroxyacyl-Coenzyme A dehydrogenase, type II, hydroxyacyl-Coenzyme A dehydrogenase, type II</ns1:Alias>
    <ns1:Alias>Short-chain type dehydrogenase/reductase XH98G2</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>ERAB</ns1:Alias>
    <ns1:Alias>mental retardation, X-linked, syndromic 10</ns1:Alias>
    <ns1:Alias>3-hydroxy-2-methylbutyryl-CoA dehydrogenase</ns1:Alias>
    <ns1:Alias>MRPP2</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>MRX17</ns1:Alias>
    <ns1:Alias>HSD17B10</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q99714"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:921</ns1:URN>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>17b-HSD10</ns1:Alias>
    <ns1:Description>HSD17B10, hydroxysteroid (17-beta) dehydrogenase 10, is a member of the short-chain dehydrogenase/reductase superfamily. HSD17B10 functions in mitochondrial tRNA maturation and     catalyzes the oxidation of a wide variety of fatty acids, alcohols, and steroids.  The protein is thought to play a role in the development of Alzheimer's disease.  There are several alternatively spliced transcript variants, of which only two have been fully sequenced.</ns1:Description>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>3-hydroxyacyl-CoA dehydrogenase type II</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/902">
    <ns1:Alias>cyclin D1 (PRAD1: parathyroid adenomatosis 1)</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Title>CCND1</ns1:Title>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>B-cell lymphoma 1 protein</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL28&amp;search=ccl28"/>
    <ns1:Alias>PRAD1</ns1:Alias>
    <ns1:HgncName>CCND1</ns1:HgncName>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>BCL-1</ns1:Alias>
    <ns1:Alias>BCL-1 oncogene</ns1:Alias>
    <ns1:Alias>PRAD1 oncogene</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/56477"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:902</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9NRJ3"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=17700"/>
    <ns1:Alias>B-cell CLL/lymphoma 1</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>U21B31</ns1:Alias>
    <ns1:Alias>G1/S-specific cyclin-D1</ns1:Alias>
    <ns1:Alias>D11S287E</ns1:Alias>
    <ns1:Alias>CCND1</ns1:Alias>
    <ns1:Alias>BCL1</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Description>CCND1 is a member of the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. CCND1 forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition.</ns1:Description>
    <ns1:Alias>cyclin D1</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/230">
    <ns1:Alias>Placental protein 12</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>insulin-like growth factor binding protein 1</ns1:Alias>
    <ns1:Alias>AFBP</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=5469"/>
    <ns1:Alias>IGF-binding protein 1</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>IGF-BP25</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P08833"/>
    <ns1:Alias>IBP1</ns1:Alias>
    <ns1:Alias>IGFBP1</ns1:Alias>
    <ns1:Alias>IGFBP-1</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:230</ns1:URN>
    <ns1:Title>IGFBP1</ns1:Title>
    <ns1:Alias>hIGFBP-1</ns1:Alias>
    <ns1:Alias>IBP-1</ns1:Alias>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Description>IGFBP1, a secreted protein, is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. It binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors. IGFBP1 promotes cell migration.</ns1:Description>
    <ns1:HgncName>IGFBP1</ns1:HgncName>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:3484"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000587.1"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/174"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>PP12</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>alpha-pregnancy-associated endometrial globulin</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/226">
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:HgncName>KRT19</ns1:HgncName>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Description>KRT19, a member of the keratin family which exists as a heterotetramer of two type I and two type II keratins, is involved in the organization of myofibers. Together with KRT8, KRT19 helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.  KRT18 is expressed in a defined zone of basal keratinocytes in the deep outer root sheath of hair follicles.  It is also observed in sweat gland and mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, ectocervical epithelium (at protein level). It is expressed in epidermal basal cells and in nipple epidermis. It is also evident in a subset of vascular wall cells in both the veins and artery of human umbilical cord, and in umbilical cord vascular smooth muscle, as well as in muscle fibers accumulating in the costameres of myoplasm at the sarcolemma in structures that contain dystrophin and spectrin.</ns1:Description>
    <ns1:Alias>CK19</ns1:Alias>
    <ns1:Alias>CK-19</ns1:Alias>
    <ns1:Alias>MGC15366</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:3880"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>Keratin-19</ns1:Alias>
    <ns1:Alias>cytokeratin 19</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:226</ns1:URN>
    <ns1:Alias>keratin, type I, 40-kd</ns1:Alias>
    <ns1:Alias>keratin 19</ns1:Alias>
    <ns1:Title>KRT19</ns1:Title>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>keratin, type I cytoskeletal 19</ns1:Alias>
    <ns1:Alias>Cytokeratin-19</ns1:Alias>
    <ns1:Alias>K19</ns1:Alias>
    <ns1:Alias>K1CS</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/170"/>
    <ns1:Alias>Cytokeratin 19</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/169"/>
    <ns1:Alias>KRT19</ns1:Alias>
    <ns1:Alias>40-kDa keratin intermediate filament</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6436"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_002267.2"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P08727"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/76">
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:HgncName>CCL11</ns1:HgncName>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:Alias>eotaxin-1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Description>From NCBI Gene: This antimicrobial gene is one of several chemokine genes clustered on the q-arm of chromosome 17. Chemokines form a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of the N-terminal cysteine residues of the mature peptide. This chemokine, a member of the CC subfamily, displays chemotactic activity for eosinophils, but not mononuclear cells or neutrophils. This eosinophil-specific chemokine is thought to be involved in eosinophilic inflammatory diseases such as atopic dermatitis, allergic rhinitis, asthma and parasitic infections. [provided by RefSeq, Sep 2014]</ns1:Description>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Instititute</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/6356"/>
    <ns1:Alias>SCYA11</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q6I9T4"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>eotaxin</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=10610"/>
    <ns1:Alias>C-C motif chemokine 11</ns1:Alias>
    <ns1:Alias>small inducible cytokine subfamily A (Cys-Cys), member 11 (eotaxin)</ns1:Alias>
    <ns1:Alias>chemokine (C-C motif) ligand 11</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:76</ns1:URN>
    <ns1:Alias>small inducible cytokine A11</ns1:Alias>
    <ns1:Title>CCL11</ns1:Title>
    <ns1:Alias>eosinophil chemotactic protein</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_002977.1"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:6356"/>
    <ns1:Alias>CCL11</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>MGC22554</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/924">
    <ns1:Description>JUNB, or jun B proto-oncogene, is a transcription factor involved in regulating gene activity following the primary growth factor response. Binds to the DNA sequence 5'-TGA[CG]TCA-3'.</ns1:Description>
    <ns1:Alias>transcription factor jun-B</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/?query=human+junb&amp;sort=score"/>
    <ns1:Alias>AP-1</ns1:Alias>
    <ns1:Title>JUNB</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=JUNB&amp;search=junb"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/219"/>
    <ns1:Alias>jun B proto-oncogene</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6205"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:924</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/3726"/>
    <ns1:HgncName>JUNB</ns1:HgncName>
    <ns1:Alias>JUNB</ns1:Alias>
    <ns1:Alias>activator protein 1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/841">
    <ns1:Security>Public</ns1:Security>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Title>STOM</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>EPB72</ns1:Alias>
    <ns1:Alias>erythrocyte band 7 integral membrane protein</ns1:Alias>
    <ns1:Alias>EPB7</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>erythrocyte membrane protein band 7.2 (stomatin)</ns1:Alias>
    <ns1:Alias>Stomatin</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:HgncName>STOM</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/2040"/>
    <ns1:Alias>stomatin</ns1:Alias>
    <ns1:Alias>erythrocyte surface protein band 7.2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3383"/>
    <ns1:Alias>protein 7.2b</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=STOM&amp;search=stom"/>
    <ns1:Alias>BND7</ns1:Alias>
    <ns1:Alias>Protein 7.2b</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Description>STOM, or stomatin, is an integral membrane protein located in the cell membrane of red blood cells and other cell types, where it is thought to regulate ion channels and transporters. Multiple transcript variants are produced by alternative splicing.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>STOM</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:841</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P27105"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/509">
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Type>Proteomic</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/122"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:HgncName></ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:509</ns1:URN>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:Title>Bianchi 34-marker miRNA Signature for Lung Cancer</ns1:Title>
    <ns1:Description>This signature was developed based on the detection of 34 microRNAs (miRNAs) from serum that could identify patients with early stage non-small cell lung carcinomas (NSCLCs) in a population of asymptomatic high-risk individuals with 80% accuracy. The signature could assign disease probability accurately either in asymptomatic or symptomatic patients, is able to distinguish between benign and malignant lesions, and to capture the onset of the malignant disease in individual patients over time.</ns1:Description>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:IsPanel>1</ns1:IsPanel>
    <ns1:Alias>Bianchi 34-marker miRNA Signature for Lung Cancer</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/369">
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>O60487</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/10205"/>
    <ns1:Alias>EVA</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=3496"/>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:369</ns1:URN>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>EVA1</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>myelin protein zero-like 2</ns1:Alias>
    <ns1:HgncName>MPZL2</ns1:HgncName>
    <ns1:Description>The EVA1, or MPZL2 gene is expressed in the thymus and in several epithelial structures early in embryogenesis.  The protein MPZL2 displays an ability to mediate cell adhesion through a homophilic interaction, and its selective regulation by T cell maturation might imply the participation of MPZL2 in the earliest phases of thymus organogenesis. Two transcript variants encoding the same protein have been found for this gene.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O60487"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MPZL2&amp;search=mpzl2"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Title>MPZL2</ns1:Title>
    <ns1:Alias>MPZL2</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Epithelial V-like antigen 1</ns1:Alias>
    <ns1:Alias>epithelial V-like antigen 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/199"/>
    <ns1:Alias>myelin protein zero-like protein 2</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/940">
    <ns1:Alias>protein-tyrosine phosphatase 2C</ns1:Alias>
    <ns1:Alias>protein-tyrosine phosphatase 1D</ns1:Alias>
    <ns1:Alias>SHPTP2</ns1:Alias>
    <ns1:Alias>PTP-1D</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>Shp2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=9644"/>
    <ns1:Alias>SH-PTP3</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:URN>urn:edrn:bmdb:biomarker:940</ns1:URN>
    <ns1:Alias>PTPN11</ns1:Alias>
    <ns1:Alias>SHP2</ns1:Alias>
    <ns1:Alias>tyrosine-protein phosphatase non-receptor type 11</ns1:Alias>
    <ns1:Alias>SH-PTP2</ns1:Alias>
    <ns1:Alias>SHP-2</ns1:Alias>
    <ns1:Alias>PTP-2C</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Protein-tyrosine phosphatase 1D</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q06124"/>
    <ns1:Alias>NS1</ns1:Alias>
    <ns1:Alias>Noonan syndrome 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/5781"/>
    <ns1:Title>PTPN11</ns1:Title>
    <ns1:Alias>CFC</ns1:Alias>
    <ns1:Alias>Protein-tyrosine phosphatase 2C</ns1:Alias>
    <ns1:Alias>EC 3.1.3.48</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PTPN11&amp;search=ptpn11"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>PTP2C</ns1:Alias>
    <ns1:Description>PTPN11 is a member of the protein tyrosine phosphatase (PTP) family.  PTP family members are a group of enzymes that catalyze the removal of phosphate groups from tyrosine residues by the hydrolysis of phosphoric acid monoesters.  The activity of PTPs opposite that of kinases and phosphorylases and therefore PTPs play an integral role in many signal transduction pathways. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. PTPN11 is     widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration.</ns1:Description>
    <ns1:Alias>BPTP3</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>protein tyrosine phosphatase, non-receptor type 11</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:HgncName>PTPN11</ns1:HgncName>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/451">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/151"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:URN>urn:edrn:bmdb:biomarker:451</ns1:URN>
    <ns1:Phase></ns1:Phase>
    <ns1:Title>Yildiz MALDI MS signature for lung cancer</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Type>Proteomic</ns1:Type>
    <ns1:Description>A serum proteomic signature of seven features identified by MALDI MS has been identified.  The serum signature was associated with the diagnosis of lung cancer independently of gender, smoking status, smoking pack-years, and C-reactive protein levels.</ns1:Description>
    <ns1:IsPanel>1</ns1:IsPanel>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>Yildiz MALDI MS signature for lung cancer</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:HgncName></ns1:HgncName>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/227">
    <ns1:HgncName>ERBB2</ns1:HgncName>
    <ns1:Alias>c-ErbB-2</ns1:Alias>
    <ns1:Alias>HER-2</ns1:Alias>
    <ns1:Title>ERBB2</ns1:Title>
    <ns1:Alias>HER-2/neu</ns1:Alias>
    <ns1:Alias>p185erbB2</ns1:Alias>
    <ns1:Alias>Proto-oncogene Neu</ns1:Alias>
    <ns1:Alias>Tyrosine kinase-type cell surface receptor HER2</ns1:Alias>
    <ns1:Alias>Receptor tyrosine-protein kinase erbB-2</ns1:Alias>
    <ns1:Alias>NEU</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>Metastatic lymph node gene 19 protein</ns1:Alias>
    <ns1:Alias>MLN19</ns1:Alias>
    <ns1:Alias>ERBB2</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:227</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:2064"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>NGL</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/167000"/>
    <ns1:Alias>MLN 19</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>HER2</ns1:Alias>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=3430"/>
    <ns1:Alias>v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/2064"/>
    <ns1:Alias>v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/171"/>
    <ns1:Alias>CD340</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P04626"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>CD_antigen=CD340</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Description>From NCBI Gene: This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. [provided by RefSeq, Jul 2008]</ns1:Description>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/116"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_004439.2"/>
    <ns1:Alias>Proto-oncogene c-ErbB-2</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>TKR1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/371">
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=25850"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>protein RMD5 homolog A</ns1:Alias>
    <ns1:Alias>RMD5</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9H871"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:HgncName>RMND5A</ns1:HgncName>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=RMND5A&amp;search=flj13910"/>
    <ns1:Alias>p44CTLH</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>C-terminal to LisH motif, 44 kDa</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:371</ns1:URN>
    <ns1:Phase></ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/?term=human+flj13910"/>
    <ns1:Alias>Q9H871</ns1:Alias>
    <ns1:Title>RMND5A</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>RMND5A</ns1:Alias>
    <ns1:Alias>FLJ13910</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Alias>CTLH</ns1:Alias>
    <ns1:Description>RMND5A (FLJ13910) is also known as required for meiotic nuclear division 5 homolog A (S. cerevisiae).  There are two isoforms of this human protein, produced by alternative splicing.</ns1:Description>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>required for meiotic nuclear division 5 homolog A (S. cerevisiae)</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/381">
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:HgncName>HOXA9</ns1:HgncName>
    <ns1:Description>HOXA9 is a sequence-specific transcription factor.  It is a member of the homeobox gene family.  These transcription factors are spatially and temporally regulated during embryonic development.  HOXA9 is part of the A cluster on chromosome 7 and encodes a DNA-binding transcription factor which may regulate gene expression, morphogenesis, and differentiation. Read-through transcription exists between this gene and the upstream homeobox A10 (HOXA10) gene.</ns1:Description>
    <ns1:Alias>homeo box A9</ns1:Alias>
    <ns1:Alias>homeobox protein Hox-A9</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>homeodomain protein HOXA9</ns1:Alias>
    <ns1:Alias>homeobox protein Hox-1G</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/128"/>
    <ns1:Alias>homeobox A9</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>Homeobox protein Hox-1G</ns1:Alias>
    <ns1:Alias>HOX1G</ns1:Alias>
    <ns1:Title>HOXA9</ns1:Title>
    <ns1:Alias>HOXA9</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Alias>HOX1.7</ns1:Alias>
    <ns1:Alias>ABD-B</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/index.php?path=/Search/keyword/hoxa9"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/3205"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:URN>urn:edrn:bmdb:biomarker:381</ns1:URN>
    <ns1:Alias>P31269</ns1:Alias>
    <ns1:Alias>HOX1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=5109"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P31269"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/914">
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>E1A-associated protein p300</ns1:Alias>
    <ns1:Alias>E1A-binding protein, 300kD</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3373"/>
    <ns1:Alias>KAT3B</ns1:Alias>
    <ns1:Alias>E1A binding protein p300</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=EP300&amp;search=ep300"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>p300</ns1:Alias>
    <ns1:Alias>p300 HAT</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:914</ns1:URN>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:HgncName>EP300</ns1:HgncName>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>P300</ns1:Alias>
    <ns1:Alias>EC 2.3.1.48</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/2033"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>EP300</ns1:Alias>
    <ns1:Description>EP300, or E1A binding protein p300, functions as a histone acetyltransferase and regulates transcription via chromatin remodeling. EP300 is important in the processes of cell proliferation and differentiation, and also functions as acetyltransferase for nonhistone targets. EP300 mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF.</ns1:Description>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Title>EP300</ns1:Title>
    <ns1:Alias>histone acetyltransferase p300</ns1:Alias>
    <ns1:Alias>RSTS2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q09472"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/922">
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>ITGB1</ns1:Alias>
    <ns1:Alias>VLA-4 subunit beta</ns1:Alias>
    <ns1:Alias>integrin beta-1</ns1:Alias>
    <ns1:Alias>CD29</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Description>ITGB1 is a beta subunit of the heterodimeric integrin protein.  Integrins are ubiquitously expressed adhesion molecules composed of alpha and beta subunits.  In mammals, 18 alpha and 8 beta subunits have been identified.     Integrin family members are membrane receptors involved in cell adhesion and recognition in a variety of processes including embryogenesis, hemostasis, tissue repair, immune response and metastatic diffusion of tumor cells.  Several protein isoforms have been identifed, arising from alternatively spliced transcript variants.</ns1:Description>
    <ns1:Alias>VLAB</ns1:Alias>
    <ns1:Alias>integrin VLA-4 beta subunit</ns1:Alias>
    <ns1:Alias>FNRB</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P05556"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>MSK12</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ITGB1&amp;search=itgb1"/>
    <ns1:Alias>GPIIA</ns1:Alias>
    <ns1:Alias>CD29 antigen</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Title>ITGB1</ns1:Title>
    <ns1:Alias>Fibronectin receptor subunit beta</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6153"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/3688"/>
    <ns1:Alias>very late activation protein, beta polypeptide</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>VLA-BETA</ns1:Alias>
    <ns1:Alias>MDF2</ns1:Alias>
    <ns1:HgncName>ITGB1</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:922</ns1:URN>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/959">
    <ns1:Alias>PBRS</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/231"/>
    <ns1:Alias>PBS</ns1:Alias>
    <ns1:Alias>PBR</ns1:Alias>
    <ns1:Alias>benzodiazapine receptor (peripheral)</ns1:Alias>
    <ns1:Alias>mitochondrial benzodiazepine receptor</ns1:Alias>
    <ns1:HgncName>TSPO</ns1:HgncName>
    <ns1:Alias>Mitochondrial benzodiazepine receptor</ns1:Alias>
    <ns1:Alias>translocator protein (18kDa)</ns1:Alias>
    <ns1:Alias>TSPO</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>IBP</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>DBI</ns1:Alias>
    <ns1:Alias>PKBS</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=1158"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>BZRP</ns1:Alias>
    <ns1:Description>TSPO is a conserved protein found at the outer mitochondrial membrane.  TSPO     interacts with some benzodiazepines and isoquinoline carboxamides and has different affinities than its endogenous counterpart. TSPO is also involved in the transport of porphyrins and heme.</ns1:Description>
    <ns1:Alias>pk18</ns1:Alias>
    <ns1:Alias>Peripheral-type benzodiazepine receptor</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>PTBR</ns1:Alias>
    <ns1:Alias>BPBS</ns1:Alias>
    <ns1:Alias>mDRC</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=TSPO&amp;search=tspo"/>
    <ns1:Alias>MBR</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/232"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>peripheral-type benzodiazepine receptor</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/706"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>translocator protein</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:959</ns1:URN>
    <ns1:Title>TSPO</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P30536"/>
    <ns1:Alias>benzodiazepine peripheral binding site</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/954">
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=11368"/>
    <ns1:Alias>STAT, interleukin4-induced</ns1:Alias>
    <ns1:Alias>D12S1644</ns1:Alias>
    <ns1:HgncName>STAT6</ns1:HgncName>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>IL-4 Stat</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>IL-4-STAT</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P42226"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>signal transducer and activator of transcription 6, interleukin-4 induced</ns1:Alias>
    <ns1:Description>STAT6 is a member of the STAT family of transcription factors. STAT family members are phosphorylated by the receptor associated kinases in response to cytokines and growth factors and are involved in signal transduction and activation of transcription.  There are several transcript variants produced by alternative splicing.</ns1:Description>
    <ns1:Alias>STAT6B</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>signal transducer and activator of transcription 6</ns1:Alias>
    <ns1:Alias>STAT6C</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/226"/>
    <ns1:Alias>transcription factor IL-4 STAT</ns1:Alias>
    <ns1:Alias>STAT6</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=STAT6&amp;search=stat6"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:954</ns1:URN>
    <ns1:Security>Public</ns1:Security>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/6778"/>
    <ns1:Title>STAT6</ns1:Title>
    <ns1:Phase>Two</ns1:Phase>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/364">
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:364</ns1:URN>
    <ns1:Alias>BD1</ns1:Alias>
    <ns1:Alias>beta-defensin-1</ns1:Alias>
    <ns1:Description>DEFB1 is a member of the defensin family of microbicidal and cytotoxic peptides made by neutrophils. DEFB1 is an antimicrobial peptide implicated in the resistance of epithelial surfaces to microbial colonization.  DEFB1 is thought to be involved in the pathogenesis of cystic fibrosis.</ns1:Description>
    <ns1:Alias>HBD-1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=2766"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>beta-defensin 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB1&amp;search=defb1"/>
    <ns1:Alias>Defensin, beta 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1672"/>
    <ns1:Alias>DEFB101</ns1:Alias>
    <ns1:Alias>HBD1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>DEFB1</ns1:Alias>
    <ns1:Alias>DEFB-1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Title>DEFB1</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>hBD-1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>BD-1</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P60022"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>defensin, beta 1</ns1:Alias>
    <ns1:HgncName>DEFB1</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Alias>P60022</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/968">
    <ns1:HgncName>SERPINE1</ns1:HgncName>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SERPINE1&amp;search=pai1"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Serpin E1</ns1:Alias>
    <ns1:Description>The SERPINE1 protein is a serine proteinase inhibitor (serpin) superfamily.  SERPINE1 is the main inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), the activators of plasminogen and hence fibrinolysis.  It is found in plasma and platelets and in endothelial, hepatoma and fibrosarcoma cells.  Alternatively spliced transcript variants encoding different isoforms have been found for this gene.</ns1:Description>
    <ns1:Alias>Serine (Or Cysteine) Proteinase Inhibitor, Clade E (Nexin, Plasminogen     Activator Inhibitor Type 1), Member 1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/5054"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>Endothelial plasminogen activator inhibitor</ns1:Alias>
    <ns1:Title>SERPINE1</ns1:Title>
    <ns1:URN>urn:edrn:bmdb:biomarker:968</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P05121"/>
    <ns1:Alias>Serpin Peptidase Inhibitor, Clade E (Nexin, Plasminogen Activator Inhibitor     Type 1), Member 1</ns1:Alias>
    <ns1:Alias>PAI-1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=8583"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>SERPINE1</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>PAI1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/175"/>
    <ns1:Alias>PAI</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>PLANH1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Plasminogen Activator Inhibitor 1</ns1:Alias>
    <ns1:Alias>tPAI1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/962">
    <ns1:HgncName>XBP1</ns1:HgncName>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>XBP1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/234"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>XBP-1</ns1:Alias>
    <ns1:Alias>tax-responsive element-binding protein 5</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7494"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P17861"/>
    <ns1:Alias>XBP2</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=12801"/>
    <ns1:Alias>TREB5</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:962</ns1:URN>
    <ns1:Alias>X-box binding protein 1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>X-box-binding protein 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=XBP1&amp;search=xbp1"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Title>XBP1</ns1:Title>
    <ns1:Alias>Tax-responsive element-binding protein 5</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Description>XBP1 is a transcription factor involved in hepatocyte growth, differentiation of plasma cells, immunoglobulin secretion, and the unfolded protein response (UPR). XBP1 regulates MHC class II genes by binding to a promoter element referred to as an X box.  XBP1 also plays a role in activating unfolded protein response (UPR) target genes via direct binding to the UPR element (UPRE) during endoplasmic reticulum stress.  There is an XBP1 pseudogene on chromosome 5.</ns1:Description>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/910">
    <ns1:Description>EED is a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. EED is part of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' and 'Lys-27' of histone H3, leading to transcriptional repression of the affected target gene.  Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1 and CDKN2A. There are two known isoforms arising from two distinct transcript variants for this gene.</ns1:Description>
    <ns1:Alias>embryonic ectoderm development</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>EED</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=EED&amp;search=eed"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>WAIT1</ns1:Alias>
    <ns1:HgncName>EED</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Title>EED</ns1:Title>
    <ns1:Alias>polycomb protein EED</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>WD protein associating with integrin cytoplasmic tails 1</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:910</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8726"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O75530"/>
    <ns1:Alias>WAIT-1</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>HEED</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3188"/>
    <ns1:Alias>hEED</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/378">
    <ns1:URN>urn:edrn:bmdb:biomarker:378</ns1:URN>
    <ns1:Alias>T-cell death-associated gene 8 protein</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=GPR65&amp;search=gpr65"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Alias>hTDAG8</ns1:Alias>
    <ns1:HgncName>GPR65</ns1:HgncName>
    <ns1:Title>GPR65</ns1:Title>
    <ns1:Alias>GPR65</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=4517"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>psychosine receptor</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>Q8IYL9</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>G protein-coupled receptor 65</ns1:Alias>
    <ns1:Alias>G-protein coupled receptor 65</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8477"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q8IYL9"/>
    <ns1:Description>GPR65, a member of the G-protein coupled receptor 1 family, is a receptor for the glycosphingolipid psychosine (PSY) and several related glycosphingolipids. GPR65 may have a role in activation-induced cell death or differentiation of T-cells.  It is expressed in thymus, spleen, lymph nodes, small intestine, lung, placenta and peripheral blood leukocytes.</ns1:Description>
    <ns1:Alias>TDAG8</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/118">
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>[-2]proPSA</ns1:Alias>
    <ns1:Description>ProPSA (-2), or [-2]proPSA, is a PSA isoform which has a leader peptide (-2) amino acids at its N terminal region and does not interact with ACT or alpha-2-macroglobulin or spermidine and therefore is detected as a separate isoform. ProPSA is produced primarily in the peripheral zone of the prostate gland and therefore is very useful in distinguishing between prostate cancer patients with PSA range of 2-10, from those who have BPH. Percent proPSA is the ratio of proPSA to free PSA.  
In July 2012 the FDA approved an assay measuring levels of [-2]proPSA for monitoring and diagnostic purposes.</ns1:Description>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=KLK3&amp;search=prostate+specific+antigen"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.cancer.gov/newscenter/newsfromnci/2010/proPSA"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/354"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/87"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/251"/>
    <ns1:Alias>free prostate-specific antigen (PSA) isoform</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.accessdata.fda.gov/cdrh_docs/pdf9/P090026c.pdf"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:118</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.accessdata.fda.gov/cdrh_docs/pdf9/P090026b.pdf"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/250"/>
    <ns1:referencesResource rdf:resource="http://www.cancer.gov/cancertopics/factsheet/detection/PSA"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/97"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/98"/>
    <ns1:referencesResource rdf:resource="http://www.accessdata.fda.gov/cdrh_docs/reviews/K112603.pdf"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Chan Johns Hopkins Medical Institutions</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Prostate and Urologic</ns1:AccessGrantedTo>
    <ns1:HgncName></ns1:HgncName>
    <ns1:Alias>proPSA</ns1:Alias>
    <ns1:Title>proPSA</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm309081.htm"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/377">
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>KIAA0001</ns1:Alias>
    <ns1:Alias>GPR105</ns1:Alias>
    <ns1:Alias>P2RY14</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=16442"/>
    <ns1:HgncName>P2RY14</ns1:HgncName>
    <ns1:Alias>P2Y14 receptor</ns1:Alias>
    <ns1:Alias>G protein coupled receptor for UDP-glucose</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>G-protein coupled receptor 105</ns1:Alias>
    <ns1:Alias>P2Y(14) receptor</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:URN>urn:edrn:bmdb:biomarker:377</ns1:URN>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Q15391</ns1:Alias>
    <ns1:Alias>purinergic receptor P2Y, G-protein coupled, 14</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=P2RY14&amp;search=gpr105"/>
    <ns1:Title>P2RY14</ns1:Title>
    <ns1:Alias>P2Y14</ns1:Alias>
    <ns1:Alias>P2Y purinoceptor 14</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Description>P2RY14, or GPR105, is a G-protein coupled receptor that responds to extracellular purine and pyrimidine nucleotides.  P2RY14 is not activated by ATP, ADP, UTP or ATP, but is a receptor for UDP-glucose and other UDP-sugars coupled to G-proteins.  P2RY14 is thought to be involved in extending the known immune system functions of P2Y receptors by participating in the regulation of the stem cell compartment, and it may also play a role in neuroimmune function. Two transcript variants encoding the same protein have been identified for this gene.  There are two transcript variants for this gene that result in the same protein.</ns1:Description>
    <ns1:Alias>UDP-glucose receptor</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/9934"/>
    <ns1:Alias>G protein-coupled receptor 105</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q15391"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/671">
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Negative growth regulatory protein MyD118</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/search?search_type=symbols&amp;search=gadd45b&amp;submit=Submit"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:HgncName>GADD45B</ns1:HgncName>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Myeloid differentiation primary response protein MyD118</ns1:Alias>
    <ns1:Alias>MYD118</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:671</ns1:URN>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/604948"/>
    <ns1:Alias>DKFZP566B133</ns1:Alias>
    <ns1:Alias>negative growth regulatory protein MyD118</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase>One</ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O75293"/>
    <ns1:Description>growth arrest and DNA-damage-inducible, beta</ns1:Description>
    <ns1:Title>GADD45B</ns1:Title>
    <ns1:Alias>growth arrest and DNA damage-inducible protein GADD45 beta</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Alias>growth arrest and DNA-damage-inducible, beta</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/4616"/>
    <ns1:Alias>GADD45BETA</ns1:Alias>
    <ns1:Alias>myeloid differentiation primary response protein MyD118</ns1:Alias>
    <ns1:Alias>GADD45B</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/772">
    <ns1:Phase>One</ns1:Phase>
    <ns1:HgncName>PGC</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:772</ns1:URN>
    <ns1:Alias>pepsinogen group II</ns1:Alias>
    <ns1:Alias>Pepsinogen C</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=8890"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/169740"/>
    <ns1:Alias>PGII</ns1:Alias>
    <ns1:Alias>PEPC</ns1:Alias>
    <ns1:Alias>progastricsin (pepsinogen C)</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>PGC</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P20142"/>
    <ns1:Description>progastricsin (pepsinogen C)</ns1:Description>
    <ns1:Title>PGC</ns1:Title>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>pepsinogen C</ns1:Alias>
    <ns1:Alias>gastricsin</ns1:Alias>
    <ns1:Alias>pepsin C</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/5225"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>preprogastricsin</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Alias>EC 3.4.23.3</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/931">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Description>The MYO5A gene is one of three myosin V heavy-chain genes, belonging to the myosin gene superfamily. The MYO5A protein functions as a processive actin-based motor that can move in large steps approximating the 36-nm pseudo-repeat of the actin filament.  MYO5A is also involved in cytoplasmic vesicle transport and anchorage, spindle-pole alignment and mRNA translocation. Different isoforms, encoded by alternatively spliced transcript variants, have been reported.</ns1:Description>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Myoxin</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>dilute myosin heavy chain, non-muscle</ns1:Alias>
    <ns1:Alias>myoxin</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=7602"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>MYO5A</ns1:Alias>
    <ns1:Alias>myosin, heavy polypeptide kinase</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>myosin VA (heavy chain 12, myoxin)</ns1:Alias>
    <ns1:Alias>Myosin-12</ns1:Alias>
    <ns1:Alias>GS1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>MYH12</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Title>MYO5A</ns1:Title>
    <ns1:Alias>myosin-Va</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:URN>urn:edrn:bmdb:biomarker:931</ns1:URN>
    <ns1:Alias>MYR12</ns1:Alias>
    <ns1:HgncName>MYO5A</ns1:HgncName>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>myosin VA (heavy polypeptide 12, myoxin)</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MYO5A&amp;search=myo5a"/>
    <ns1:Alias>myosin V</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9Y4I1"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>Dilute myosin heavy chain, non-muscle</ns1:Alias>
    <ns1:Alias>MYO5</ns1:Alias>
    <ns1:Alias>myosin-12</ns1:Alias>
    <ns1:Alias>Myosin heavy chain 12</ns1:Alias>
    <ns1:Alias>unconventional myosin-Va</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/4644"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/810">
    <ns1:Alias>Suppressor of lin-12-like protein 3</ns1:Alias>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>protein sel-1 homolog 3</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>suppressor of lin-12-like protein 3</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Sel-1L3</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/23231"/>
    <ns1:Alias>sel-1 suppressor of lin-12-like 3 (C. elegans)</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=29108"/>
    <ns1:Alias>SEL1L3</ns1:Alias>
    <ns1:Title>SEL1L3</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Description>sel-1 suppressor of lin-12-like 3 (C. elegans)</ns1:Description>
    <ns1:Alias>KIAA0746</ns1:Alias>
    <ns1:HgncName>SEL1L3</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q68CR1"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:810</ns1:URN>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/387">
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q68BL8"/>
    <ns1:Alias>olfactomedin-like 2B</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Photomedin-2</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/196"/>
    <ns1:Alias>DKFZP586L151</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=OLFML2B&amp;search=olfml2b"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=24558"/>
    <ns1:Alias>RP11-227F8.1</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>OLFML2B</ns1:Alias>
    <ns1:Description>OLFML2B is a secreted protein.  The gene is conserved across many species.  The protein is a homodimer.</ns1:Description>
    <ns1:Alias>photomedin-2</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Title>OLFML2B</ns1:Title>
    <ns1:URN>urn:edrn:bmdb:biomarker:387</ns1:URN>
    <ns1:Alias>Q68BL8</ns1:Alias>
    <ns1:Alias>olfactomedin-like protein 2B</ns1:Alias>
    <ns1:HgncName>OLFML2B</ns1:HgncName>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/25903"/>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/38">
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:FHCRCHanashAnnexinLamr"/>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/41"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/26"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/27"/>
    <ns1:Alias>ubiquitin C-terminal hydrolase</ns1:Alias>
    <ns1:Title>UCHL1</ns1:Title>
    <ns1:Alias>PARK5</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>PGP9.5, also called Ubiquitin-protein hydrolase (UCHL1), is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. Expression of UCHL1 is highly specific to neurons and to cells of the diffuse neuroendocrine system and their tumors. This enzyme is a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. Oxidation of Met-1, Met-6, Met-12, Met-124 and Met-179 to methionine sulfoxide, and oxidation of Cys-220 to cysteine sulfonic acid have been observed in brains from Alzheimer disease (AD) and Parkinson disease (PD) patients. PGP9.5 has been proposed as a marker with a potential role in carcinogenesis.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=12513"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P09936"/>
    <ns1:Alias>Neuron cytoplasmic protein 9.5</ns1:Alias>
    <ns1:Alias>UCH-L1</ns1:Alias>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/59"/>
    <ns1:Alias>PGP95</ns1:Alias>
    <ns1:Alias>PGP9.5</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/39"/>
    <ns1:Alias>ubiquitin carboxyl-terminal hydrolase isozyme L1</ns1:Alias>
    <ns1:HgncName>UCHL1</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/40"/>
    <ns1:AccessGrantedTo>Hanash Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>PGP 9.5</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Uch-L1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:7345"/>
    <ns1:Alias>UCHL1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N092b5a6001ac4cb6b8fc0bdd6b906084">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/38/999"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Ubiquitin thioesterase L1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:38</ns1:URN>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/75"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/73"/>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000154277"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/242">
    <ns1:Alias>interleukin-2 receptor subunit alpha</ns1:Alias>
    <ns1:Alias>CD25 antigen</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>TCGFR</ns1:Alias>
    <ns1:Alias>TAC antigen</ns1:Alias>
    <ns1:Alias>interleukin 2 receptor, alpha</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000134460"/>
    <ns1:Alias>OTTHUMP00000019031</ns1:Alias>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>IL2-RA</ns1:Alias>
    <ns1:Alias>IL2RA</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>IL2R</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:HgncName>IL2RA</ns1:HgncName>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>IL-2 receptor subunit alpha</ns1:Alias>
    <ns1:Description>The interleukin 2 receptor exists in three forms which differ in their ability to bind interleukin 2.  The low affinity form of the receptor is a monomer of IL2RA, the alpha subunit.  The alpha/beta subunit heterodimer, formed by IL2RA and IL2RB, is an intermediate affinity form.  The alpha/beta/gamma heterotrimer formed by IL2RA, IL2RB, and IL2RG is the high affinity form.  IL2RA is normally an integral membrane protein, although soluble IL2RA has been isolated.  There are known alternately-spliced versions of IL2RA mRNAs, but their functions are unknown.  Mutations in the IL2RA gene are associated with diabetes mellitus insulin-dependent type 10 (IDDM10).  Complications of IDDM10 can adversely affect the eyes, kidneys, nerves, and blood vessels.</ns1:Description>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000408.1"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Alias>p55</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P01589"/>
    <ns1:Alias>IL-2R subunit alpha</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6008"/>
    <ns1:Title>IL2RA</ns1:Title>
    <ns1:Alias>IL-2-RA</ns1:Alias>
    <ns1:Alias>IDDM10</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:242</ns1:URN>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>CD25</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/383">
    <ns1:Alias>HBEBP36</ns1:Alias>
    <ns1:Title>WWC1</ns1:Title>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Description>WWC1, or KIBRA, is a cytoplasmic phosphoprotein.  Expression has been detected in the brain, heart, colon and kidney, as well as mammary epithelial cells and breast cancer cell lines.  WWC1 interacts with PRKC-zeta and dynein light chain-1. Alleles of this gene have been found that may be associated with memory performance. Three transcript variants encoding different isoforms have been found for the WWC1 gene.</ns1:Description>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q8IX03"/>
    <ns1:Alias>kidney and brain protein</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>protein KIBRA</ns1:Alias>
    <ns1:Alias>WW, C2 and coiled-coil domain containing 1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:HgncName>WWC1</ns1:HgncName>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Q8IX03</ns1:Alias>
    <ns1:Alias>HBEBP3</ns1:Alias>
    <ns1:Alias>WW and C2 domain containing 1</ns1:Alias>
    <ns1:Alias>protein WWC1</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>Kidney and brain protein</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=WWC1&amp;search=kibra"/>
    <ns1:Alias>HBeAg-binding protein 3</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:383</ns1:URN>
    <ns1:Alias>WW domain-containing protein 1</ns1:Alias>
    <ns1:Alias>WWC1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>KIAA0869</ns1:Alias>
    <ns1:Alias>KIBRA</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/23286"/>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=29435"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/225">
    <ns1:Alias>chitinase 3-like 1 (cartilage glycoprotein-39)</ns1:Alias>
    <ns1:Alias>CHI3L1</ns1:Alias>
    <ns1:Alias>Chitinase-3-like protein 1</ns1:Alias>
    <ns1:Alias>ASRT7</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>hCGP-39</ns1:Alias>
    <ns1:Alias>YKL40</ns1:Alias>
    <ns1:Description>CHI3L1, also known as chitinase, a secreted protein, is a carbohydrate-binding lectin with a preference for chitin. It may play a role in defense against pathogens, or in tissue remodeling. It may also play an important role in the capacity of cells to respond to and cope with changes in their environment. CHI3L1 is present in activated macrophages, articular chondrocytes, synovial cells as well as in liver. It is undetectable in muscle tissues, lung, pancreas, mononuclear cells, or fibroblasts.</ns1:Description>
    <ns1:Alias>39 kDa synovial protein</ns1:Alias>
    <ns1:Alias>DKFZp686N19119</ns1:Alias>
    <ns1:Alias>Cartilage glycoprotein 39</ns1:Alias>
    <ns1:Title>CHI3L1</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:HgncName>CHI3L1</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Alias>YYL-40</ns1:Alias>
    <ns1:Alias>HC-gp39</ns1:Alias>
    <ns1:Alias>GP39</ns1:Alias>
    <ns1:Alias>YKL-40</ns1:Alias>
    <ns1:Alias>GP-39</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P36222"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:1116"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>Chitinase</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_001267.2"/>
    <ns1:Alias>FLJ38139</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=1932"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>HCGP-3P</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:225</ns1:URN>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>CGP-39</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/952">
    <ns1:Phase>Two</ns1:Phase>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>signal recognition particle 54kDa</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/6729"/>
    <ns1:Alias>signal recognition particle 54 kDa protein</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Title>SRP54</ns1:Title>
    <ns1:URN>urn:edrn:bmdb:biomarker:952</ns1:URN>
    <ns1:Alias>signal recognition particle 54kD</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P61011"/>
    <ns1:Alias>SRP54</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SRP54&amp;search=srp54"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=11301"/>
    <ns1:Description>SRP54, or signal recognition particle 54kDa, contains a 7S RNA molecule of 300 nucleotides and six protein subunits.  SRP54 binds to the signal sequence of presecretory proteins as they emerge from the ribosomes and transfers them to a translocating chain-associating membrane protein.</ns1:Description>
    <ns1:Security>Public</ns1:Security>
    <ns1:HgncName>SRP54</ns1:HgncName>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/393">
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=19305"/>
    <ns1:Alias>MST103</ns1:Alias>
    <ns1:Alias>Zinc transporter 6</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/55676"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q6NXT4"/>
    <ns1:HgncName>SLC30A6</ns1:HgncName>
    <ns1:Alias>OTTHUMP00000201178</ns1:Alias>
    <ns1:Alias>MSTP103</ns1:Alias>
    <ns1:Alias>OTTHUMP00000201177</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Solute carrier family 30 member 6</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>MGC45055</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:393</ns1:URN>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC30A6&amp;search=slc30a6"/>
    <ns1:Alias>solute carrier family 30 (zinc transporter), member 6</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Description>SLC30A6 is a zinc-efflux transporter which has been shown by similarity to be involved in distributing the cytoplasmic zinc to the trans-Golgi network (TGN) as well as the vesicular compartment.  SLC30A6, a member of the zinc transporter (ZNT)/SLC30 subfamily of the cation diffusion facilitator family, permits cellular efflux of zinc.</ns1:Description>
    <ns1:Alias>ZNT6</ns1:Alias>
    <ns1:Alias>FLJ31101</ns1:Alias>
    <ns1:Title>SLC30A6</ns1:Title>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>Q6NXT4</ns1:Alias>
    <ns1:Alias>OTTHUMP00000201174</ns1:Alias>
    <ns1:Alias>OTTHUMP00000158572</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>SLC30A6</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/392">
    <ns1:Alias>protein transport protein Sec23B</ns1:Alias>
    <ns1:HgncName>SEC23B</ns1:HgncName>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/10483"/>
    <ns1:Title>SEC23B</ns1:Title>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>HEMPAS</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=10702"/>
    <ns1:Alias>transport protein SEC23B</ns1:Alias>
    <ns1:Alias>SEC23B</ns1:Alias>
    <ns1:Alias>Sec23 (S. cerevisiae) homolog B</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Description>SEC23B is a member of the SEC23B/SEC24B family.  SEC23B is a component of the COPII coat, that covers ER-derived vesicles involved in transport from the endoplasmic reticulum to the Golgi apparatus.  By similarity, it has been shown that COPII acts in the cytoplasm to promote the transport of secretory, plasma membrane, and vacuolar proteins from the endoplasmic reticulum to the Golgi complex.</ns1:Description>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>congenital dyserythropoietic anemia, type II</ns1:Alias>
    <ns1:Alias>SEC23-related protein B</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:URN>urn:edrn:bmdb:biomarker:392</ns1:URN>
    <ns1:Alias>CDAN2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/index.php?path=/Search/keyword/sec23b"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>CDAII</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>SEC23-like protein B</ns1:Alias>
    <ns1:Alias>Sec23 homolog B (S. cerevisiae)</ns1:Alias>
    <ns1:Alias>Q15437</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q15437"/>
    <ns1:Alias>CDA-II</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/376">
    <ns1:Alias>GPM6B</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>M6B</ns1:Alias>
    <ns1:Title>GPM6B</ns1:Title>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>MGC17150</ns1:Alias>
    <ns1:Alias>MGC54284</ns1:Alias>
    <ns1:Alias>M6b</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>neuronal membrane glycoprotein M6-b</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>glycoprotein M6B</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q13491"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:376</ns1:URN>
    <ns1:HgncName>GPM6B</ns1:HgncName>
    <ns1:Alias>protolipid M6B</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>GPM6B is a membrane glycoprotein belonging to the proteolipid protein family.  It is thought to be involved in neural development.  This protein family is expressed in the brain and may be involved in cellular housekeeping functions.  GPM6B is involved in the regulation of osteoblast function and bone formation and matrix vesicle release by osteoblasts.  GPM6B may be involved in cellular trafficking of SERT and thereby in regulation of serotonin uptake.</ns1:Description>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=4461"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=GPM6B&amp;search=gpm6b"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/193"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>Q13491</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/2824"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/215"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/366">
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q8IUX8"/>
    <ns1:Alias>W80</ns1:Alias>
    <ns1:Alias>epidermal growth factor-like protein 6</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>EGF-like protein 6</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/197"/>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=EGFL6&amp;search=egfl6"/>
    <ns1:HgncName>EGFL6</ns1:HgncName>
    <ns1:Description>EGFL6 is a member of the epidermal growth factor (EGF) repeat superfamily.  This family is characterized by EGF-like repeats.  Members are involved in the regulation of cell cycle, proliferation, and developmental processes.  The presence of a signal peptide indicates it is a secreted protein.  The EGFL6 gene is expressed during early development.</ns1:Description>
    <ns1:Alias>EGF repeat-containing protein 6</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>EGF-like-domain, multiple 6</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Title>EGFL6</ns1:Title>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/196"/>
    <ns1:Alias>MAM and EGF domain containing</ns1:Alias>
    <ns1:Alias>MAM and EGF domains-containing gene protein</ns1:Alias>
    <ns1:Alias>EGFL6</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/25975"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:366</ns1:URN>
    <ns1:Alias>MAEG</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=3235"/>
    <ns1:Alias>Q8IUX8</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/912">
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>NERF-1A</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>EU32</ns1:Alias>
    <ns1:Alias>New ETS-related factor</ns1:Alias>
    <ns1:HgncName>ELF2</ns1:HgncName>
    <ns1:Alias>E74-like factor 2 (ets domain transcription factor)</ns1:Alias>
    <ns1:Alias>ETS-related transcription factor Elf-2</ns1:Alias>
    <ns1:Alias>NERF-1a,b</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:912</ns1:URN>
    <ns1:Alias>NERF</ns1:Alias>
    <ns1:Alias>NERF-1B</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>E74-like factor 2</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>new Ets-related factor</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q15723"/>
    <ns1:Alias>ELF2</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3317"/>
    <ns1:Title>ELF2</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ELF2&amp;search=elf2"/>
    <ns1:Alias>ets family transcription factor ELF2C</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Description>ELF2 is a nuclear protein that is conserved across several species.  Multiple isoforms have been identified.  Isoform 1 transcriptionally activates the LYN and BLK promoters and acts synergistically with RUNX1 to transactivate the BLK promoter, while isoform 2 is thought to function in repression of RUNX1-mediated transactivation.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1998"/>
    <ns1:Alias>NERF-2</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/951">
    <ns1:Alias>small nuclear ribonucleoprotein polypeptide A'</ns1:Alias>
    <ns1:Alias>U2 snRNP A'</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/6627"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>Lea1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SNRPA1&amp;search=snrpa1"/>
    <ns1:Alias>U2 small nuclear ribonucleoprotein A'</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Description>SNRPA1 is a nuclear protein associated with sn-RNP U2. It helps the A' protein to bind stem loop IV of U2 snRNA. SNRPA1 has four LRR (leucine-rich) repeats and one LRRCT domain.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=11152"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:HgncName>SNRPA1</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:951</ns1:URN>
    <ns1:Alias>SNRPA1</ns1:Alias>
    <ns1:Alias>U2 small nuclear ribonucleoprotein polypeptide A'</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P09661"/>
    <ns1:Title>SNRPA1</ns1:Title>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/370">
    <ns1:Alias>four-jointed protein homolog</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>Four-jointed protein homolog</ns1:Alias>
    <ns1:Alias>FLJ25593</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:370</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/pubmed/?term=21617380"/>
    <ns1:Title>FJX1</ns1:Title>
    <ns1:HgncName>FJX1</ns1:HgncName>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Q86VR8</ns1:Alias>
    <ns1:Description>FJX1 is the human ortholog of mouse and Drosophila four-jointed gene product. The Drosophila protein is important for growth and differentiation of legs and wings, and for proper development of the eyes.  It is predicted, based on similarity, that human FJX1 may act as an inhibitor of dendrite extension and branching.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Alias>FLJ22416</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=17166"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/24147"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>FJX1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=FJX1&amp;search=fjx1"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>four jointed box 1 (Drosophila)</ns1:Alias>
    <ns1:Alias>putative secreted ligand homologous to fjx1</ns1:Alias>
    <ns1:Alias>four-jointed box protein 1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/566">
    <ns1:Alias>Autocrine motility factor receptor, isoform 2</ns1:Alias>
    <ns1:Alias>autocrine motility factor receptor</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>EC 6.3.2.-</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>RING finger protein 45</ns1:Alias>
    <ns1:Alias>gp78</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Description>autocrine motility factor receptor, E3 ubiquitin protein ligase</ns1:Description>
    <ns1:Title>AMFR</ns1:Title>
    <ns1:Alias>AMFR</ns1:Alias>
    <ns1:Alias>AMF receptor, isoform 2</ns1:Alias>
    <ns1:Alias>RNF45</ns1:Alias>
    <ns1:Alias>E3 ubiquitin-protein ligase AMFR</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9UKV5"/>
    <ns1:Alias>autocrine motility factor receptor, E3 ubiquitin protein ligase</ns1:Alias>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>GP78</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=463"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/267"/>
    <ns1:Alias>AMF receptor, isoform 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/603243?search=603243&amp;highlight=603243"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:566</ns1:URN>
    <ns1:HgncName>AMFR</ns1:HgncName>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/961">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=UPP1&amp;search=upp1"/>
    <ns1:Alias>EC 2.4.2.3</ns1:Alias>
    <ns1:Alias>urdPase 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Description>UPP1, or uridine phosphorylase 1, is a pyrimidine nucleoside phosphorylase.  UPP1, in the presence of orthophosphate, catalyzes the reversible phosphorylytic cleavage of uridine and deoxyuridine to uracil and ribose- or deoxyribose-1-phosphate. Pyrimidine nucleoside phosphorylases can add ribose or deoxyribose to pyrimidine bases to form nucleosides that can be incorporated into RNA or DNA.</ns1:Description>
    <ns1:Alias>UDRPASE</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=12576"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7378"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:HgncName>UPP1</ns1:HgncName>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:961</ns1:URN>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>UrdPase 1</ns1:Alias>
    <ns1:Alias>UPP1</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>UPase 1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>UPASE</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q16831"/>
    <ns1:Alias>uridine phosphorylase</ns1:Alias>
    <ns1:Alias>UPP</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Title>UPP1</ns1:Title>
    <ns1:Alias>UP</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>uridine phosphorylase 1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/389">
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>FOLH2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=FOLH1B&amp;search=FOLH1B"/>
    <ns1:Alias>folate hydrolase 2</ns1:Alias>
    <ns1:Alias>folate hydrolase 1B</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>GCPIII</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9HBA9"/>
    <ns1:Alias>PSMA-LIKE</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>N-acetylated-alpha-linked-acidic dipeptidase</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>PSM</ns1:Alias>
    <ns1:Alias>cell growth-inhibiting gene 26 protein</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>FOLHP</ns1:Alias>
    <ns1:Alias>NAALADase</ns1:Alias>
    <ns1:Alias>prostate-specific membrane antigen-like protein</ns1:Alias>
    <ns1:Alias>EC 3.4.-.-</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/219595"/>
    <ns1:Alias>Q9HBA9</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>putative N-acetylated-alpha-linked acidic dipeptidase</ns1:Alias>
    <ns1:Alias>PSMAL</ns1:Alias>
    <ns1:Alias>putative folate hydrolase 1B</ns1:Alias>
    <ns1:Description>FOLH1B, or PSMAL, is a cytoplasmic protein.  It has been found in the kidney and liver, and has not been detected in the prostate. GO annotations related to this gene include metallopeptidase activity and dipeptidase activity.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=13636"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Putative folate hydrolase 1B</ns1:Alias>
    <ns1:Alias>glutamate carboxypeptidase III</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:389</ns1:URN>
    <ns1:HgncName>FOLH1B</ns1:HgncName>
    <ns1:Alias>folate hydrolase pseudogene</ns1:Alias>
    <ns1:Alias>GCP3</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Title>FOLH1B</ns1:Title>
    <ns1:Alias>FOLH1B</ns1:Alias>
    <ns1:Alias>Prostate-specific membrane antigen-like protein</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>Cell growth-inhibiting gene 26 protein</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/905">
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/53336"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>CT77</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:905</ns1:URN>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CPXCR1&amp;search=cpxcr1"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Cancer/testis antigen 77</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>CPX chromosome region, candidate 1</ns1:Alias>
    <ns1:Description>CPXCR1 is located in a region on the X chromosome that has been associated with X-linked cleft palate (CPX) disorder.  CPXCR1 contains a motif found in several zinc finger proteins.  Several alternatively spliced transcripts have been isolated, all encoding the same protein.</ns1:Description>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:HgncName>CPXCR1</ns1:HgncName>
    <ns1:Alias>CPX chromosomal region candidate gene 1 protein</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=2332"/>
    <ns1:Title>CPXCR1</ns1:Title>
    <ns1:Alias>CPXCR1</ns1:Alias>
    <ns1:Alias>cancer/testis antigen 77</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q8N123"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/923">
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/search?search_type=symbols&amp;search=itglb1&amp;submit=Submit"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>ten integrin EGF-like repeat domain-containing protein</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>integrin, beta-like 1 (with EGF-like repeat domains)</ns1:Alias>
    <ns1:Alias>ITGBL1</ns1:Alias>
    <ns1:Title>ITGBL1</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>OSCP</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/9358"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>integrin beta-like protein 1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>osteoblast-specific cysteine-rich protein</ns1:Alias>
    <ns1:HgncName>ITGBL1</ns1:HgncName>
    <ns1:Alias>Ten integrin EGF-like repeat domain-containing protein</ns1:Alias>
    <ns1:Alias>ten integrin EGF-like repeat domains protein</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Description>ITGBL1, or integrin, beta-like 1 (with EGF-like repeat domains), is a member of the EGF-like protein family.  It is a beta integrin-related protein containing integrin-like cysteine-rich repeats. Multiple transcript variants result from alternative splicing.</ns1:Description>
    <ns1:Alias>TIED</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:923</ns1:URN>
    <ns1:Alias>Osteoblast-specific cysteine-rich protein</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O95965"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ITGBL1&amp;search=itgbl1"/>
    <ns1:Type>Protein</ns1:Type>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/361">
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>SBP1</ns1:Alias>
    <ns1:Alias>Vps20-associated 1 homolog (S. cerevisiae)</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:361</ns1:URN>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9NP79"/>
    <ns1:Alias>SKD1-binding protein 1</ns1:Alias>
    <ns1:Alias>HSPC228</ns1:Alias>
    <ns1:Alias>My012</ns1:Alias>
    <ns1:Alias>LIP5</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=20954"/>
    <ns1:Alias>Dopamine-responsive gene 1 protein</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>homolog of mouse SKD1-binding protein 1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>C6orf55</ns1:Alias>
    <ns1:Alias>DRG1</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>chromosome 6 open reading frame 55</ns1:Alias>
    <ns1:Alias>DRG-1</ns1:Alias>
    <ns1:Description>VTA1 (C6ORF55) is involved in activities of the multivesicular body, an endosomal compartment involved in sorting membrane proteins for degradation in lysosomes.  VTA1 is thought to be a cofactor of VPS4A/B. VTA1 is involved in HIV-1 budding. It has been shown by similarity to be involved in the sorting and down-regulation of EGFR.</ns1:Description>
    <ns1:Alias>C6ORF55</ns1:Alias>
    <ns1:Alias>LYST-interacting protein 5</ns1:Alias>
    <ns1:Alias>dopamine-responsive gene 1 protein</ns1:Alias>
    <ns1:Alias>Q9NP79</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/51534"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=VTA1&amp;search=vta1"/>
    <ns1:Title>VTA1</ns1:Title>
    <ns1:HgncName>VTA1</ns1:HgncName>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>vacuolar protein sorting-associated protein VTA1 homolog</ns1:Alias>
    <ns1:Alias>VTA1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/943">
    <ns1:Title>RAB13</ns1:Title>
    <ns1:Alias>ras-related protein Rab-13</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:943</ns1:URN>
    <ns1:Alias>RAB13</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=RAB13&amp;search=rab13"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>growth-inhibiting gene 4 protein</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/5872"/>
    <ns1:Alias>RAS-associated protein RAB13</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>RAB13, member RAS oncogene family</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Cell growth-inhibiting gene 4 protein</ns1:Alias>
    <ns1:HgncName>RAB13</ns1:HgncName>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Description>RAB13 is a member of the Rab family of small G proteins and plays a role in regulating membrane trafficking between trans-Golgi network (TGN) and recycling endosomes (RE). RAB13 is thought to participate in polarized transport, in the assembly and/or the activity of tight junctions, which are components of the apical junctional complex (AJC) of epithelial cells.  There are several alternatively spliced transcript variants for this gene, and a pseudogene located on chromosome 12.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=9762"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P51153"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>cell growth-inhibiting gene 4 protein</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/229">
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000259384"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=4261"/>
    <ns1:Alias>Growth hormone 1</ns1:Alias>
    <ns1:HgncName>GH1</ns1:HgncName>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>GH-N</ns1:Alias>
    <ns1:Alias>Pituitary growth hormone</ns1:Alias>
    <ns1:Description>Growth hormone, a secreted protein which exists as a monomer, dimer, trimer, tetramer and pentamer and is disulfide-linked or non-covalently associated in homopolymeric and heteropolymeric combinations, plays an important role in growth control. Its major role in stimulating body growth is to stimulate the liver and other tissues to secrete IGF-1. It stimulates both the differentiation and proliferation of myoblasts. It also stimulates amino acid uptake and protein synthesis in muscle and other tissues. GH belongs to the somatotropin/prolactin family.</ns1:Description>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:229</ns1:URN>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>GH</ns1:Alias>
    <ns1:Alias>growth hormone 1</ns1:Alias>
    <ns1:Alias>Growth hormone</ns1:Alias>
    <ns1:Alias>GHN</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P01241"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Somatotropin</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Title>GH1</ns1:Title>
    <ns1:Alias>pituitary growth hormone</ns1:Alias>
    <ns1:Alias>hGH-N</ns1:Alias>
    <ns1:Alias>IGHD1B</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=GH1&amp;search=growth+hormone"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Alias>GH1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/2688"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/359">
    <ns1:Alias>CD353</ns1:Alias>
    <ns1:Title>SLAMF8</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:HgncName>SLAMF8</ns1:HgncName>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>CD353 antigen</ns1:Alias>
    <ns1:Alias>SLAM family member 8</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9P0V8"/>
    <ns1:Alias>Q9P0V8</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=21391"/>
    <ns1:Alias>BLAME</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:URN>urn:edrn:bmdb:biomarker:359</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SLAMF8&amp;search=blame"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>B lymphocyte activator macrophage expressed</ns1:Alias>
    <ns1:Description>SLAMF8 is a membrane protein belonging to the CD2 family of cell surface proteins.  This protein family is characterized by Ig domains. SLAMF8 is expressed in lymph node, spleen, thymus and bone marrow.  SLAMF8 may play a role in B-lineage commitment and/or modulation of signaling through the B-cell receptor.  There are two isoforms of this protein, produced by alternative splicing.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/56833"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>B-lymphocyte activator macrophage expressed</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Alias>SLAMF8</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>SBBI42</ns1:Alias>
    <ns1:Alias>BCM-like membrane protein</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/938">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:HgncName>PTCHD1</ns1:HgncName>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>PTCHD1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/139411"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=26392"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>FLJ30296</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q96NR3"/>
    <ns1:Title>PTCHD1</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>patched domain containing 1</ns1:Alias>
    <ns1:Description>PTCHD1 is a membrane protein with a patched domain that is similar to Drosophila proteins which act as receptors for the morphogen sonic hedgehog. Deletions in the PTCHD1 gene, which is located on the X
chromosome, are associated with intellectual disability and autism spectrum disorder.</ns1:Description>
    <ns1:URN>urn:edrn:bmdb:biomarker:938</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PTCHD1&amp;search=ptchd1"/>
    <ns1:Alias>patched domain-containing protein 1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/950">
    <ns1:Alias>D10S105E</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P16260"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>Mitochondrial solute carrier protein homolog</ns1:Alias>
    <ns1:Alias>graves disease autoantigen</ns1:Alias>
    <ns1:Alias>graves disease carrier protein</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>SLC25A16</ns1:Alias>
    <ns1:Alias>GDC</ns1:Alias>
    <ns1:Alias>HGT.1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=10986"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>solute carrier family 25 member 16</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>mitochondrial solute carrier protein homolog</ns1:Alias>
    <ns1:Alias>GDA</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8034"/>
    <ns1:Alias>Graves disease autoantigen</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Solute carrier family 25 member 16</ns1:Alias>
    <ns1:Alias>ML7</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Description>SLC25A16 is a member of the mitochondrial carrier family and contains three tandemly repeated mitochondrial carrier protein domains.  The SLC26A16 protein is found in the inner membrane of the mitochondria where it is necessary     for the accumulation of coenzyme A in the mitochondrial matrix. SLC25A16 also facilitates the rapid transport and exchange of molecules between the cytosol and the mitochondrial matrix space. The SLC25A16 gene is thought to be involved in Graves' disease.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>hML7</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Title>SLC25A16</ns1:Title>
    <ns1:URN>urn:edrn:bmdb:biomarker:950</ns1:URN>
    <ns1:HgncName>SLC25A16</ns1:HgncName>
    <ns1:Alias>solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC25A16&amp;search=slc25a16"/>
    <ns1:Type>Protein</ns1:Type>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/897">
    <ns1:Alias>ATPase, H+ transporting, lysosomal (vacuolar proton pump), member J</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>ATP6G</ns1:Alias>
    <ns1:Alias>V-ATPase subunit G 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ATP6V1G1&amp;search=atp6v1g1"/>
    <ns1:Alias>ATP6GL</ns1:Alias>
    <ns1:Description>ATP6V1G1 is a subunit of vacuolar ATPase (V-ATPase), a multisubunit enzyme. V-ATPase is an enzyme transporter that functions to acidify intracellular compartments in eukaryotic cells. This acidification process is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is ubiquitously expressed and is present in endomembrane organelles such as vacuoles, lysosomes, endosomes, the Golgi apparatus, chromaffin granules and coated vesicles, as well as in the plasma membrane. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A, three B, and two G subunits, as well as a C, D, E, F, and H subunit. The V1 domain contains the ATP catalytic site.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O75348"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=864"/>
    <ns1:Alias>ATP6V1G1</ns1:Alias>
    <ns1:Alias>ATP6G1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:897</ns1:URN>
    <ns1:Alias>Vacuolar proton pump subunit G 1</ns1:Alias>
    <ns1:Title>ATP6V1G1</ns1:Title>
    <ns1:Alias>Vacuolar proton pump subunit M16</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>vacuolar proton pump subunit M16</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>V-ATPase 13 kDa subunit 1</ns1:Alias>
    <ns1:Alias>DKFZp547P234</ns1:Alias>
    <ns1:Alias>vacuolar H(+)-ATPase subunit G 1</ns1:Alias>
    <ns1:Alias>ATP6J</ns1:Alias>
    <ns1:Alias>ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1</ns1:Alias>
    <ns1:HgncName>ATP6V1G1</ns1:HgncName>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>Vma10</ns1:Alias>
    <ns1:Alias>vacuolar proton pump subunit G 1</ns1:Alias>
    <ns1:Alias>ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G isoform 1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/9550"/>
    <ns1:Alias>vacuolar ATP synthase subunit M16</ns1:Alias>
    <ns1:Alias>V-type proton ATPase subunit G 1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/640">
    <ns1:Description>From NCBI Gene: This gene encodes a protein that belongs to an ETS transcription factor subfamily characterized by epithelial-specific expression (ESEs). The encoded protein acts as a transcriptional repressor and may be involved in epithelial differentiation and carcinogenesis. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2011]</ns1:Description>
    <ns1:Alias>Epithelium-specific Ets transcription factor 3</ns1:Alias>
    <ns1:Alias>ETS homologous factor</ns1:Alias>
    <ns1:Alias>ETS domain-containing transcription factor</ns1:Alias>
    <ns1:Alias>ESEJ</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>ESE3B</ns1:Alias>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>ets homologous factor</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Alias>ESE3</ns1:Alias>
    <ns1:Alias>EHF</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9NZC4"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/605439"/>
    <ns1:Title>EHF</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3246"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>ESE-3</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:HgncName>EHF</ns1:HgncName>
    <ns1:Alias>hEHF</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/26298"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>ESE3 transcription factor</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:640</ns1:URN>
    <ns1:Alias>epithelium-specific Ets transcription factor 3</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/238">
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P05231"/>
    <ns1:Alias>IFN-beta-2</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Title>IL6</ns1:Title>
    <ns1:Alias>B-cell stimulatory factor 2</ns1:Alias>
    <ns1:Alias>Hybridoma growth factor</ns1:Alias>
    <ns1:Alias>IFNB2</ns1:Alias>
    <ns1:Alias>BSF-2</ns1:Alias>
    <ns1:Alias>HGF</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/176"/>
    <ns1:Description>Interleukin 6 (IL6) is a cytokine that is involved in inflammation and the maturation of B cells as well as induction of the acute phase response.  In addition to inducing myeloma and plasmacytoma growth and nerve cell differentiation, it also plays an important role in the differentiation of B-cells into Ig-secreting cells involved in lymphocyte and monocyte differentiation.  The IL6 protein is produced mainly at sites of acute and chronic inflammation, where it is secreted into the serum and induces a transcriptional inflammatory response through interleukin 6 receptor, alpha.  The IL6 gene is involved in many inflammation-associated disease states, including diabetes mellitus, where it acts on insulin resistance, and systemic juvenile rheumatoid arthritis.  IL6 is discharged into the bloodstream after muscle contraction.</ns1:Description>
    <ns1:Alias>CTL differentiation factor</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>HSF</ns1:Alias>
    <ns1:HgncName>IL6</ns1:HgncName>
    <ns1:Alias>interleukin 6 (interferon, beta 2)</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>IL-6</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6018"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:238</ns1:URN>
    <ns1:Alias>Interferon beta-2</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>B-cell differentiation factor</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>B cell stimulatory factor-2</ns1:Alias>
    <ns1:Alias>IL6</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>CDF</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:3569"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>BSF2</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000591.1"/>
    <ns1:Alias>Interleukin 6</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/19">
    <ns1:Alias>PIVKA II</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:HgncName></ns1:HgncName>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Title>DCP</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/132"/>
    <ns1:AccessGrantedTo>G.I. and Other Associated</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>DCP</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/34"/>
    <ns1:Alias>Prothrombin Induced by Vitamin K Absence II</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/33"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:19</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=2795"/>
    <ns1:Description>Des-gamma-carboxy prothrombin (DCP) is a non-functional precursor of prothrombin.  Prothrombin, produced by the liver, serves a critical role in normal hemostasis. Functional prothrombin contains several gamma-carboxy-glutamic acid (Gla) residues that are produced as the result of post-translational modification of glutamic acid residues mediated by vitamin K dependent gamma-glutamyl carboxylase. The formation of Gla residues can be impaired in patients with vitamin K deficiency or in patients receiving oral anticoagulant therapy. DCP lacks thrombotic activity and has been shown in multiple studies to be present in the serum of patients with HCC. DCP arises from an acquired defect in the post-translational carboxylation of the pro-thrombin precursor in malignant hepatocytes.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.med.umich.edu/gi/staff/Marrero.htm"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/23"/>
    <ns1:Alias>Des-gamma carboxyprothrombin</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/893">
    <ns1:Alias>anoctamin-1</ns1:Alias>
    <ns1:Alias>DOG1</ns1:Alias>
    <ns1:Alias>TMEM16A</ns1:Alias>
    <ns1:Alias>Transmembrane protein 16A</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q5XXA6"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Title>ANO1</ns1:Title>
    <ns1:Alias>FLJ10261</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:893</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>tumor-amplified and overexpressed sequence 2</ns1:Alias>
    <ns1:Alias>transmembrane protein 16A (eight membrane-spanning domains)</ns1:Alias>
    <ns1:Description>ANO1, or anoctamin-1, is a calcium-activated chloride channel gene overexpressed in many tumors.  ANO1 is ubiquitously expressed in epithelia and is thought to be important in epithelial fluid transport.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/55107"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Oral cancer overexpressed protein 2</ns1:Alias>
    <ns1:Alias>ORAOV2</ns1:Alias>
    <ns1:Alias>ANO1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=21625"/>
    <ns1:Alias>anoctamin 1, calcium activated chloride channel</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/216"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>oral cancer overexpressed 2</ns1:Alias>
    <ns1:Alias>Discovered on gastrointestinal stromal tumors protein 1</ns1:Alias>
    <ns1:HgncName>ANO1</ns1:HgncName>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>TAOS2</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ANO1&amp;search=ano1"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>transmembrane protein 16A</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>Tumor-amplified and overexpressed sequence 2</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>discovered on gastrointestinal stromal tumors protein 1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/927">
    <ns1:Alias>MAGE3B antigen</ns1:Alias>
    <ns1:Description>The members of the MAGEA protein family display 50-80% sequence identity among their members.  MAGEA proteins are thought to play a role in tumor transformation or aspects of tumor progression. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. Alternative splicing results in multiple transcript variants.</ns1:Description>
    <ns1:Alias>cancer/testis antigen family 1, member 6</ns1:Alias>
    <ns1:Alias>Cancer/testis antigen 1.6</ns1:Alias>
    <ns1:Alias>melanoma-associated antigen 6</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>MAGE-6 antigen</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P43360"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:927</ns1:URN>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>MAGE3B</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>MAGE-3b</ns1:Alias>
    <ns1:Alias>cancer/testis antigen 1.6</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Title>MAGEA6</ns1:Title>
    <ns1:HgncName>MAGEA6</ns1:HgncName>
    <ns1:Alias>MAGEA6</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>CT1.6</ns1:Alias>
    <ns1:Alias>MAGE6</ns1:Alias>
    <ns1:Alias>melanoma antigen family A, 6</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6804"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MAGEA6&amp;search=magea6"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/4105"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/904">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>cytochrome c oxidase subunit VIIa-M</ns1:Alias>
    <ns1:Alias>Cytochrome c oxidase subunit VIIa-heart</ns1:Alias>
    <ns1:Alias>COX7A1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1346"/>
    <ns1:Alias>Cytochrome c oxidase subunit VIIa-muscle</ns1:Alias>
    <ns1:Alias>cytochrome c oxidase subunit 7A1, mitochondrial</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>Cytochrome c oxidase subunit VIIa-M</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>COX7A1, cytochrome c oxidase subunit VIIa polypeptide 1 (muscle), is one of the polypeptide chains of cytochrome c oxidase, the terminal component of the mitochondrial respiratory chain.  This polypeptide is present only in muscle tissues. Other polypeptides of subunit VIIa are present in both muscle and nonmuscle tissues, and are encoded by different genes.</ns1:Description>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P24310"/>
    <ns1:Alias>cytochrome c oxidase subunit VIIa heart/muscle isoform</ns1:Alias>
    <ns1:Alias>cytochrome c oxidase subunit VIIa-heart</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=COX7A1&amp;search=cox7a1"/>
    <ns1:HgncName>COX7A1</ns1:HgncName>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=2287"/>
    <ns1:Alias>COX7A</ns1:Alias>
    <ns1:Alias>cytochrome c oxidase subunit VIIa-muscle</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>COX7AH</ns1:Alias>
    <ns1:Alias>cytochrome c oxidase subunit VIIa polypeptide 1 (muscle)</ns1:Alias>
    <ns1:Alias>cytochrome c oxidase subunit VIIa-H</ns1:Alias>
    <ns1:Alias>Cytochrome c oxidase subunit VIIa-H</ns1:Alias>
    <ns1:Title>COX7A1</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>COX7AM</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:904</ns1:URN>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/82">
    <ns1:Alias>FLJ44734</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>Somatomedin-A</ns1:Alias>
    <ns1:Title>IGF2</ns1:Title>
    <ns1:Description>IGF2 is a member of the insulin family of polypeptide growth factors that is involved in development and growth. The IGF2 gene is an imprinted gene and is expressed only from the paternally inherited allele. It is a candidate gene for eating disorders. There is a read-through, INS-IGF2, which aligns to this gene at the 3' region and to the upstream INS gene at the 5' region. Alternatively spliced transcript variants, encoding either the same or different isoform, have been found for this gene. IGF2 is influenced by placental lactogen and may play a role in fetal development.</ns1:Description>
    <ns1:Alias>FLJ22066</ns1:Alias>
    <ns1:Alias>pp9974</ns1:Alias>
    <ns1:Alias>insulin-like growth factor 2 (somatomedin A)</ns1:Alias>
    <ns1:Alias>IGF2</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=5466"/>
    <ns1:AccessGrantedTo>Mor Yale University</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>IGF-II</ns1:Alias>
    <ns1:Alias>PP1446</ns1:Alias>
    <ns1:Alias>INSIGF</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P35858"/>
    <ns1:Alias>C11orf43</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:3481"/>
    <ns1:Alias>chromosome 11 open reading frame 43</ns1:Alias>
    <ns1:Alias>Insulin-like growth factor II</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:URN>urn:edrn:bmdb:biomarker:82</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/254"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:HgncName>IGF2</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000603.1"/>
    <ns1:Security>Public</ns1:Security>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/911">
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>EPH-related receptor tyrosine kinase ligand 7</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>EFL5</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=EFNA5&amp;search=efna5"/>
    <ns1:Alias>AF1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3225"/>
    <ns1:Title>EFNA5</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1946"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>AL-1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Description>EFNA5 is a cell surface-bound member of the ephrin gene family.  Ephrins are proteins that function as ligands for the ephrin receptors (Eph receptors). Eph receptors are a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins.</ns1:Description>
    <ns1:URN>urn:edrn:bmdb:biomarker:911</ns1:URN>
    <ns1:Alias>RAGS</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>eph-related receptor tyrosine kinase ligand 7</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P52803"/>
    <ns1:HgncName>EFNA5</ns1:HgncName>
    <ns1:Alias>LERK7</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>GLC1M</ns1:Alias>
    <ns1:Alias>EFNA5</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>ephrin-A5</ns1:Alias>
    <ns1:Alias>LERK-7</ns1:Alias>
    <ns1:Alias>EPLG7</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/163">
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/4053"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Latent-transforming growth factor beta-binding protein 2</ns1:Alias>
    <ns1:Alias>latent transforming growth factor beta binding protein 2</ns1:Alias>
    <ns1:Alias>LTBP2</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:HgncName>LTBP2</ns1:HgncName>
    <ns1:Alias>MSTP031</ns1:Alias>
    <ns1:AccessGrantedTo>Diamandis Mount Sinai Hospital</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>LTBP3</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6715"/>
    <ns1:Alias>C14orf141</ns1:Alias>
    <ns1:Description>LTBP2, the largest member of the latent transforming growth factor (TGF)-beta binding protein family, possesses unique regions and is most similar to the fibrillins. It has thus been suggested that it may have multiple functions: as a member of the TGF-beta latent complex, as a structural component of microfibrils, and a role in cell adhesion. LTBP2 forms part of the large latent transforming growth factor beta precursor complex; removal is essential for activation of complex. It is expressed in lung, weakly expressed in heart, placenta, liver and skeletal muscle.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=LTBP2&amp;search=ltbp2"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>LTBP-2</ns1:Alias>
    <ns1:Title>LTBP2</ns1:Title>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q14767"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:163</ns1:URN>
    <ns1:Alias>chromosome 14 open reading frame 141</ns1:Alias>
    <ns1:Alias>GLC3D</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/929">
    <ns1:Alias>SMC-CF</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:929</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Monocyte chemotactic protein 1</ns1:Alias>
    <ns1:Alias>monocyte chemoattractant protein 1</ns1:Alias>
    <ns1:Alias>GDCF-2</ns1:Alias>
    <ns1:Description>From NCBI Gene: This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Chemokines are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of N-terminal cysteine residues of the mature peptide. This chemokine is a member of the CC subfamily which is characterized by two adjacent cysteine residues. This cytokine displays chemotactic activity for monocytes and basophils but not for neutrophils or eosinophils. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It binds to chemokine receptors CCR2 and CCR4. [provided by RefSeq, Jul 2013]</ns1:Description>
    <ns1:Title>CCL2</ns1:Title>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>MCAF</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>C-C motif chemokine 2</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>Monocyte secretory protein JE</ns1:Alias>
    <ns1:Alias>SCYA2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P13500"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>Monocyte chemoattractant protein 1</ns1:Alias>
    <ns1:Alias>chemokine (C-C motif) ligand 2</ns1:Alias>
    <ns1:Alias>Small-inducible cytokine A2</ns1:Alias>
    <ns1:Alias>small-inducible cytokine A2</ns1:Alias>
    <ns1:Alias>HSMCR30</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=10618"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>small inducible cytokine A2 (monocyte chemotactic protein 1, homologous to mouse Sig-je)</ns1:Alias>
    <ns1:Alias>monocyte secretory protein JE</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL2&amp;search=ccl2"/>
    <ns1:HgncName>CCL2</ns1:HgncName>
    <ns1:Alias>MCP-1</ns1:Alias>
    <ns1:Alias>monocyte chemoattractant protein-1</ns1:Alias>
    <ns1:Alias>monocyte chemotactic protein 1</ns1:Alias>
    <ns1:Alias>MCP1</ns1:Alias>
    <ns1:Alias>small inducible cytokine subfamily A (Cys-Cys), member 2</ns1:Alias>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>monocyte chemotactic and activating factor</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/6347"/>
    <ns1:Alias>Monocyte chemotactic and activating factor</ns1:Alias>
    <ns1:Alias>CCL2</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>HC11</ns1:Alias>
    <ns1:Alias>MGC9434</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/903">
    <ns1:Alias>cortical thymocyte antigen CD1A</ns1:Alias>
    <ns1:Alias>hTa1 thymocyte antigen</ns1:Alias>
    <ns1:Alias>differentiation antigen CD1-alpha-3</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Description>CD1A is a transmembrane glycoprotein that is structurally related to the major histocompatibility complex (MHC) proteins and forms heterodimers with beta-2-microglobulin.  CD1A functions as an     antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells.</ns1:Description>
    <ns1:Alias>CD1</ns1:Alias>
    <ns1:Alias>T6</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:903</ns1:URN>
    <ns1:Alias>CD1A antigen, a polypeptide</ns1:Alias>
    <ns1:Alias>HTA1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>epidermal dendritic cell marker CD1a</ns1:Alias>
    <ns1:Alias>R4</ns1:Alias>
    <ns1:Alias>T-cell surface antigen T6/Leu-6</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P06126"/>
    <ns1:Alias>FCB6</ns1:Alias>
    <ns1:Alias>CD1A</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=1634"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/909"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:HgncName>CD1A</ns1:HgncName>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>T-cell surface glycoprotein CD1a</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Title>CD1A</ns1:Title>
    <ns1:Alias>CD1a molecule</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CD1A&amp;search=cd1a"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>cluster of differentiation 1 A</ns1:Alias>
    <ns1:Alias>CD1a antigen</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/930">
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>c-myc binding protein</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q99417"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>MYCBP</ns1:Alias>
    <ns1:Alias>AMY1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:HgncName>MYCBP</ns1:HgncName>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=7554"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:930</ns1:URN>
    <ns1:Description>MYCBP, or MYC binding protein, or C-MYC binding protein, binds to the     N-terminus of the oncogenic protein MYC, also known as C-MYC, enhancing the ability of MYC to activate E box-dependent transcription. MYCBP is normally found in the cytoplasm, but it moves to the nucleus during the S phase of the cell cycle and associates with MYC.</ns1:Description>
    <ns1:Alias>associate of myc-1</ns1:Alias>
    <ns1:Alias>Associate of Myc 1</ns1:Alias>
    <ns1:Alias>AMY-1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/26292"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MYCBP&amp;search=mycBP"/>
    <ns1:Alias>C-Myc-binding protein</ns1:Alias>
    <ns1:Title>MYCBP</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/390">
    <ns1:Alias>secretoglobin, family 2A, member 1</ns1:Alias>
    <ns1:Alias>Secretoglobin family 2A member 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=7051"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>SCGB2A1</ns1:Alias>
    <ns1:Alias>MGB2</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Lipophilin-C</ns1:Alias>
    <ns1:Alias>LPHC</ns1:Alias>
    <ns1:Alias>mammaglobin-2</ns1:Alias>
    <ns1:Alias>lipophilin-C</ns1:Alias>
    <ns1:Alias>UGB3</ns1:Alias>
    <ns1:Title>SCGB2A1</ns1:Title>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O75556"/>
    <ns1:Alias>mammaglobin 2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/4246"/>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>mammaglobin-B</ns1:Alias>
    <ns1:Alias>lacryglobin</ns1:Alias>
    <ns1:Alias>Lacryglobin</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/196"/>
    <ns1:HgncName>SCGB2A1</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB2A1&amp;search=scgb2a1"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>lipophilin C</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Description>SCGB2A1, also known as MGB2 or mammaglobin B, encodes a small secreted protein from the secretoglobin family, part of the uterglobin superfamily.  SCGB2A1 is normally expressed in the thymus, trachea, kidney, steroid responsive tissues (prostate, testis, uterus, breast and ovary) and salivary gland.</ns1:Description>
    <ns1:Alias>LIPHC</ns1:Alias>
    <ns1:Alias>O75556</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/200"/>
    <ns1:Alias>MGC71973</ns1:Alias>
    <ns1:Alias>mammaglobin B</ns1:Alias>
    <ns1:Alias>Mammaglobin-2</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/201"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:390</ns1:URN>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/549">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/149"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/148"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>80-gene panel</ns1:Alias>
    <ns1:IsPanel>1</ns1:IsPanel>
    <ns1:Alias>Spira 80-marker panel plus clinical factors</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:HgncName></ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:549</ns1:URN>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Title>Spira 80-marker panel plus clinical factors</ns1:Title>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Description>This clinicogenomic model incorporates the gene expression pattern of histologcially normal large airway epithelial cells collected at time of bronchoscopy (see 'Spira 80-marker panel for lung cancer') with clinical parameters about lung cancer risk.</ns1:Description>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/957">
    <ns1:Alias>Toll/interleukin-1 receptor-like protein 4</ns1:Alias>
    <ns1:Alias>CD282</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>TIL4</ns1:Alias>
    <ns1:Description>TLR2, or toll-like receptor 2, is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLR2 is involved in the innate immune response to bacterial lipoproteins and other microbial cell wall components.  TLR2 also plays a role in NF-kappa-B activation, cytokine secretion and the inflammatory response.</ns1:Description>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=11848"/>
    <ns1:Alias>toll-like receptor 2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O60603"/>
    <ns1:Alias>TLR2</ns1:Alias>
    <ns1:Alias>toll/interleukin 1 receptor-like 4</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>CD282 antigen</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:957</ns1:URN>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:HgncName>TLR2</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=TLR2&amp;search=tlr2"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7097"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Title>TLR2</ns1:Title>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>toll/interleukin-1 receptor-like protein 4</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/228"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/138">
    <ns1:Title>PSAP</ns1:Title>
    <ns1:Alias>SAP1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>variant Gaucher disease and variant metachromatic leukodystrophy</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>prosaposin</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>FLJ00245</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>Proactivator polypeptide</ns1:Alias>
    <ns1:Alias>PSAP</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>sphingolipid activator protein-1</ns1:Alias>
    <ns1:Alias>MGC110993</ns1:Alias>
    <ns1:HgncName>PSAP</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:138</ns1:URN>
    <ns1:AccessGrantedTo>Diamandis Mount Sinai Hospital</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>GLBA</ns1:Alias>
    <ns1:Description>The PSAP gene encodes a highly conserved glycoprotein which is a precursor for 4 cleavage products: saposins A, B, C, and D. Each domain of the precursor protein is approximately 80 amino acid residues long with nearly identical placement of cysteine residues and glycosylation sites. Saposins A-D localize primarily to the lysosomal compartment where they facilitate the catabolism of glycosphingolipids with short oligosaccharide groups. The precursor protein exists both as a secretory protein and as an integral membrane protein and has neurotrophic activities. Mutations in this gene have been associated with Gaucher disease, Tay-Sachs disease, and metachromatic leukodystrophy. Alternative splicing results in multiple transcript variants encoding different isoforms.</ns1:Description>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/396">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:HgncName>TNFAIP1</ns1:HgncName>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7126"/>
    <ns1:Alias>BACURD2</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>EDP1</ns1:Alias>
    <ns1:Alias>MGC2317</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q13829"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Title>TNFAIP1</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Tumor necrosis factor, alpha-induced protein 1, endothelial</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=11894"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Protein B12</ns1:Alias>
    <ns1:Alias>protein 2</ns1:Alias>
    <ns1:Alias>BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>TNFAIP1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFAIP1&amp;search=tnfaip1"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase></ns1:Phase>
    <ns1:URN>urn:edrn:bmdb:biomarker:396</ns1:URN>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>B61</ns1:Alias>
    <ns1:Alias>tumor necrosis factor, alpha-induced protein 1</ns1:Alias>
    <ns1:Alias>Q13829</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>B12</ns1:Alias>
    <ns1:Alias>BTB/POZ domain-containing protein TNFAIP1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>hBACURD2</ns1:Alias>
    <ns1:Alias>OTTHUMP00000163324</ns1:Alias>
    <ns1:Description>The expression of this gene can be induced by the tumor necrosis factor alpha (TNF) in umbilical vein endothelial cells.  Mouse studies suggest the expression of this gene is developmentally regulated in a tissue-specific manner. Thought to be involved in regulation of cytoskeleton structure.</ns1:Description>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/941">
    <ns1:Alias>CD45 antigen</ns1:Alias>
    <ns1:Alias>B220</ns1:Alias>
    <ns1:Alias>L-CA</ns1:Alias>
    <ns1:Alias>T200 leukocyte common antigen</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=9666"/>
    <ns1:Alias>CD45R</ns1:Alias>
    <ns1:Alias>LY5</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P08575"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:941</ns1:URN>
    <ns1:HgncName>PTPRC</ns1:HgncName>
    <ns1:Alias>protein tyrosine phosphatase, receptor type, C</ns1:Alias>
    <ns1:Alias>CD45</ns1:Alias>
    <ns1:Alias>PTPRC</ns1:Alias>
    <ns1:Alias>T200 glycoprotein</ns1:Alias>
    <ns1:Alias>GP180</ns1:Alias>
    <ns1:Description>PTPRC is a member of the protein tyrosine phosphatase (PTP) family.  Members of the PTP family are signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitosis, and oncogenic transformation. PTPRC is required for T-cell activation through the antigen receptor. PTPRC     contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and is classified as a receptor type PTP.</ns1:Description>
    <ns1:Alias>Leukocyte common antigen</ns1:Alias>
    <ns1:Alias>EC 3.1.3.48</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>LCA</ns1:Alias>
    <ns1:Alias>T200</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>protein tyrosine phosphatase, receptor type, c polypeptide</ns1:Alias>
    <ns1:Alias>receptor-type tyrosine-protein phosphatase C</ns1:Alias>
    <ns1:Title>PTPRC</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PTPRC&amp;search=ptprc"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/5788"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/900">
    <ns1:Alias>CCL27</ns1:Alias>
    <ns1:Alias>CTACK</ns1:Alias>
    <ns1:Title>CCL27</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=10626"/>
    <ns1:Alias>Small-inducible cytokine A27</ns1:Alias>
    <ns1:Alias>small-inducible cytokine A27</ns1:Alias>
    <ns1:Alias>chemokine (C-C motif) ligand 27</ns1:Alias>
    <ns1:Alias>small inducible cytokine subfamily A (Cys-Cys), member 27</ns1:Alias>
    <ns1:Alias>PESKY</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>Skinkine</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Cutaneous T-cell-attracting chemokine</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL27&amp;search=ccl27"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:URN>urn:edrn:bmdb:biomarker:900</ns1:URN>
    <ns1:HgncName>CCL27</ns1:HgncName>
    <ns1:Alias>cutaneous T-cell-attracting chemokine</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/10850"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>SCYA27</ns1:Alias>
    <ns1:Alias>ESkine</ns1:Alias>
    <ns1:Alias>IL-11 R-alpha-locus chemokine</ns1:Alias>
    <ns1:Alias>ILC</ns1:Alias>
    <ns1:Description>CCL27 is a member of the CC cytokine family, and is involved in immunoregulatory and inflammatory processes.  CC cytokines are characterized by two adjacent cysteines.  CCL27 functions as a chemotactic factor that attracts skin-associated memory T-lymphocytes. CCL27 may also play a role in mediating homing of lymphocytes to cutaneous sites.  CCL27 binds specifically to chemokine receptor 10 (CCR10).</ns1:Description>
    <ns1:Alias>IL-11 Ralpha-locus chemokine</ns1:Alias>
    <ns1:Alias>CC chemokine ILC</ns1:Alias>
    <ns1:Alias>CTAK</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9Y4X3"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>ALP</ns1:Alias>
    <ns1:Alias>ESKINE</ns1:Alias>
    <ns1:Alias>cutaneous T-cell attracting chemokine</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>C-C motif chemokine 27</ns1:Alias>
    <ns1:Alias>skinkine</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/963">
    <ns1:Alias>exportin, tRNA (nuclear export receptor for tRNAs)</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Title>XPOT</ns1:Title>
    <ns1:Alias>exportin-T</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/11260"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=12826"/>
    <ns1:Alias>tRNA exportin</ns1:Alias>
    <ns1:HgncName>XPOT</ns1:HgncName>
    <ns1:Alias>Exportin(tRNA)</ns1:Alias>
    <ns1:Alias>XPO3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=XPOT&amp;search=xpot"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:963</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O43592"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>XPOT</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Description>XPOT, or exportin-T, belongs to the RAN-GTPase exportin family.  This protein facilitates export of tRNA from the nucleus to the cytoplasm. XPOT shuttles between the nucleus and the cytoplasm, transporting the aminoacylated tRNAs out of the nucleus, and returning back for another round.</ns1:Description>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>exportin(tRNA)</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/388">
    <ns1:Alias>O14917</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Title>PCDH17</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=14267"/>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>protocadherin 17</ns1:Alias>
    <ns1:Alias>Protocadherin-68</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>PCH68</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/27253"/>
    <ns1:HgncName>PCDH17</ns1:HgncName>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:388</ns1:URN>
    <ns1:Alias>protocadherin-17</ns1:Alias>
    <ns1:Alias>PCDH68</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>PCDH17</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O14917"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Description>PCDH17 is a member of the protocadherin gene family, a subfamily of the cadherin superfamily.  PCDH17 has six extracellular cadherin domains, a transmembrane domain, and a cytoplasmic tail which is different from those of the classical cadherins.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PCDH17&amp;search=pcdh17"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>protocadherin-68</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Alias>protocadherin 68</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/953">
    <ns1:Description>SSBP1 is a housekeeping gene that is thought to be involved in mitochondrial DNA replication.  SSBP1, or single-stranded DNA-binding protein binds to single stranded DNA.  It is also a subunit of a single-stranded DNA (ssDNA)-binding complex involved in the maintenance of genome stability.</ns1:Description>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>PWP1-interacting protein 17</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>MtSSB</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>single-stranded DNA binding protein 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:HgncName>SSBP1</ns1:HgncName>
    <ns1:Title>SSBP1</ns1:Title>
    <ns1:Security>Public</ns1:Security>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>SSBP1</ns1:Alias>
    <ns1:Alias>SSBP</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/6742"/>
    <ns1:Alias>single-stranded DNA-binding protein, mitochondrial</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q04837"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:953</ns1:URN>
    <ns1:Alias>single-stranded DNA binding protein 1, mitochondrial</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SSBP1&amp;search=ssbp1"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Mt-SSB</ns1:Alias>
    <ns1:Alias>single-stranded DNA-binding protein</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=11317"/>
    <ns1:Alias>SOSS-B1</ns1:Alias>
    <ns1:Alias>mtSSB</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/537">
    <ns1:HgncName>NID2</ns1:HgncName>
    <ns1:Alias>Osteonidogen</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:Description>NID2 is a member of the nidogen family of basement membrane proteins.  It is a cell adhesion glycoprotein that binds collagens I and IV and laminin.  NID2 may be involved in maintaining the structure of the basement membrane, and in cell-extracellular matrix interactions.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=13389"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:537</ns1:URN>
    <ns1:Alias>NID-2</ns1:Alias>
    <ns1:Alias>osteonidogen</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=NID2&amp;search=nid2"/>
    <ns1:Title>NID2</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/128"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>NID2</ns1:Alias>
    <ns1:Alias>nidogen-2</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q14112"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene?term=22795"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/145"/>
    <ns1:Alias>nidogen 2 (osteonidogen)</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/603">
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>CAP20</ns1:Alias>
    <ns1:Alias>p21Cip1/Waf1</ns1:Alias>
    <ns1:Alias>MDA6</ns1:Alias>
    <ns1:Title>CDKN1A</ns1:Title>
    <ns1:Alias>CDK-interaction protein 1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>p21</ns1:Alias>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>CDKN1A</ns1:Alias>
    <ns1:Alias>SDI1</ns1:Alias>
    <ns1:Alias>cyclin-dependent kinase inhibitor 1</ns1:Alias>
    <ns1:Alias>cyclin-dependent kinase inhibitor 1A (p21, Cip1)</ns1:Alias>
    <ns1:Alias>Melanoma differentiation-associated protein 6</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P38936"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>MDA-6</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Alias>PIC1</ns1:Alias>
    <ns1:Alias>DNA synthesis inhibitor</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>CDK-interacting protein 1</ns1:Alias>
    <ns1:Alias>P21</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>CDKN1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=1784"/>
    <ns1:Alias>wild-type p53-activated fragment 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>CIP1</ns1:Alias>
    <ns1:Description>From NCBI Gene: This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]</ns1:Description>
    <ns1:URN>urn:edrn:bmdb:biomarker:603</ns1:URN>
    <ns1:Alias>p21CIP1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1026"/>
    <ns1:HgncName>CDKN1A</ns1:HgncName>
    <ns1:Alias>WAF1</ns1:Alias>
    <ns1:Alias>melanoma differentiation associated protein 6</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/116899"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/358">
    <ns1:Phase></ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>MCMP</ns1:Alias>
    <ns1:Alias>ADAM metallopeptidase domain 12</ns1:Alias>
    <ns1:Alias>ADAM12</ns1:Alias>
    <ns1:Alias>meltrin-alpha</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>a disintegrin and metalloproteinase domain 12 (meltrin alpha)</ns1:Alias>
    <ns1:HgncName>ADAM12</ns1:HgncName>
    <ns1:Alias>ADAM 12</ns1:Alias>
    <ns1:Alias>EC 3.4.24.-</ns1:Alias>
    <ns1:Alias>disintegrin and metalloproteinase domain-containing protein 12</ns1:Alias>
    <ns1:Title>ADAM12</ns1:Title>
    <ns1:Description>ADAM12 is a member of the ADAM (a disintegrin and metalloprotease) protein family.  ADAM family members are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions. ADAM12 has two alternatively spliced transcripts: a shorter secreted form and a longer membrane-bound form. The shorter form is found to stimulate myogenesis.</ns1:Description>
    <ns1:Alias>MLTN</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:358</ns1:URN>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>MCMPMltna</ns1:Alias>
    <ns1:Alias>O43184</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ADAM12&amp;search=adam12"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O43184"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>MLTNA</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=190"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8038"/>
    <ns1:Alias>Meltrin-alpha</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Security>Public</ns1:Security>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/898">
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/55024"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Title>BANK1</ns1:Title>
    <ns1:HgncName>BANK1</ns1:HgncName>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Security>Public</ns1:Security>
    <ns1:Description>BANK1 is a B-cell-specific scaffold protein that functions in B-cell receptor-induced calcium mobilization from intracellular stores.  It also promotes Lyn-mediated phosphorylation of IP3 receptors 1 and 2.  There are several transcript variants resulting from alternative splicing.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>BANK1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=BANK1&amp;search=bank1"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=18233"/>
    <ns1:Alias>BANK</ns1:Alias>
    <ns1:Alias>B-cell scaffold protein with ankyrin repeats 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q8NDB2"/>
    <ns1:Alias>FLJ20706</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:898</ns1:URN>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>B-cell scaffold protein with ankyrin repeats</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/886">
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/605066"/>
    <ns1:Alias>14-3-3E</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7531"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P62258"/>
    <ns1:Title>YWHAE</ns1:Title>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Alias>KCIP-1</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>14-3-3 protein epsilon</ns1:Alias>
    <ns1:Alias>protein kinase C inhibitor protein-1</ns1:Alias>
    <ns1:Alias>MDS</ns1:Alias>
    <ns1:Alias>14-3-3 epsilon</ns1:Alias>
    <ns1:Alias>tyrosine 3/tryptophan 5 -monooxygenase activation protein, epsilon polypeptide</ns1:Alias>
    <ns1:Phase>One</ns1:Phase>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:886</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=12851"/>
    <ns1:Alias>YWHAE</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:HgncName>YWHAE</ns1:HgncName>
    <ns1:Alias>FLJ45465</ns1:Alias>
    <ns1:Alias>mitochondrial import stimulation factor L subunit</ns1:Alias>
    <ns1:Alias>MDCR</ns1:Alias>
    <ns1:Description>tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/357">
    <ns1:HgncName>ACTR3</ns1:HgncName>
    <ns1:Alias>Actin-like protein 3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/10096"/>
    <ns1:Title>ACTR3</ns1:Title>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=170"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>ARP3 (actin-related protein 3, yeast) homolog</ns1:Alias>
    <ns1:Alias>actin-like protein 3</ns1:Alias>
    <ns1:Alias>actin-related protein 3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ACTR3&amp;search=actr3"/>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/?query=human+actr3&amp;sort=score"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>ACTR3</ns1:Alias>
    <ns1:Alias>ARP3</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Description>The ACTR3 protein is a component of the ARP2/3 complex, which is essential to cell shape and motility.</ns1:Description>
    <ns1:Alias>ARP3 actin-related protein 3 homolog (yeast)</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:357</ns1:URN>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>P61158</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1012">
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>H2BFA</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>H2B/k</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>H2BFH</ns1:Alias>
    <ns1:Alias>Histone 1, H2bi</ns1:Alias>
    <ns1:Alias>Histone Cluster 1, H2bi</ns1:Alias>
    <ns1:Alias>H2B/g</ns1:Alias>
    <ns1:Alias>Histone H2B.K</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>H2B/h</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8346"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=4756"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:1012</ns1:URN>
    <ns1:Alias>Histone H2B.L</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/602807"/>
    <ns1:Alias>Histone H2B.H</ns1:Alias>
    <ns1:HgncName>HIST1H2BI</ns1:HgncName>
    <ns1:Alias>H2B Histone Family, Member K</ns1:Alias>
    <ns1:Alias>H2B/a</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>HIST1H2BI</ns1:Alias>
    <ns1:Alias>H2BFL</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>histone cluster 1, H2bi</ns1:Description>
    <ns1:Alias>H2B/l</ns1:Alias>
    <ns1:Alias>Histone H2B.G</ns1:Alias>
    <ns1:Alias>Histone H2B.A</ns1:Alias>
    <ns1:Alias>H2BFG</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Title>HIST1H2BI</ns1:Title>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Histone H2B Type 1-C/E/F/G/I</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Alias>Histone H2B.1 A</ns1:Alias>
    <ns1:Alias>H2BFK</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P62807"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/234">
    <ns1:Alias>hK8</ns1:Alias>
    <ns1:Alias>PRSS19</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/192"/>
    <ns1:Alias>neuropsin</ns1:Alias>
    <ns1:Alias>Neuropsin</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000129455"/>
    <ns1:Alias>HNP</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Title>KLK8</ns1:Title>
    <ns1:Alias>KLK8</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/11202"/>
    <ns1:HgncName>KLK8</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:234</ns1:URN>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Serine protease 19</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6369"/>
    <ns1:Alias>kallikrein-related peptidase 8</ns1:Alias>
    <ns1:Alias>Ovasin</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>TADG14</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Tumor-associated differentially expressed gene 14 protein</ns1:Alias>
    <ns1:Alias>Serine protease TADG-14</ns1:Alias>
    <ns1:Alias>ovasin</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=KLK8&amp;search=klk8"/>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O60259"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>NP</ns1:Alias>
    <ns1:Description>KLK8, a member of the kallikrein subgroup of serine proteases, is capable of degrading a number of proteins such as casein, fibrinogen, kininogen, fibronectin and collagen type IV.  Kallikreins have been implicated in carcinogenesis, and some have potential as novel cancer and other disease biomarkers.  KLK8 is one of fifteen kallikrein subfamily members located in a cluster on chromosome 19.  The four isoforms of KLK8 are a result of alternate splicing of the gene.  The isoforms exhibit distinct patterns of expression that suggest roles in brain plasticity and ovarian cancer.</ns1:Description>
    <ns1:Alias>kallikrein 8 (neuropsin/ovasin)</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>NRPN</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/21">
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/191"/>
    <ns1:Alias>Neurosin</ns1:Alias>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BGWHCramerPLCOPhaseIIIAnalysis"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.expasy.org/cgi-bin/niceprot.pl?Q92876"/>
    <ns1:Alias>Serine protease 18</ns1:Alias>
    <ns1:AccessGrantedTo>Cramer Brigham and Women's Hospital</ns1:AccessGrantedTo>
    <ns1:Alias>Zyme</ns1:Alias>
    <ns1:Alias>Klk7</ns1:Alias>
    <ns1:Title>KLK6</ns1:Title>
    <ns1:Alias>kallikrein-related peptidase 6</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>PRSS9</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6367"/>
    <ns1:Alias>Bssp</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>Protease M</ns1:Alias>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N7b6860807fa94f448ae76ec860ba1d39">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/21/15"/>
        <rdf:_3 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/21/1006"/>
        <rdf:_2 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/21/43"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:Alias>HK-6</ns1:Alias>
    <ns1:Alias>SP59</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000167755"/>
    <ns1:Alias>Serine protease 9</ns1:Alias>
    <ns1:Alias>KLK-6</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>KLK6</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:URN>urn:edrn:bmdb:biomarker:21</ns1:URN>
    <ns1:Alias>Kallikrein-6</ns1:Alias>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/42"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/9"/>
    <ns1:Alias>PRSS18</ns1:Alias>
    <ns1:HgncName>KLK6</ns1:HgncName>
    <ns1:Description>Serine protease M expressed on epithelial cell surface and released in ECM. Tumor cells treated with a neutralizing KLK6 antibody migrate less than control cells, suggesting a role in invasion and metastasis. Overexpressed in primary breast tumors but not expressed in metastatic tumors.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:5653"/>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BGWHCramerPrePLCOPhaseIIAnalysis"/>
    <ns1:Phase></ns1:Phase>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/915">
    <ns1:Alias>APO-1</ns1:Alias>
    <ns1:Alias>FAS (Ab2)</ns1:Alias>
    <ns1:Alias>Delta Fas/APO-1/CD95</ns1:Alias>
    <ns1:Alias>apoptosis antigen 1</ns1:Alias>
    <ns1:Alias>CD95</ns1:Alias>
    <ns1:Alias>FAS</ns1:Alias>
    <ns1:Alias>TNFRSF6</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Title>FAS</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/355"/>
    <ns1:Alias>FAS1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=11920"/>
    <ns1:Alias>Fas AMA</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:915</ns1:URN>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>FAS 827dupA</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P25445"/>
    <ns1:Alias>tumor necrosis factor receptor superfamily member 6</ns1:Alias>
    <ns1:Alias>apoptosis-mediating surface antigen FAS</ns1:Alias>
    <ns1:Alias>tumor necrosis factor receptor superfamily, member 6</ns1:Alias>
    <ns1:Alias>ALPS1A</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>FAS (Ab1)</ns1:Alias>
    <ns1:Alias>APT1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=FAS&amp;search=fas"/>
    <ns1:Alias>Apoptosis-mediating surface antigen FAS</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>CD95 antigen</ns1:Alias>
    <ns1:Alias>FASLG receptor</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>FAS is a member of the TNF-receptor superfamily. The FAS protein is a  receptor for TNFSF6/FASLG and has been shown to play a central role in the physiological regulation of programmed cell death, and has been implicated in the pathogenesis of various malignancies and diseases of the immune system.     Several alternatively spliced transcript variants have been described, some of which are candidates for nonsense-mediated mRNA decay (NMD). The isoforms lacking the transmembrane domain may negatively regulate the apoptosis mediated by the full length isoform.</ns1:Description>
    <ns1:HgncName>FAS</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>Apo-1 antigen</ns1:Alias>
    <ns1:Alias>Fas (TNF receptor superfamily, member 6)</ns1:Alias>
    <ns1:Alias>FASTM</ns1:Alias>
    <ns1:Alias>APO-1 cell surface antigen</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/908">
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>TPR repeat protein 2</ns1:Alias>
    <ns1:Title>DNAJC7</ns1:Title>
    <ns1:Alias>dnaJ homolog subfamily C member 7</ns1:Alias>
    <ns1:Alias>TTC2</ns1:Alias>
    <ns1:HgncName>DNAJC7</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=12392"/>
    <ns1:Alias>DJC7</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q99615"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7266"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>TPR2</ns1:Alias>
    <ns1:Alias>tetratricopeptide repeat protein 2</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>DJ11</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=DNAJC7&amp;search=dnajc7"/>
    <ns1:Alias>DANJC7</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:URN>urn:edrn:bmdb:biomarker:908</ns1:URN>
    <ns1:Alias>tetratricopeptide repeat domain 2</ns1:Alias>
    <ns1:Description>DNAJC7 is a member of the DNAJ heat shock protein 40 family.  This family is characterized by two N-terminal tetratricopeptide repeat domains and a C-terminal DNAJ domain. DNAJC7 functions as a co-chaperone regulating the molecular chaperones HSP70 and HSP90 in folding of steroid receptors, such as the glucocorticoid receptor and the progesterone receptor.  There are pseudogenes of this gene on chromosomes 1 and 6.  Multiple transcript variants of DNAJC7 exist from alternate splicing.</ns1:Description>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Tetratricopeptide repeat protein 2</ns1:Alias>
    <ns1:Alias>DNAJC7</ns1:Alias>
    <ns1:Alias>DnaJ (Hsp40) homolog, subfamily C, member 7</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/499">
    <ns1:Title>Philips VOCs signature</ns1:Title>
    <ns1:URN>urn:edrn:bmdb:biomarker:499</ns1:URN>
    <ns1:Security>Public</ns1:Security>
    <ns1:IsPanel>1</ns1:IsPanel>
    <ns1:Phase></ns1:Phase>
    <ns1:HgncName></ns1:HgncName>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/157"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Type>Metabolomic</ns1:Type>
    <ns1:Alias>Philips VOCs signature</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>A combination of 22 breath volatile organic compounds (VOCs), predominantly alkanes, alkane derivatives, and benzene derivatives, that can discriminate between patients with and without lung cancer, regardless of stage (all p&lt;0.0003).</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/964">
    <ns1:Alias>NuBI1</ns1:Alias>
    <ns1:Alias>4930573H17Rik</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>Glioma-amplified sequence 41</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:964</ns1:URN>
    <ns1:Alias>glioma-amplified sequence 41</ns1:Alias>
    <ns1:Alias>nuMA-binding protein 1</ns1:Alias>
    <ns1:HgncName>YEATS4</ns1:HgncName>
    <ns1:Alias>NuMA-binding protein 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>NUBI-1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8089"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>YAF9</ns1:Alias>
    <ns1:Title>YEATS4</ns1:Title>
    <ns1:Alias>Gas41</ns1:Alias>
    <ns1:Alias>NuBI-1</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>glioma-amplified sequence-41</ns1:Alias>
    <ns1:Alias>YEATS4</ns1:Alias>
    <ns1:Alias>NuMA binding protein 1</ns1:Alias>
    <ns1:Description>YEATS4 has high sequence similarity to human MLLT1, and yeast and human MLLT3 proteins, both transcription factors, and is therefore hypothesized to be a transcription factor itself.  YEATS4 is thought to be required for RNA transcription. YEATS4 is also a component of the NuA4 histone acetyltransferase (HAT) complex.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=24859"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>YEATS domain containing 4</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O95619"/>
    <ns1:Alias>YEATS domain-containing protein 4</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>nuBI1</ns1:Alias>
    <ns1:Alias>B230215M10Rik</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>GAS41</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=YEATS4&amp;search=yeats4"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/552">
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Type>Proteomic</ns1:Type>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Title>Boeri miRNA signature of diagnosis of lung cancer</ns1:Title>
    <ns1:HgncName></ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/153"/>
    <ns1:Description>miRNA expression analyses in plasma samples collected 1-2 years before the onset of disease, at the time of CT detection and in disease-free smokers enrolled in the screening trial, resulted in the generation of miRNA signatures with strong predictive, diagnostic, and prognostic potential (area under the ROC curve &gt; or = 0.85).  The signature of diagnosis of lung cancer is comprised of 16 ratios composed from 13 miRNAs: 21, 92a, 140-3p, 17, 106a, 140-5p, 660, 19b, 451, 30c, 15b, 28-3p, 486-5p. (from PMID:21300873)</ns1:Description>
    <ns1:URN>urn:edrn:bmdb:biomarker:552</ns1:URN>
    <ns1:IsPanel>1</ns1:IsPanel>
    <ns1:Alias>Boeri miRNA signature of diagnosis of lung cancer</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/362">
    <ns1:HgncName>CDCP1</ns1:HgncName>
    <ns1:Alias>CD318</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CDCP1&amp;search=cdcp1"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>Q9H5V8</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:362</ns1:URN>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>CD318 antigen</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>Membrane glycoprotein gp140</ns1:Alias>
    <ns1:Alias>membrane glycoprotein gp140</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Subtractive immunization M plus HEp3-associated 135 kDa protein</ns1:Alias>
    <ns1:Alias>CUB domain containing protein 1</ns1:Alias>
    <ns1:Description>CDCP1 is a transmembrane protein containing three extracellular CUB domains. It is found to be overexpressed in colon and lung cancers. Its expression level is correlated with the metastatic ability of carcinoma cells. CDCP1 is located on the cell surface and may be involved in cell adhesion and cell matrix association.  Alternatively spliced transcript variants encoding distinct isoforms have been reported.</ns1:Description>
    <ns1:Alias>Transmembrane and associated with src kinases</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9H5V8"/>
    <ns1:Alias>CDCP1</ns1:Alias>
    <ns1:Alias>CUB domain-containing protein 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Alias>transmembrane and associated with src kinases</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=24357"/>
    <ns1:Alias>subtractive immunization M plus HEp3-associated 135 kDa protein</ns1:Alias>
    <ns1:Alias>TRASK</ns1:Alias>
    <ns1:Alias>SIMA135</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/64866"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Title>CDCP1</ns1:Title>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/498">
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=12680"/>
    <ns1:Alias>Vascular permeability factor</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=VEGFA&amp;search=human+vegf"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/106"/>
    <ns1:Description>Vascular endothelial growth factor (VEGFA or VEGF) is a growth factor and signaling protein involved in the regulation of angiogenesis,  vasculogenesis, and endothelial cell grown.  It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Three VEGFR isoforms have been identified in humans; VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGFR-2 mediates the majority of cellular responses to VEGF. VEGFR-1 is thought to modulate VEGFR-2 signaling or to act as a dummy/decoy receptor to sequester VEGF away from VEGFR-2.</ns1:Description>
    <ns1:Alias>vascular endothelial growth factor A</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7422"/>
    <ns1:Alias>VEGFA</ns1:Alias>
    <ns1:Alias>MVCD1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>VEGF</ns1:Alias>
    <ns1:HgncName>VEGFA</ns1:HgncName>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:Alias>VEGF-A</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P15692"/>
    <ns1:Title>VEGFA</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/233"/>
    <ns1:Alias>VPF</ns1:Alias>
    <ns1:Alias>vascular endothelial growth factor</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:498</ns1:URN>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/540">
    <ns1:Alias>melanoma adhesion molecule</ns1:Alias>
    <ns1:Alias>cell surface glycoprotein MUC18</ns1:Alias>
    <ns1:Alias>MUC18</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:540</ns1:URN>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>CD146 antigen</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Alias>cell surface glycoprotein P1H12</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>MCAM</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/128"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:6934"/>
    <ns1:Alias>Melanoma-associated antigen MUC18</ns1:Alias>
    <ns1:HgncName>MCAM</ns1:HgncName>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Description>From UniProtKB/Swiss-Prot: Plays a role in cell adhesion, and in cohesion of the endothelial monolayer at intercellular junctions in vascular tissue. Its expression may allow melanoma cells to interact with cellular elements of the vascular system, thereby enhancing hematogeneous tumor spread. Could be an adhesion molecule active in neural crest cells during embryonic development. Acts as surface receptor that triggers tyrosine phosphorylation of FYN and PTK2/FAK1, and a transient increase in the intracellular calcium concentration.</ns1:Description>
    <ns1:Alias>Melanoma cell adhesion molecule</ns1:Alias>
    <ns1:Title>MCAM</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>melanoma-associated antigen MUC18</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Gicerin</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/4162"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>Cell surface glycoprotein P1H12</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MCAM"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Alias>Melanoma-associated antigen A32</ns1:Alias>
    <ns1:Alias>melanoma cell adhesion molecule</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P43121"/>
    <ns1:Alias>melanoma-associated antigen A32</ns1:Alias>
    <ns1:Alias>S-endo 1 endothelial-associated antigen</ns1:Alias>
    <ns1:Alias>CD146</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/30">
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:1404"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:30</ns1:URN>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>HPLN1</ns1:Alias>
    <ns1:Alias>Proteoglycan link protein</ns1:Alias>
    <ns1:Alias>Cartilage link protein</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://ca.expasy.org/cgi-bin/niceprot.pl?P10915"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Title>HAPLN1</ns1:Title>
    <ns1:Alias>CRTL1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Hyaluronan and proteoglycan link protein 1 [Precursor]</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q8IYL9"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=2380"/>
    <ns1:Alias>cartilage linking protein 1</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:HgncName>HAPLN1</ns1:HgncName>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Pass New York University School of Medicine</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/22"/>
    <ns1:Alias>HAPLN1</ns1:Alias>
    <ns1:Description>This widely expressed protein stabilizes the aggregates of proteoglycan monomers with hyaluronic acid in the extracellular cartilage matrix.</ns1:Description>
    <ns1:Alias>LP</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/542">
    <ns1:Alias>Katacalcin</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Calcitonin 1</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:542</ns1:URN>
    <ns1:Title>CALCA</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Calcitonin</ns1:Alias>
    <ns1:Alias>CGRP</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Alpha-Type CGRP</ns1:Alias>
    <ns1:Alias>CGRP-1</ns1:Alias>
    <ns1:Alias>Calcitonin/Calcitonin-Related Polypeptide, Alpha</ns1:Alias>
    <ns1:Alias>CGRP1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Phase></ns1:Phase>
    <ns1:HgncName>CALCA</ns1:HgncName>
    <ns1:Description>From NCBI Gene: This gene encodes the peptide hormones calcitonin, calcitonin gene-related peptide and katacalcin by tissue-specific alternative RNA splicing of the gene transcripts and cleavage of inactive precursor proteins. Calcitonin is involved in calcium regulation and acts to regulate phosphorus metabolism. Calcitonin gene-related peptide functions as a vasodilator while katacalcin is a calcium-lowering peptide. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CALCA&amp;search=44254e68817007e1a192f8a1c333eaf8"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/128"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P06881"/>
    <ns1:Alias>KC</ns1:Alias>
    <ns1:Alias>CALCA</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Calcitonin Gene-Related Peptide I</ns1:Alias>
    <ns1:Alias>CT</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/796"/>
    <ns1:Alias>Calcitonin-Related Polypeptide Alpha</ns1:Alias>
    <ns1:Alias>CALC1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:1437"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/936">
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O96011"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>peroxisomal biogenesis factor 11B</ns1:Alias>
    <ns1:Alias>Peroxin-11B</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>peroxin-11B</ns1:Alias>
    <ns1:Alias>Peroxisomal biogenesis factor 11B</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Protein PEX11 homolog beta</ns1:Alias>
    <ns1:Alias>peroxisomal biogenesis factor 11 beta</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:936</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8799"/>
    <ns1:Description>PEX11B, or peroxisomal biogenesis factor 11 beta, is involved in peroxisomal proliferation and interacts with PEX19. PEX11B is located in the peroxisomal membrane and is thought to regulate peroxisome division by recruiting the dynamin-related GTPase DNM1L to the peroxisomal membrane.</ns1:Description>
    <ns1:Title>PEX11B</ns1:Title>
    <ns1:HgncName>PEX11B</ns1:HgncName>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>peroxisomal membrane protein 11B</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=8853"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PEX11B&amp;search=pex11b"/>
    <ns1:Alias>PEX11-BETA</ns1:Alias>
    <ns1:Alias>PEX11-beta</ns1:Alias>
    <ns1:Alias>protein PEX11 homolog beta</ns1:Alias>
    <ns1:Alias>PEX11B</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/551">
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/153"/>
    <ns1:Title>Boeri miRNA signature of risk for lung cancer</ns1:Title>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:IsPanel>1</ns1:IsPanel>
    <ns1:URN>urn:edrn:bmdb:biomarker:551</ns1:URN>
    <ns1:Security>Public</ns1:Security>
    <ns1:HgncName></ns1:HgncName>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Type>Proteomic</ns1:Type>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Description>miRNA expression analyses in plasma samples collected 1-2 years before the onset of disease, at the time of CT detection and in disease-free smokers enrolled in the screening trial, resulted in the generation of miRNA signatures with strong predictive, diagnostic, and prognostic potential (area under the ROC curve &amp;gt; or = 0.85).  The signature of diagnosis of lung cancer is comprised of 16 ratios composed from 13 miRNAs: 21, 92a, 140-3p, 17, 106a, 140-5p, 660, 19b, 451, 30c, 15b, 28-3p, 486-5p. (from PMID:21300873)</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Boeri miRNA signature of risk for lung cancer</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/945">
    <ns1:Alias>T-cell-specific protein RANTES</ns1:Alias>
    <ns1:Alias>T cell-specific protein P228</ns1:Alias>
    <ns1:Alias>Small-inducible cytokine A5</ns1:Alias>
    <ns1:Alias>CCL5</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/223"/>
    <ns1:Alias>regulated upon activation, normally T-expressed, and presumably secreted</ns1:Alias>
    <ns1:Alias>SISd</ns1:Alias>
    <ns1:Alias>SCYA5</ns1:Alias>
    <ns1:Alias>Eosinophil chemotactic cytokine</ns1:Alias>
    <ns1:Alias>TCP228</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>beta-chemokine RANTES</ns1:Alias>
    <ns1:Alias>EoCP</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL5&amp;search=ccl5"/>
    <ns1:Alias>C-C motif chemokine 5</ns1:Alias>
    <ns1:Alias>D17S136E</ns1:Alias>
    <ns1:Alias>t cell-specific protein P228</ns1:Alias>
    <ns1:Alias>T-cell specific protein p288</ns1:Alias>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:Title>CCL5</ns1:Title>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>eoCP</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>small inducible cytokine subfamily A (Cys-Cys), member 5</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=10632"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:Alias>SIS-delta</ns1:Alias>
    <ns1:Alias>small inducible cytokine A5 (RANTES)</ns1:Alias>
    <ns1:Alias>MGC17164</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>RANTES</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:HgncName>CCL5</ns1:HgncName>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>eosinophil chemotactic cytokine</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P13501"/>
    <ns1:Alias>small-inducible cytokine A5</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Description>From NCBI Gene: This gene is one of several chemokine genes clustered on the q-arm of chromosome 17. Chemokines form a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of the N-terminal cysteine residues of the mature peptide. This chemokine, a member of the CC subfamily, functions as a chemoattractant for blood monocytes, memory T helper cells and eosinophils. It causes the release of histamine from basophils and activates eosinophils. This cytokine is one of the major HIV-suppressive factors produced by CD8+ cells. It functions as one of the natural ligands for the chemokine receptor chemokine (C-C motif) receptor 5 (CCR5), and it suppresses in vitro replication of the R5 strains of HIV-1, which use CCR5 as a coreceptor. Alternative splicing results in multiple transcript variants that encode different isoforms. [provided by RefSeq, Jul 2013]</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/6352"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:945</ns1:URN>
    <ns1:Alias>chemokine (C-C motif) ligand 5</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1011">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P62807"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>H2B Histone Family, Member A</ns1:Alias>
    <ns1:Alias>Histone H2B.1 A</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Histone H2B.G</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Alias>H2B/l</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Histone H2B Type 1-C/E/F/G/I</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/602798"/>
    <ns1:Alias>Histone 1, H2bg</ns1:Alias>
    <ns1:Alias>H2B.1A</ns1:Alias>
    <ns1:Alias>Histone H2B.A</ns1:Alias>
    <ns1:Alias>Histone Cluster 1, H2bg</ns1:Alias>
    <ns1:Title>HIST1H2BG</ns1:Title>
    <ns1:Alias>Histone H2B.L</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Histone H2B.H</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=4746"/>
    <ns1:Description>histone cluster 1, H2bg</ns1:Description>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>H2B/g</ns1:Alias>
    <ns1:Alias>dJ221C16.8</ns1:Alias>
    <ns1:Alias>H2B/h</ns1:Alias>
    <ns1:Alias>H2B/a</ns1:Alias>
    <ns1:Alias>H2B/k</ns1:Alias>
    <ns1:Alias>H2BFA</ns1:Alias>
    <ns1:Alias>H2BFH</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Histone H2B.K</ns1:Alias>
    <ns1:Alias>HIST1H2BG</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8339"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:1011</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:HgncName>HIST1H2BG</ns1:HgncName>
    <ns1:Alias>H2BFK</ns1:Alias>
    <ns1:Alias>H2BFG</ns1:Alias>
    <ns1:Alias>H2BFL</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/960">
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=15473"/>
    <ns1:Alias>STK22C</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:960</ns1:URN>
    <ns1:Alias>serine/threonine-protein kinase 22C</ns1:Alias>
    <ns1:Alias>TSSK-3</ns1:Alias>
    <ns1:Alias>Testis-specific kinase 3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=TSSK3&amp;search=tssk3"/>
    <ns1:Alias>STK22D</ns1:Alias>
    <ns1:Title>TSSK3</ns1:Title>
    <ns1:Alias>testis-specific serine kinase 3</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q96PN8"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Description>TSSK3 is a testis-specific kinase that is thought to be involved in either germ cell differentiation or mature sperm function.</ns1:Description>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>testis-specific serine/threonine kinase 22C</ns1:Alias>
    <ns1:Alias>TSSK3</ns1:Alias>
    <ns1:Alias>testis-specific serine/threonine-protein kinase 3</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>serine/threonine kinase 22C (spermiogenesis associated)</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>testis-specific kinase 3</ns1:Alias>
    <ns1:Alias>Serine/threonine-protein kinase 22C</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>TSK3</ns1:Alias>
    <ns1:Alias>spermiogenesis associated 3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/81629"/>
    <ns1:HgncName>TSSK3</ns1:HgncName>
    <ns1:Alias>EC 2.7.11.1</ns1:Alias>
    <ns1:Alias>TSK-3</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>SPOGA3</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/958">
    <ns1:Alias>RNF83</ns1:Alias>
    <ns1:Alias>TRAF4</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:958</ns1:URN>
    <ns1:Alias>malignant 62</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>RING finger protein 83</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/230"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>cysteine-rich domain associated with RING and Traf domains protein 1</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Description>TRAF4 is a member of the TNF receptor associated factor (TRAF) family. Members of the TRAF family are the major signal transducers for the TNF receptor (TNFR) superfamily and the interleukin-1 receptor/Toll-like receptor superfamily.  TRAF4 is involved in the activation of NF-kappa-B and JNK, and in the regulation of cell survival and apoptosis.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>MLN62</ns1:Alias>
    <ns1:Alias>Cysteine-rich domain associated with RING and Traf domains protein 1</ns1:Alias>
    <ns1:Alias>CART1</ns1:Alias>
    <ns1:Alias>Metastatic lymph node gene 62 protein</ns1:Alias>
    <ns1:HgncName>TRAF4</ns1:HgncName>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=TRAF4&amp;search=traf4"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/9618"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=12034"/>
    <ns1:Alias>metastatic lymph node gene 62 protein</ns1:Alias>
    <ns1:Alias>tumor necrosis receptor-associated factor 4A</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/229"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>MLN 62</ns1:Alias>
    <ns1:Alias>TNF receptor-associated factor 4</ns1:Alias>
    <ns1:Title>TRAF4</ns1:Title>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>cysteine-rich domain associated with ring and TRAF domain</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9BUZ4"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/906">
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Cysteine-rich protein 2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1466"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CSRP2&amp;search=csrp2"/>
    <ns1:Alias>CRP2</ns1:Alias>
    <ns1:Alias>cysteine and glycine-rich protein 2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=2470"/>
    <ns1:Alias>LMO-5</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>smooth muscle cell LIM protein</ns1:Alias>
    <ns1:Description>CSRP2 encodes a LIM domain protein.  LIM domain proteins may be involved in
regulatory processes important for development and cellular differentiation. CSRP2 has two copies of the cysteine-rich amino acid sequence motif (LIM) with putative zinc-binding activity, and may be involved in regulating
ordered cell growth.  CSRP2 is thought to play a role in the development of the embryonic vascular system.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>SMLIM</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:906</ns1:URN>
    <ns1:Alias>cysteine-rich protein 2</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:HgncName>CSRP2</ns1:HgncName>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>SmLIM</ns1:Alias>
    <ns1:Alias>LIM domain only protein 5</ns1:Alias>
    <ns1:Alias>CSRP2</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Title>CSRP2</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q16527"/>
    <ns1:Alias>LMO5</ns1:Alias>
    <ns1:Alias>LIM domain only 5, smooth muscle</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>Smooth muscle cell LIM protein</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/385">
    <ns1:Alias>leucine zipper putative tumor suppressor 1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Title>LZTS1</ns1:Title>
    <ns1:Alias>Fez1</ns1:Alias>
    <ns1:HgncName>LZTS1</ns1:HgncName>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>F37/esophageal cancer-related gene-coding leucine-zipper motif</ns1:Alias>
    <ns1:Alias>LZTS1</ns1:Alias>
    <ns1:Alias>F37</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=LZTS1&amp;search=lzts1"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9Y250"/>
    <ns1:Alias>leucine zipper, putative tumor suppressor 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/11178"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:385</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/196"/>
    <ns1:Alias>FEZ1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>F37/Esophageal cancer-related gene-coding leucine-zipper motif</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>Q9Y250</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=13861"/>
    <ns1:Description>LZTS1 is a tumor suppressor protein that is widely expressed in normal tissues.  It is involved in regulating cell growth and is also thought to interact with the active CDC2-cyclin B1 complex and contribute to the regulation of the cell cycle and the prevention of uncontrolled cell proliferation. Loss of heterozygosity (LOH) in the 8p arm is a common characteristic of many types of cancer, and this gene is located on 8p22.</ns1:Description>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/684">
    <ns1:referencesResource rdf:resource="http://omim.org/entry/608268"/>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>H2BFL</ns1:Alias>
    <ns1:Title>HIST1H2BF</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Histone H2B.h</ns1:Alias>
    <ns1:Alias>HIST1H2BF</ns1:Alias>
    <ns1:Alias>Histone H2B.k</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>histone cluster 1, H2bf</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8343"/>
    <ns1:Alias>H2BFH</ns1:Alias>
    <ns1:Alias>H2B/g</ns1:Alias>
    <ns1:Alias>H2B/k</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Histone H2B.a</ns1:Alias>
    <ns1:Alias>H2BFA</ns1:Alias>
    <ns1:Alias>histone H2B.g</ns1:Alias>
    <ns1:Alias>H2B/h</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Histone H2B.l</ns1:Alias>
    <ns1:Alias>H2BFG</ns1:Alias>
    <ns1:Alias>H2BFK</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P62807"/>
    <ns1:Alias>histone H2B.1 A</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>H2B histone family, member G</ns1:Alias>
    <ns1:Alias>Histone H2B.g</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Description>histone cluster 1, H2bf</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=4752"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>H2B/l</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>H2B/a</ns1:Alias>
    <ns1:HgncName>HIST1H2BF</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:684</ns1:URN>
    <ns1:Alias>histone H2B type 1-C/E/F/G/I</ns1:Alias>
    <ns1:Alias>histone 1, H2bf</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>Histone H2B.1 A</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/191">
    <ns1:Alias>endocan</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Description>ESM1, a secreted protein containing multiple polyadenylation and mRNA instability signals, may have potent implications in lung endothelial cell-leukocyte interactions. It is expressed in lung, on the vascular capillary network within alveolar walls, and also at lower level in kidney. The expression of the ESM1 gene is regulated by cytokines, suggesting that it may play a role in endothelium-dependent pathological disorders. Two transcript variants encoding different isoforms have been found for this gene.</ns1:Description>
    <ns1:Alias>endothelial cell-specific molecule 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ESM1&amp;search=ESM1"/>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9NQ30"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3466"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>ESM1</ns1:Alias>
    <ns1:Title>ESM1</ns1:Title>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>ESM-1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:HgncName>ESM1</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:191</ns1:URN>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/11082"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/554">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Description>Exhaled breath was collected and differences in concentration for more than 50 volatile organic compounds (VOCs) was assayed by various methods.</ns1:Description>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:554</ns1:URN>
    <ns1:Alias>Bajtarevic VOCs signature</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:HgncName></ns1:HgncName>
    <ns1:Title>Bajtarevic VOCs signature</ns1:Title>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/158"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/368">
    <ns1:Alias>EPSTI1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>Q96J88</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Description>EPSTI1 is highly expressed in placenta, small intestine, spleen, kidney, thymus, liver, salivary gland and testes. There are three isoforms of this protein, produced by alternative splicing.</ns1:Description>
    <ns1:Title>EPSTI1</ns1:Title>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>BRESI1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=EPSTI1&amp;search=epsti1"/>
    <ns1:Alias>epithelial stromal interaction 1 (breast)</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:368</ns1:URN>
    <ns1:HgncName>EPSTI1</ns1:HgncName>
    <ns1:Alias>epithelial stromal interaction protein 1</ns1:Alias>
    <ns1:Alias>epithelial-stromal interaction protein 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/94240"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/214"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q96J88"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/search?search_type=symbols&amp;search=epsti1&amp;submit=Submit"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>MGC29634</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/28">
    <ns1:AccessGrantedTo>Pass New York University School of Medicine</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/146"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MSLN&amp;search=msln"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Title>SMRP</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q13421"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>MSLN</ns1:Alias>
    <ns1:Alias>SMRP</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Alias>Soluble Mesothelin Related Peptide</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/42"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/10232"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Description>Soluble mesothelin-related protein (SMRP) is related to the mesothelin family of molecules.  It is overexpressed in ovarian cancer, malignant pleural mesothelioma (MPM), and certain other cancers.  One hypothesis for the origin of SMRP is that this mesothelin-like molecule was released from tumor cells into culture supernatants, sera, and malignant effusions from certain tumors.  Another hypothesis is that SMRP is actually a proteolytically cleaved fragment of membrane-bound mesothelin.  Currently SMRP is considered to be an isoform of mesothelin (MSLN).  UniprotKB/SwissProt lists isoform 3 of human mesothelin (identifier Q13421-2) as SMRP.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/43"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:28</ns1:URN>
    <ns1:HgncName>MSLN</ns1:HgncName>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/7"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=7371"/>
    <ns1:Phase></ns1:Phase>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/36">
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_001125.1"/>
    <ns1:Alias>OTTHUMP00000160480</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:36</ns1:URN>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>HP</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/132"/>
    <ns1:Alias>FETA</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/33"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=317"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:174"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P02771"/>
    <ns1:HgncName>AFP</ns1:HgncName>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Alpha-fetoprotein</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>AFP</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm078610.htm"/>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Instititute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Description>AFP is a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatoma or teratoma. However, hereditary persistance of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. Alpha-fetoprotein is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin.</ns1:Description>
    <ns1:Title>AFP</ns1:Title>
    <ns1:Alias>HPAFP</ns1:Alias>
    <ns1:Alias>Alpha-1-fetoprotein</ns1:Alias>
    <ns1:Alias>Alpha-fetoglobulin</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/233">
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/3586"/>
    <ns1:Alias>CSIF</ns1:Alias>
    <ns1:Alias>IL10</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Description>From NCBI Gene: The protein encoded by this gene is a cytokine produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract. Mutations in this gene are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis.[provided by RefSeq, May 2011]</ns1:Description>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>TGIF</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P22301"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:233</ns1:URN>
    <ns1:Alias>Interleukin-10</ns1:Alias>
    <ns1:Alias>T-cell growth inhibitory factor</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>cytokine synthesis inhibitory factor</ns1:Alias>
    <ns1:Alias>IL-10</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>IL10A</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:3586"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:HgncName>IL10</ns1:HgncName>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>interleukin 10</ns1:Alias>
    <ns1:Title>IL10</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=5962"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=IL10"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000563.1"/>
    <ns1:QAState>Curated</ns1:QAState>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/548">
    <ns1:Alias>80 Gene Panel for Lung Cancer</ns1:Alias>
    <ns1:Description>This 80-gene biomarker panel is used to distinguish smokers with lung cancer from smokers without lung cancer.  The biomarker panel had approximately 90% sensitivity for stage 1 cancer across all subjects.  Adding cytopathology data gives 95% sensitivity and 95% negative predictive value.  (7 of the 80 biomarker probesets had no annotated gene symbol associated with them.)

List of genes in the panel:
DMD, NELL2, FGF14, TMEM47, ANXA3, PLA2G4A, DNAJC12, SLC39A8, DEFB1, PPBP, C6, FCGR3A, IL8, SERPINA1, CXCL2, RGS1, DUSP6, TOB1, FOS, SOX9, CD55, CD55, SLC4A4, CD164, ATP6AP2, ARL6IP5, CCT2, UBXD2, RAB1A, TRAM1, TMED2, YWHAE, C1orf80, TPD52, ACTR2, CPNE3, PTK9, UBE2J1, FXR1, SPN, PPP2CA, AD7C-NTP, STARD7, KIAA0738, RPL35A, GTF2H3, ZNF611, LOC152719, PRR11, ZC3H7B, ZNF354A, UBE2D2, ZNF160, FBXW12, ALMS1, ATP8B1, BACH2, TSR1, HDGF2, FLJ14346, LOC653471, DCLRE1C, DUOX1, LOC153561, DKFZP434A0131, GLT28D1, SENP6, FTO, LMO4, CCDC81, COX5B, FTL, NUCKS1</ns1:Description>
    <ns1:IsPanel>1</ns1:IsPanel>
    <ns1:Title>80 Gene Panel for Lung Cancer</ns1:Title>
    <ns1:URN>urn:edrn:bmdb:biomarker:548</ns1:URN>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/148"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>80-gene panel</ns1:Alias>
    <ns1:Alias>Spira 80-marker panel for lung cancer</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:HgncName></ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:AccessGrantedTo>Spira Boston University</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/949">
    <ns1:Alias>hSLAP</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/6503"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=10902"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>SLA1</ns1:Alias>
    <ns1:Description>SLA, or Src-like-adaptor, is an adaptor protein involved in negative regulation of T-cell receptor (TCR) signaling and regulation of receptor tyrosine kinase signaling by direct association.     SLA is also involved in the negative regulation of positive selection and mitosis of T-cells.</ns1:Description>
    <ns1:Alias>SLA</ns1:Alias>
    <ns1:Alias>Src-like-adaptor</ns1:Alias>
    <ns1:Alias>Src-like-adapter</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SLA&amp;search=sla"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>SLAP</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:949</ns1:URN>
    <ns1:Alias>SLAP1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>SLAP-1</ns1:Alias>
    <ns1:Alias>src-like-adapter protein 1</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Title>SLA</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:HgncName>SLA</ns1:HgncName>
    <ns1:Alias>src-like-adapter</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q13239"/>
    <ns1:Alias>Src-like-adapter protein 1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/901">
    <ns1:Description>CCL28 is a member of the small cytokine CC subfamily, and is involved in immunoregulatory and inflammatory processes.  CC cytokines are characterized by two adjacent cysteines.  CCL28 functions as a chemotactic factor for resting CD4 or CD8 T cells and eosinophils. CCL28 binds to CCR3 and CCR10 and induces calcium mobilization in a dose-dependent manner.</ns1:Description>
    <ns1:Alias>CCL28</ns1:Alias>
    <ns1:Alias>MEC</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>CCK1</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>mucosae-associated epithelial chemokine</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:HgncName>CCL28</ns1:HgncName>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9NRJ3"/>
    <ns1:Alias>chemokine (C-C motif) ligand 28</ns1:Alias>
    <ns1:Alias>small-inducible cytokine A28</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/56477"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:901</ns1:URN>
    <ns1:Alias>C-C motif chemokine 28</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL28&amp;search=ccl28"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=17700"/>
    <ns1:Alias>Mucosae-associated epithelial chemokine</ns1:Alias>
    <ns1:Alias>small inducible cytokine subfamily A (Cys-Cys), member 28</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>SCYA28</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>chemokine (C-C motif) ligand 28 splice variant chi</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>CC chemokine CCL28</ns1:Alias>
    <ns1:Title>CCL28</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>small inducible cytokine A28</ns1:Alias>
    <ns1:Alias>Protein CCK1</ns1:Alias>
    <ns1:Alias>Small-inducible cytokine A28</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/363">
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>CXCR7</ns1:Alias>
    <ns1:Alias>G-protein coupled receptor 159</ns1:Alias>
    <ns1:Alias>CXCR-7</ns1:Alias>
    <ns1:Alias>CMKOR1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Chemokine orphan receptor 1</ns1:Alias>
    <ns1:Alias>chemokine orphan receptor 1</ns1:Alias>
    <ns1:HgncName>ACKR3</ns1:HgncName>
    <ns1:Alias>G-protein coupled receptor RDC1 homolog</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P25106"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>G protein-coupled receptor</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>P25106</ns1:Alias>
    <ns1:Title>ACKR3</ns1:Title>
    <ns1:Alias>C-X-C chemokine receptor type 7</ns1:Alias>
    <ns1:Alias>RDC-1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/57007"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=23692"/>
    <ns1:Alias>GPR159</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>RDC1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ACKR3&amp;search=CMKOR1"/>
    <ns1:Description>ACKR3 (CXCR7, CMKOR1) is a member of the G-protein coupled receptor family.  It is a receptor for chemokines CXCL12/SDF1 and CXCL11.  ACKR3 does not elicit classical chemokine receptor signaling; chemokine binding does not activate G-protein-mediated signal transduction but instead induces beta-arrestin recruitment, leading to ligand internalization and activation of MAPK signaling pathway.  ACKR3 is also a coreceptor for human immunodeficiency viruses (HIV).</ns1:Description>
    <ns1:URN>urn:edrn:bmdb:biomarker:363</ns1:URN>
    <ns1:Alias>ACKR3</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>chemokine (C-X-C motif) receptor 7</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>CXC-R7</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/550">
    <ns1:Alias>Chen 10-marker miRNA signature for non-small cell lung cancer</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/150"/>
    <ns1:Type>Genomic</ns1:Type>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Description>A panel of 10 serum miRNAs has been identified that were found to have significantly different expression levels in non-small cell lung cancer (NSCLC) serum samples compared with the control serum samples. This panel of miRNAs was able to distinguish NSCLC cases from controls with high sensitivity and specificity.  The ten miRNAs are: miR-20a, miR-24, miR-25, miR-145, miR-152, miR-199a-5p, miR-221, miR-222, miR-223, miR-320.</ns1:Description>
    <ns1:URN>urn:edrn:bmdb:biomarker:550</ns1:URN>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Title>Chen 10-marker miRNA signature for non-small cell lung cancer</ns1:Title>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:IsPanel>1</ns1:IsPanel>
    <ns1:Security>Public</ns1:Security>
    <ns1:HgncName></ns1:HgncName>
    <ns1:QAState>Curated</ns1:QAState>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/895">
    <ns1:Alias>APAF1</ns1:Alias>
    <ns1:Alias>KIAA0413</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>apoptotic peptidase activating factor</ns1:Alias>
    <ns1:Title>APAF1</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O14727"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/317"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=APAF1&amp;search=apaf1"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>apoptotic protease-activating factor 1</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>apoptotic peptidase activating factor 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=576"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:895</ns1:URN>
    <ns1:HgncName>APAF1</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Description>APAF1 is a cytoplasmic protein that initiates apoptosis.     APAF1 binds  cytochrome c and dATP, forming an oligomeric apoptosome. The apoptosome binds and cleaves caspase 9 preproprotein, releasing its mature, activated form. Activated caspase 9 stimulates the subsequent caspase cascade that commits the cell to apoptosis.</ns1:Description>
    <ns1:Alias>apoptotic protease activating factor</ns1:Alias>
    <ns1:Alias>CED4</ns1:Alias>
    <ns1:Alias>APAF-1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/231">
    <ns1:Alias>thyrotropin beta subunit</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Thyrotropin alfa</ns1:Alias>
    <ns1:Alias>TSH-B</ns1:Alias>
    <ns1:Alias>TSH-beta</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Title>TSHB</ns1:Title>
    <ns1:Alias>thyrotropin subunit beta</ns1:Alias>
    <ns1:Alias>TSH</ns1:Alias>
    <ns1:Alias>TSHB</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:7252"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>TSH-BETA</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>CHNG4</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>Thyrotropin beta chain</ns1:Alias>
    <ns1:Alias>thyroid stimulating hormone, beta</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000540.2"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=12372"/>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>INN=Thyrotropin alfa</ns1:Alias>
    <ns1:HgncName>TSHB</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:231</ns1:URN>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>Thyroid-stimulating hormone subunit beta</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P01222"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Description>TSH, a secreted protein belonging to the glycoprotein hormones subunit beta family, is essential for the control of thyroid structure and metabolism. The four human glycoprotein hormones - chorionic gonadotropin (CG), luteinizing hormone (LH), follicle stimulating hormone (FSH), and thyroid stimulating hormone (TSH)- are dimers consisting of alpha and beta subunits that are associated noncovalently. The alpha subunits of these hormones are identical, however, their beta chains are unique and confer biological specificity. Congenital hypothyroidism is caused by mutation in the TSH gene.</ns1:Description>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/382">
    <ns1:Alias>KIAA0143</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:382</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q14156"/>
    <ns1:Alias>EFR3 homolog A (S. cerevisiae)</ns1:Alias>
    <ns1:Alias>Q14156</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=28970"/>
    <ns1:HgncName>EFR3A</ns1:HgncName>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>protein EFR3 homolog A</ns1:Alias>
    <ns1:Description>EFR3A (KIAA0143) is a membrane protein.  Little is known about its function, although studies on the mouse homolog have suggested a role in hearing.  It has been shown in mice that it is differentially expressed in the auditory brainstem neurons of mice with hearing deficit, compared to mice with normal hearing ability.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/23167"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=EFR3A&amp;search=kiaa0143"/>
    <ns1:Alias>Protein EFR3-like</ns1:Alias>
    <ns1:Alias>EFR3A</ns1:Alias>
    <ns1:Title>EFR3A</ns1:Title>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Security>Public</ns1:Security>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/397">
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>tumor necrosis factor-stimulated gene-6 protein</ns1:Alias>
    <ns1:Alias>TNFAIP6</ns1:Alias>
    <ns1:Alias>Hyaluronate-binding protein</ns1:Alias>
    <ns1:Alias>Tumor necrosis factor-inducible gene 6 protein</ns1:Alias>
    <ns1:Alias>TSG6</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=11898"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:397</ns1:URN>
    <ns1:Description>TNFAIP6 is a secretory protein that contains a hyaluronan-binding domain, and thus is a member of the hyaluronan-binding protein family. It is possibly involved in cell-cell and cell-matrix interactions during inflammation and tumorigenesis. Enhanced levels of this protein are found in the synovial fluid of patients with osteoarthritis and rheumatoid arthritis.</ns1:Description>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>TNF alpha-induced protein 6</ns1:Alias>
    <ns1:Alias>tumor necrosis factor-inducible gene 6 protein</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>P98066</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFAIP6&amp;search=tnfaip6"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>TNF-stimulated gene 6 protein</ns1:Alias>
    <ns1:Alias>TSG-6</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:HgncName>TNFAIP6</ns1:HgncName>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7130"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P98066"/>
    <ns1:Title>TNFAIP6</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>tumor necrosis factor, alpha-induced protein 6</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/373">
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>FAM83H variant 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/?term=human+fam83h"/>
    <ns1:Alias>protein FAM83H</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>AI3</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>FLJ46072</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Q6ZRV2</ns1:Alias>
    <ns1:Description>FAM83H is a member of the FAM83 family and plays an important role in the structural development and calcification of tooth enamel. Defects in this gene are a cause of amelogenesis imperfecta type 3 (AI3).  Lack of a recognizable signal peptide indicates that the protein functions within the cell.  It is expressed in the tooth follicle.</ns1:Description>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=24797"/>
    <ns1:Alias>FAM83H</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:373</ns1:URN>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:HgncName>FAM83H</ns1:HgncName>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q6ZRV2"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=FAM83H&amp;search=fam83h"/>
    <ns1:Title>FAM83H</ns1:Title>
    <ns1:Alias>family with sequence similarity 83, member H</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/946">
    <ns1:Alias>MST092</ns1:Alias>
    <ns1:Alias>MSTP092</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8490"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O15539"/>
    <ns1:Alias>MST106</ns1:Alias>
    <ns1:HgncName>RGS5</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:946</ns1:URN>
    <ns1:Alias>MST129</ns1:Alias>
    <ns1:Description>RGS5 is a member of the regulators of G protein signaling (RGS) family, which are signal transduction molecules that are involved in the regulation of heterotrimeric G proteins by acting as GTPase activators.  RGS5 has been found to be involved in tumor angiogenesis and to antagonize the angiogenic effect of VEGF.  Multiple alternatively spliced transcript variants have been found.</ns1:Description>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>MSTP032</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>MSTP106</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Title>RGS5</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=RGS5&amp;search=rgs5"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>RGS5</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>regulator of G-protein signalling 5</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=10001"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>regulator of G-protein signaling 5</ns1:Alias>
    <ns1:Alias>MSTP129</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/937">
    <ns1:Alias>RPB10 homolog</ns1:Alias>
    <ns1:Alias>polymerase (RNA) II (DNA directed) polypeptide L (7.6kD)</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>DNA-directed RNA polymerases I, II, and III subunit RPABC5</ns1:Alias>
    <ns1:Alias>polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:937</ns1:URN>
    <ns1:HgncName>POLR2L</ns1:HgncName>
    <ns1:Alias>hRPB7.6</ns1:Alias>
    <ns1:Alias>RPABC5</ns1:Alias>
    <ns1:Alias>RNA polymerases I, II, and III subunit ABC5</ns1:Alias>
    <ns1:Alias>RPB7.6</ns1:Alias>
    <ns1:Alias>DNA-directed RNA polymerase III subunit L</ns1:Alias>
    <ns1:Alias>RNA polymerase II 7.6 kDa subunit</ns1:Alias>
    <ns1:Alias>hsRPB10b</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=9199"/>
    <ns1:Alias>RPB10beta</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/5441"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>RPB10</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Description>POLR2L is the central component of RNA polymerase II.  RNA polymerase II is the polymerase responsible for synthesizing messenger RNA in eukaryotes. This subunit may be shared by the other two DNA-directed RNA polymerases, I and III.  RNA polymerases, or Pols, are composed of mobile elements that move relative to each other. In Pol II, POLR2L/RBP10 is thought to be part of the core element with the central large cleft.</ns1:Description>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>RBP10</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=POLR2L&amp;search=polr2l"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P62875"/>
    <ns1:Alias>POLR2L</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Title>POLR2L</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/367">
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>KIAA0987</ns1:Alias>
    <ns1:Title>EPB41L3</ns1:Title>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>DAL1</ns1:Alias>
    <ns1:HgncName>EPB41L3</ns1:HgncName>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>Differentially expressed in adenocarcinoma of the lung protein 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3380"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>differentially expressed in adenocarcinoma of the lung protein 1</ns1:Alias>
    <ns1:Alias>EPB41L3</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>Q9Y2J2</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>DAL-1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Description>EPB41L3 protein is a critical growth regulator in the pathogenesis of meningiomas.  There are three isoforms of this protein, produced by alternative splicing.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/213"/>
    <ns1:Alias>band 4.1-like protein 3</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:367</ns1:URN>
    <ns1:Alias>4.1B</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/23136"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9Y2J2"/>
    <ns1:Alias>erythrocyte membrane protein band 4.1-like 3</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1078">
    <ns1:URN>urn:edrn:bmdb:biomarker:1078</ns1:URN>
    <ns1:HgncName></ns1:HgncName>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Genomic</ns1:Type>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Description>The Prostate Core Mitomic Test is based upon a 3.4 kb mitochondrial genome deletion (3.4 mtdelta) that was identified through PCR analysis of frozen prostate cancer samples.  In cancer research it has been found that deletions in mitochondrial DNA can correlate with cellular changes that indicate development of cancer.  This deletion includes the terminal 22 bases of MT-ND4L, all of MT-ND4, 3 tRNAs (histidine, serine 2, and leucine 2), and all except the terminal 24 bases of MT-ND5.</ns1:Description>
    <ns1:Alias>Mitochondrial deletion for detection of prostate cancer</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/237"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Prostate Core Mitomic Test</ns1:Alias>
    <ns1:Alias>Mitochondrial Genome Deletion for Detection of Prostate Cancer</ns1:Alias>
    <ns1:Title>Mitochondrial Genome Deletion for Detection of Prostate Cancer</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://mitomicsinc.com/prostate-core-mitomic-test/healthcare-professionals.php"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/539">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/128"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>GATA Binding Protein 4</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/2626"/>
    <ns1:Alias>GATA-Binding Factor 4</ns1:Alias>
    <ns1:Alias>ASD2</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=GATA4"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:HgncName>GATA4</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:539</ns1:URN>
    <ns1:Alias>VSD1</ns1:Alias>
    <ns1:Alias>GATA-Binding Protein 4</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Description>From NCBI Entrez Gene: This gene encodes a member of the GATA family of zinc-finger transcription factors. Members of this family recognize the GATA motif which is present in the promoters of many genes. This protein is thought to regulate genes involved in embryogenesis and in myocardial differentiation and function. Mutations in this gene have been associated with cardiac septal defects. [provided by RefSeq, Jul 2008]</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:4173"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P43694"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Title>GATA4</ns1:Title>
    <ns1:Alias>Transcription Factor GATA-4</ns1:Alias>
    <ns1:Alias>GATA4</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/372">
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:HgncName>CCDC102B</ns1:HgncName>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Title>CCDC102B</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>chromosome 18 open reading frame 14</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>ACY1L</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>coiled-coil domain-containing protein 102B</ns1:Alias>
    <ns1:Alias>coiled-coil domain containing 102B</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/?term=human+flj23594"/>
    <ns1:Alias>C18orf14</ns1:Alias>
    <ns1:Description>CCDC102B, or coiled-coil domain-containing protein 102B, has two isoforms produced by alternative splicing.</ns1:Description>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>CCDC102B</ns1:Alias>
    <ns1:Alias>FLJ23594</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:372</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CCDC102B&amp;search=CCDC102B"/>
    <ns1:Alias>AN</ns1:Alias>
    <ns1:Alias>HsT1731</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>aminoacylase 1-like</ns1:Alias>
    <ns1:Alias>Q68D86</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=26295"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q68D86"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/853">
    <ns1:Alias>prostate-specific transglutaminase</ns1:Alias>
    <ns1:Alias>transglutaminase 4 (prostate)</ns1:Alias>
    <ns1:Alias>Transglutaminase-4</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>Fibrinoligase</ns1:Alias>
    <ns1:Alias>TG(P)</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Title>TGM4</ns1:Title>
    <ns1:Alias>Transglutaminase P</ns1:Alias>
    <ns1:Alias>protein-glutamine gamma-glutamyltransferase 4</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>TGP</ns1:Alias>
    <ns1:Alias>transglutaminase-4</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:853</ns1:URN>
    <ns1:Alias>fibrinoligase</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=11780"/>
    <ns1:HgncName>TGM4</ns1:HgncName>
    <ns1:Alias>TGase P</ns1:Alias>
    <ns1:Alias>Prostate-specific transglutaminase</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P49221"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>prostate transglutaminase</ns1:Alias>
    <ns1:Alias>Prostate transglutaminase</ns1:Alias>
    <ns1:Alias>TGM4</ns1:Alias>
    <ns1:Alias>EC 2.3.2.13</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7047"/>
    <ns1:Alias>TGase-4</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>hTGP</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/600585"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Description>transglutaminase 4 (prostate)</ns1:Description>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>transglutaminase P</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/79">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>PRL</ns1:Alias>
    <ns1:AccessGrantedTo>Mor Yale University</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/254"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:5617"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:Alias>prolactin</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000939.1"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P01236"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:79</ns1:URN>
    <ns1:HgncName>PRL</ns1:HgncName>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Title>PRL</ns1:Title>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=9445"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Description>There is increasing evidence that prolactin (PRL), a hormone/cytokine, plays a role in breast, prostate, and colorectal cancers via local production or accumulation. Elevated levels of serum PRL in ovarian and endometrial cancers have been reported, indicating a potential role for PRL in endometrial and ovarian carcinogenesis.</ns1:Description>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/934">
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/5095"/>
    <ns1:Alias>propionyl CoA carboxylase, alpha polypeptide</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Title>PCCA</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>EC 6.4.1.3</ns1:Alias>
    <ns1:Alias>propanoyl-CoA:carbon dioxide ligase alpha subunit</ns1:Alias>
    <ns1:Alias>pccA complementation group</ns1:Alias>
    <ns1:Alias>Propanoyl-CoA:carbon dioxide ligase subunit alpha</ns1:Alias>
    <ns1:Alias>propionyl Coenzyme A carboxylase, alpha polypeptide</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PCCA&amp;search=pcca"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=8653"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P05165"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>propionyl-CoA carboxylase alpha chain, mitochondrial</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:934</ns1:URN>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:HgncName>PCCA</ns1:HgncName>
    <ns1:Alias>PCCase subunit alpha</ns1:Alias>
    <ns1:Alias>PCCase alpha subunit</ns1:Alias>
    <ns1:Description>PCCA, or propionyl CoA carboxylase, alpha polypeptide, is the alpha subunit of the heterodimeric mitochondrial enzyme Propionyl-CoA carboxylase.  The beta subunit is PCCB.  The enzyme deficiency  propionic acidemia results from mutations in either PCCA or PCCB. Several isoforms for this gene have been identified, coded by multiple transcript variants.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>PCCA</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/244">
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Security>Public</ns1:Security>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>LSH-B</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Lutropin beta chain</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6584"/>
    <ns1:HgncName>LHB</ns1:HgncName>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>LH-B</ns1:Alias>
    <ns1:Alias>luteinizing hormone beta subunit</ns1:Alias>
    <ns1:Alias>lutropin subunit beta</ns1:Alias>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>LHB</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:244</ns1:URN>
    <ns1:Title>LHB</ns1:Title>
    <ns1:Alias>hLHB</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=LHB&amp;search=lutropin"/>
    <ns1:Alias>Luteinizing hormone subunit beta</ns1:Alias>
    <ns1:Alias>interstitial cell stimulating hormone, beta chain</ns1:Alias>
    <ns1:Description>The pituitary glycoprotein hormone family includes follicle stimulating hormone (FSH), luteinizing hormone (LH), chorionic gonadotropin (CG), and thyroid-stimulating hormone (TSH). All of these glycoproteins consist of an identical alpha subunit and a hormone-specific beta subunit.  LHB, the beta subunit of luteinizing hormone, confers biological specificity.  LH is expressed in the pituitary gland and promotes spermatogenesis and ovulation by stimulating the testes and ovaries to synthesize steroids. The genes for the beta chains of chorionic gonadotropin and for luteinizing hormone are contiguous on chromosome 19q13.3. Mutations in this gene are associated with hypogonadism which is characterized by infertility and pseudohermaphroditism.</ns1:Description>
    <ns1:Alias>CGB4</ns1:Alias>
    <ns1:Alias>luteinizing hormone beta polypeptide</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/3972"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>Lutropin</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P01229"/>
    <ns1:Alias>LSH-beta</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/926">
    <ns1:Alias>SH2 domain-containing leukocyte protein of 76kD</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>lymphocyte cytosolic protein 2 (SH2 domain-containing leukocyte protein of 76kD)</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:HgncName>LCP2</ns1:HgncName>
    <ns1:Alias>LCP2</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/3937"/>
    <ns1:Description>LCP2, previously known as SLP76, functions as an adaptor or scaffolding protein.  LCP2 has three modular domains.  The amino-terminal end has an acidic region that includes a PEST domain and several tyrosine residues which are phosphorylated following TCR ligation. LCP2 also contains a central proline-rich domain and a COOH-terminal SH2 domain.</ns1:Description>
    <ns1:URN>urn:edrn:bmdb:biomarker:926</ns1:URN>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>SLP-76</ns1:Alias>
    <ns1:Alias>lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=LCP2&amp;search=lcp2"/>
    <ns1:Alias>SLP76</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q13094"/>
    <ns1:Alias>76 kDa tyrosine phosphoprotein</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6529"/>
    <ns1:Alias>lymphocyte cytosolic protein 2</ns1:Alias>
    <ns1:Title>LCP2</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>SH2 domain-containing leukocyte protein of 76 kDa</ns1:Alias>
    <ns1:Alias>SLP-76 tyrosine phosphoprotein</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/663">
    <ns1:HgncName>FMO5</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Title>FMO5</ns1:Title>
    <ns1:Alias>FMO5</ns1:Alias>
    <ns1:Alias>EC 1.14.13.8</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P49326"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>FMO 5</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3773"/>
    <ns1:Phase>One</ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:663</ns1:URN>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/603957"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Hepatic flavin-containing monooxygenase 5</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/2330"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Dimethylaniline oxidase 5</ns1:Alias>
    <ns1:Alias>dimethylaniline monooxygenase [N-oxide-forming] 5</ns1:Alias>
    <ns1:Description>flavin containing monooxygenase 5</ns1:Description>
    <ns1:Alias>flavin containing monooxygenase 5</ns1:Alias>
    <ns1:Alias>dimethylaniline oxidase 5</ns1:Alias>
    <ns1:Alias>hepatic flavin-containing monooxygenase 5</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/920">
    <ns1:Alias>menage a quatre 1</ns1:Alias>
    <ns1:Alias>menage a quatre protein 1</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>MAQ1</ns1:Alias>
    <ns1:Alias>CLP1</ns1:Alias>
    <ns1:Alias>hexamethylene bisacetamide-inducible protein</ns1:Alias>
    <ns1:Alias>hexamethylene-bis-acetamide-inducible transcript 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/10614"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Cardiac lineage protein 1</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:920</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Description>HEXIM1 is an intronless transcriptional regulator which functions as a general RNA polymerase II transcription inhibitor. HEXIM1 expression is induced by hexamethylene-bis-acetamide in vascular smooth muscle cells.</ns1:Description>
    <ns1:Alias>Menage a quatre protein 1</ns1:Alias>
    <ns1:Alias>Hexamethylene bis-acetamide-inducible protein 1</ns1:Alias>
    <ns1:Alias>Estrogen down-regulated gene 1 protein</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>CLP-1</ns1:Alias>
    <ns1:Alias>HMBA-inducible</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>hexamthylene bis-acetamide inducible 1</ns1:Alias>
    <ns1:Alias>HEXIM1</ns1:Alias>
    <ns1:Alias>cardiac lineage protein 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O94992"/>
    <ns1:Alias>hexamethylene bis-acetamide inducible 1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>HIS1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Title>HEXIM1</ns1:Title>
    <ns1:Alias>hexamethylene bis-acetamide-inducible protein 1</ns1:Alias>
    <ns1:Alias>estrogen down-regulated gene 1 protein</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:HgncName>HEXIM1</ns1:HgncName>
    <ns1:Alias>EDG1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=HEXIM1&amp;search=hexim1"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=24953"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>protein HEXIM1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/101">
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Instititute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ICAM1&amp;search=icam1"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>CD54 Antigen</ns1:Alias>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>Human Rhinovirus Receptor</ns1:Alias>
    <ns1:AccessGrantedTo>Hanash Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>ICAM-1</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P05362"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Description>From NCBI Gene: This gene encodes a cell surface glycoprotein which is typically expressed on endothelial cells and cells of the immune system. It binds to integrins of type CD11a / CD18, or CD11b / CD18 and is also exploited by Rhinovirus as a receptor. [provided by RefSeq, Jul 2008]</ns1:Description>
    <ns1:Alias>BB2</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>ICAM1</ns1:Alias>
    <ns1:Alias>CD54</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:101</ns1:URN>
    <ns1:Alias>intercellular adhesion molecule 1</ns1:Alias>
    <ns1:Alias>Major group rhinovirus receptor</ns1:Alias>
    <ns1:HgncName>ICAM1</ns1:HgncName>
    <ns1:Alias>Cell Surface Glycoprotein P3.58</ns1:Alias>
    <ns1:Title>ICAM1</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=5344"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>P3.58</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/3383"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000090339"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/933">
    <ns1:Alias>Constitutive NOS</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Neuronal NOS</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=7872"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>NOS type I</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=NOS1&amp;search=nos1"/>
    <ns1:Alias>nitric oxide synthase 1 (neuronal)</ns1:Alias>
    <ns1:Title>NOS1</ns1:Title>
    <ns1:Alias>N-NOS</ns1:Alias>
    <ns1:Alias>EC 1.14.13.39</ns1:Alias>
    <ns1:Alias>NC-NOS</ns1:Alias>
    <ns1:HgncName>NOS1</ns1:HgncName>
    <ns1:Alias>peptidyl-cysteine S-nitrosylase NOS1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>constitutive NOS</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P29475"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>NOS1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>nitric oxide synthase, brain</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>IHPS1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/4842"/>
    <ns1:Alias>NOS</ns1:Alias>
    <ns1:Alias>Peptidyl-cysteine S-nitrosylase NOS1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>bNOS</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Description>NOS1, or nitric oxide synthase 1 (neuronal), along with inducible nitric oxide synthase (NOS2) and endothelial nitric oxide synthase (NOS3), catalyze the generation of nitric oxide and L-citrulline from L-arginine and molecular oxygen.  Nitric oxide is a messenger molecule with diverse functions throughout the body. In the brain and peripheral nervous system, nitric oxide displays many properties of a neurotransmitter.  NOS1 also displays antimicrobial and antitumoral activities.</ns1:Description>
    <ns1:URN>urn:edrn:bmdb:biomarker:933</ns1:URN>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>neuronal NOS</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>nNOS</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1008">
    <ns1:Alias>PIG11</ns1:Alias>
    <ns1:Alias>3-Alkyladenine DNA Glycosylase</ns1:Alias>
    <ns1:Alias>N-methylpurine DNA glycosylase</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:1008</ns1:URN>
    <ns1:Description>MPG is a DNA repair enzyme that repairs hypoxanthine, which is formed by spontaneous or oxidative deamination of adenine.  MPG also repairs secondary oxidative lesions such as 1,N6-ethenoadenine alkylated bases, and 3-methyladenine and 7-methylguanine.</ns1:Description>
    <ns1:Alias>Alkyladenine DNA Glycosylase</ns1:Alias>
    <ns1:Alias>Mid1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/4350"/>
    <ns1:Alias>MID1</ns1:Alias>
    <ns1:HgncName>MPG</ns1:HgncName>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>Proliferation-Inducing Protein 16</ns1:Alias>
    <ns1:Alias>APNG</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/209"/>
    <ns1:Alias>MDG</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/210"/>
    <ns1:Alias>3-Methyladenine DNA Glycosidase</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>3' End Of The Mid1 Gene, Localized 68 Kb Upstream The Humanzeta Globin Gene On 16p</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P29372"/>
    <ns1:Alias>CRA36.1</ns1:Alias>
    <ns1:Alias>CRA36.1 (3-Methyl-Adenine DNA Glycosylase)</ns1:Alias>
    <ns1:Alias>ADPG</ns1:Alias>
    <ns1:Alias>DNA-3-Methyladenine Glycosylase</ns1:Alias>
    <ns1:Alias>ANPG</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>AAG</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=7211"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Title>MPG</ns1:Title>
    <ns1:Alias>N-Methylpurine-DNA Glycosylase, MPG</ns1:Alias>
    <ns1:Alias>EC 3.2.2.21</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>PIG16</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Proliferation-Inducing Protein 11</ns1:Alias>
    <ns1:Alias>anpg</ns1:Alias>
    <ns1:Alias>MPG</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MPG&amp;search=N-methylpurine+DNA+glycosylase"/>
    <ns1:Type>Protein</ns1:Type>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/939">
    <ns1:Alias>MOSP</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>NB4 apoptosis/differentiation related protein</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PTPMT1&amp;search=ptpmt1"/>
    <ns1:Alias>PTPMT1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/114971"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>PTEN-like phosphatase</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>protein-tyrosine phosphatase mitochondrial 1</ns1:Alias>
    <ns1:Title>PTPMT1</ns1:Title>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Description>PTPMT1 is a lipid phosphatase which dephosphorylates phosphatidylglycerophosphate (PGP) to phosphatidylglycerol (PG). PGP is an essential intermediate in the biosynthetic pathway of cardiolipin, a mitochondrial-specific
    phospholipid regulating the membrane integrity and activities of the organelle.</ns1:Description>
    <ns1:Alias>EC 3.1.3.16,EC 3.1.3.48</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=26965"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q8WUK0"/>
    <ns1:Alias>Phosphoinositide lipid phosphatase</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:939</ns1:URN>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>PLIP</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>DUSP23</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>protein tyrosine phosphatase, mitochondrial 1</ns1:Alias>
    <ns1:HgncName>PTPMT1</ns1:HgncName>
    <ns1:Alias>phosphoinositide lipid phosphatase</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/892">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>ADHX</ns1:Alias>
    <ns1:Description>ADH5 is a member of the alcohol dehydrogenase family. This protein forms a homodimer.  ADH5 is ineffective in oxidizing ethanol, but exhibits high activity for oxidation of long-chain primary alcohols and for oxidation of S-hydroxymethyl-glutathione, a spontaneous adduct between formaldehyde and glutathione.  There are several non-transcribed pseuodogenes related to this gene.</ns1:Description>
    <ns1:Title>ADH5</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>alcohol dehydrogenase class-3</ns1:Alias>
    <ns1:Alias>ADH5</ns1:Alias>
    <ns1:Alias>Alcohol dehydrogenase class chi chain</ns1:Alias>
    <ns1:Alias>Alcohol dehydrogenase 5</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ADH5&amp;search=adh5"/>
    <ns1:AccessGrantedTo>Anderson Arizona State University</ns1:AccessGrantedTo>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>ADH-3</ns1:Alias>
    <ns1:Alias>S-(hydroxymethyl)glutathione dehydrogenase</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=253"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Glutathione-dependent formaldehyde dehydrogenase</ns1:Alias>
    <ns1:HgncName>ADH5</ns1:HgncName>
    <ns1:Alias>alcohol dehydrogenase class chi chain</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>alcohol dehydrogenase (class III), chi polypeptide</ns1:Alias>
    <ns1:Alias>GSNOR</ns1:Alias>
    <ns1:Alias>EC 1.1.1.1,EC 1.1.1.-,EC 1.1.1.284</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>GSH-FDH</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:892</ns1:URN>
    <ns1:Alias>FDH</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>formaldehyde dehydrogenase</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/128"/>
    <ns1:Alias>FALDH</ns1:Alias>
    <ns1:Alias>glutathione-dependent formaldehyde dehydrogenase</ns1:Alias>
    <ns1:Alias>Alcohol dehydrogenase class-III</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q6IRT1"/>
    <ns1:Alias>alcohol dehydrogenase 5 (class III), chi polypeptide</ns1:Alias>
    <ns1:Alias>alcohol dehydrogenase class-III</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/57">
    <ns1:HgncName>KLK4</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/71"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BethIsraelSandaDataMarkerPerformanceSummary"/>
    <ns1:Alias>PRSS17</ns1:Alias>
    <ns1:Alias>Kallikrein-4</ns1:Alias>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Title>KLK4</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>hK4</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000167749"/>
    <ns1:Alias>Human kallikrein 4</ns1:Alias>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N85ae2ffadea54ca983917332ef4f9101">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/57/26"/>
        <rdf:_3 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/57/925"/>
        <rdf:_2 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/57/27"/>
        <rdf:_4 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/57/1035"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:Phase></ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/72"/>
    <ns1:Description>The glandular kallikreins are a distinct group of serine proteases with molecular masses of 25,000 to 40,000. Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Several human kallikrein genes have been isolated. hK4 is expressed in the prostate.</ns1:Description>
    <ns1:Alias>Enamel matrix serine proteinase 1</ns1:Alias>
    <ns1:Alias>Serine protease 17</ns1:Alias>
    <ns1:Alias>KLK4</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:9622"/>
    <ns1:Alias>KLK-L1</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Prostate and Urologic</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9Y5K2"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Prostase</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:57</ns1:URN>
    <ns1:indicatorForOrgan>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/78">
        <ns1:Alias>Proto-oncogene c-ErbB-1</ns1:Alias>
        <ns1:Title>EGFR</ns1:Title>
        <ns1:URN>urn:edrn:bmdb:biomarker:78</ns1:URN>
        <ns1:HgncName>EGFR</ns1:HgncName>
        <ns1:Security>Public</ns1:Security>
        <ns1:Alias>ERBB1</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P04412"/>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:Alias>mENA</ns1:Alias>
        <ns1:Type>Protein</ns1:Type>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:Alias>c-erbB-1</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_005219.2"/>
        <ns1:Alias>epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b) oncogene homolog)</ns1:Alias>
        <ns1:Alias>EGFR</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:1956"/>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1956"/>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/137"/>
        <ns1:Phase></ns1:Phase>
        <ns1:Alias>HER1</ns1:Alias>
        <ns1:Alias>cell growth inhibiting protein 40</ns1:Alias>
        <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Instititute</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
        <ns1:Alias>PIG61</ns1:Alias>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Alias>cell proliferation-inducing protein 61</ns1:Alias>
        <ns1:Alias>Receptor tyrosine-protein kinase erbB-1</ns1:Alias>
        <ns1:Alias>avian erythroblastic leukemia viral (v-erb-b) oncogene homolog</ns1:Alias>
        <ns1:Description>From NCBI Gene: The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene. [provided by RefSeq, Jul 2010]</ns1:Description>
        <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=3236"/>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:Alias>ERBB</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
        <ns1:Alias>Epidermal growth factor receptor</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
      </ns1:Biomarker>
    </ns1:indicatorForOrgan>
    <ns1:Alias>PSTS</ns1:Alias>
    <ns1:Alias>EMSP1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6365"/>
    <ns1:Alias>Kallikrein-like protein 1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/965">
    <ns1:Description>ZFP36L1 is a member of the TIS11 family of early response genes, which are induced by various agonists such as the phorbol ester TPA and the polypeptide mitogen EGF.  The ZFP36L1 gene is well conserved across species and has a promoter that contains motifs seen in other early-response genes. ZFP36L1 contains a putative zinc finger domain with a repeating cys-his motif. ZFP36L1 is believed to be a nuclear transcription factor most likely functioning in regulating the response to growth factors. Different isoforms encoded by alternatively spliced transcript variants have been isolated.</ns1:Description>
    <ns1:Alias>BERG36</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/677"/>
    <ns1:Alias>butyrate response factor 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>BRF1</ns1:Alias>
    <ns1:Alias>RNF162B</ns1:Alias>
    <ns1:Alias>zinc finger protein 36, C3H type-like 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q07352"/>
    <ns1:Alias>ERF-1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>early response factor Berg36</ns1:Alias>
    <ns1:Alias>zinc finger protein, C3H type, 36-like 1</ns1:Alias>
    <ns1:Alias>ERF1</ns1:Alias>
    <ns1:Alias>EGF-response factor 1</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Berg36</ns1:Alias>
    <ns1:Title>ZFP36L1</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>TIS11B</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:965</ns1:URN>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>zinc finger protein 36, C3H1 type-like 1</ns1:Alias>
    <ns1:Alias>Protein TIS11B</ns1:Alias>
    <ns1:Alias>ZFP36L1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:HgncName>ZFP36L1</ns1:HgncName>
    <ns1:Alias>Butyrate response factor 1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=1107"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ZFP36L1&amp;search=zfp36l1"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>cMG1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/935">
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=8799"/>
    <ns1:HgncName>PDGFA</ns1:HgncName>
    <ns1:Alias>PDGF</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/5154"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>Platelet-derived growth factor</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:935</ns1:URN>
    <ns1:Alias>platelet-derived growth factor alpha polypeptide</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PDGFA&amp;search=pdgfa"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>PDGFA, or platelet-derived growth factor alpha polypeptide, is a member of the platelet-derived growth factor family. PDGFA is a growth factor that plays an essential role in the regulation of embryonic development, cell proliferation, cell migration, survival and chemotaxis.  There are four members of the PDGF family, characterized by a motif of eight cysteines. PDGFA exists as either a homodimer or a heterodimer with PDGFB (platelet-derived growth factor beta polypeptide).</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P04085"/>
    <ns1:Alias>PDGFA</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Title>PDGFA</ns1:Title>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/386">
    <ns1:Alias>natural resistance-associated macrophage protein 1</ns1:Alias>
    <ns1:Description>SLC11A1 is a membrane associated divalent transition metal (iron and manganese) transporter involved in iron metabolism and host resistance to certain pathogens.  SLC11A1 is a member of the solute carrier family 11 (proton-coupled divalent metal ion transporters) family.      Mutations in the SLC11A1 gene are involved in susceptibility to infectious diseases such as tuberculosis and leprosy, and inflammatory diseases such as rheumatoid arthritis and Crohn disease. Several alternatively spliced variants have been identified.</ns1:Description>
    <ns1:Alias>P49279</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>SLC11A1</ns1:Alias>
    <ns1:Alias>LSH</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:386</ns1:URN>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>solute carrier family 11 (sodium/phosphate symporters), member 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC11A1&amp;search=slc11a1"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>NRAMP 1</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/6556"/>
    <ns1:Title>SLC11A1</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=10907"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P49279"/>
    <ns1:Alias>solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>NRAMP</ns1:Alias>
    <ns1:Alias>NRAMP1</ns1:Alias>
    <ns1:HgncName>SLC11A1</ns1:HgncName>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/913">
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P17813"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/218"/>
    <ns1:Alias>endoglin</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Description>ENG, or endoglin, is a cell surface adhesion protein involved the regulation of angiogenesis. ENG is a major glycoprotein of the vascular endothelium and is also a component of the transforming growth factor beta receptor complex. ENG binds to the beta1 and beta3 peptides with high affinity. ENG may also be involved in preeclampsia and several types of cancer. There are several isoforms encoded by transcript variants.</ns1:Description>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>ORW</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>CD105 antigen</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:913</ns1:URN>
    <ns1:Alias>ENG</ns1:Alias>
    <ns1:Alias>Osler-Rendu-Weber syndrome 1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>HHT1</ns1:Alias>
    <ns1:Alias>CD105</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>ORW1</ns1:Alias>
    <ns1:Alias>END</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/2022"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3349"/>
    <ns1:HgncName>ENG</ns1:HgncName>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ENG&amp;search=eng"/>
    <ns1:Title>ENG</ns1:Title>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/243">
    <ns1:Alias>MGC104991</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:243</ns1:URN>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>IL-6R-alpha</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>CD126 antigen</ns1:Alias>
    <ns1:Alias>interleukin-6 receptor subunit alpha</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Membrane glycoprotein 80</ns1:Alias>
    <ns1:Alias>CD126</ns1:Alias>
    <ns1:Alias>interleukin 6 receptor</ns1:Alias>
    <ns1:Alias>IL-6R 1</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>IL-6 receptor subunit alpha</ns1:Alias>
    <ns1:Alias>IL6R</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:3570"/>
    <ns1:Alias>gp80</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/AAH89410.1"/>
    <ns1:Alias>IL-6RA</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Title>IL6R</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P08887"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6019"/>
    <ns1:Description>The interleukin 6 receptor is a protein complex consisting of two parts: the IL6R (interleukin 6 receptor) subunit and the IL6ST (interleukin 6 signal transducer) subunit.  The IL6R subunit binds to IL6 (interleukin 6) with low affinity, but does not transduce a signal.  The IL6ST subunit is needed for signal activation.  Impaired regulation of IL6 and IL6R have been linked to many diseases, such as multiple myeloma, autoimmune diseases, and prostate cancer.  Isoforms encoded by alternatively spliced transcripts have been reported.  Activation of the IL6/IL6R/IL6ST complex may lead to the regulation of the immune response, acute-phase reactions, and hematopoiesis.</ns1:Description>
    <ns1:HgncName>IL6R</ns1:HgncName>
    <ns1:Alias>IL-6R-1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>OTTHUMP00000217870</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>IL-6R subunit alpha</ns1:Alias>
    <ns1:Alias>interleukin 6 receptor alpha subunit</ns1:Alias>
    <ns1:Alias>IL6RA</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000160712"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/899">
    <ns1:Alias>IRIS</ns1:Alias>
    <ns1:Alias>protein phosphatase 1, regulatory subunit 53</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=BRCA1&amp;search=brca1"/>
    <ns1:Alias>BRCC1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>breast and ovarian cancer sususceptibility protein 1</ns1:Alias>
    <ns1:Alias>breast and ovarian cancer susceptibility protein 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=1100"/>
    <ns1:Alias>breast cancer type 1 susceptibility protein</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:HgncName>BRCA1</ns1:HgncName>
    <ns1:Alias>PPP1R53</ns1:Alias>
    <ns1:Alias>EC 6.3.2.-</ns1:Alias>
    <ns1:Title>BRCA1</ns1:Title>
    <ns1:Alias>BROVCA1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>BRCA1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>breast cancer 1, early onset</ns1:Alias>
    <ns1:Alias>BRCAI</ns1:Alias>
    <ns1:Alias>PSCP</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>RNF53</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q14596"/>
    <ns1:Description>BRCA1 is a nuclear phosphoprotein that functions as a tumor suppressor. BRCA1 combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). BRCA1 associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers.</ns1:Description>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/672"/>
    <ns1:Alias>BRCA1/BRCA2-containing complex, subunit 1</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>PNCA4</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:899</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>RING finger protein 53</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1007">
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>MMH</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=OGG1&amp;search=ogg1"/>
    <ns1:Alias>8-Hydroxyguanine DNA Glycosylase</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/211"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:URN>urn:edrn:bmdb:biomarker:1007</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/210"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Title>OGG1</ns1:Title>
    <ns1:Alias>OGG1 Type 1e</ns1:Alias>
    <ns1:Description>8-Oxoguanine DNA Glycosylase, or OGG1, is a DNA repair enzyme that removes both 7,8-dihydro-8-oxoguanine and 2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine (FAPY) from damaged DNA. OGG1 has a beta-lyase activity that nicks DNA 3' to the lesion.  There are two major groups of splice variants for this gene, classified by alternative splicing of the C-terminal region of the gene, type 1 and type 2, depending on the last exon of the sequence. Type 1 alternative splice variants end with exon 7 and type 2 end with exon 8. All variants share the N-terminal region in common, which contains a mitochondrial targeting signal that is essential for mitochondrial localization.</ns1:Description>
    <ns1:Alias>OGH1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O15527"/>
    <ns1:Alias>8-oxoguanine DNA glycosylase</ns1:Alias>
    <ns1:Alias>OGG1 Type 1h</ns1:Alias>
    <ns1:HgncName>OGG1</ns1:HgncName>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>OGG1 Type 1g</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=8125"/>
    <ns1:Alias>DNA-Apurinic Or Apyrimidinic Site Lyase</ns1:Alias>
    <ns1:Alias>HOGG1</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>MUTM</ns1:Alias>
    <ns1:Alias>OGG1 Type 1d</ns1:Alias>
    <ns1:Alias>OGG1 Type 1f</ns1:Alias>
    <ns1:Alias>HMMH</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/4968"/>
    <ns1:Alias>AP Lyase</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>OGG1</ns1:Alias>
    <ns1:Alias>N-Glycosylase/DNA Lyase</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/209"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/947">
    <ns1:Alias>ARHA</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>ras homolog gene family, member A</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>Aplysia ras-related homolog 12</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/387"/>
    <ns1:Alias>RHOA</ns1:Alias>
    <ns1:Alias>ras homolog family member A</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:947</ns1:URN>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>RHOH12</ns1:Alias>
    <ns1:Alias>Rho cDNA clone 12</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/225"/>
    <ns1:Alias>small GTP binding protein RhoA</ns1:Alias>
    <ns1:Description>RHOA is a member of the small GTPase superfamily. RHO family GTPases are involved in many basic cellular processes that influence cell proliferation, differentiation, motility, adhesion, survival, or secretion. RHOA regulates a signal transduction pathway linking plasma membrane receptors to the assembly of focal adhesions and actin stress fibers.</ns1:Description>
    <ns1:Alias>transforming protein RhoA</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Rho12</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:HgncName>RHOA</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=667"/>
    <ns1:Title>RHOA</ns1:Title>
    <ns1:Alias>h12</ns1:Alias>
    <ns1:Alias>ARH12</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>RhoA</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P61586"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=RHOA&amp;search=rhoa"/>
    <ns1:Alias>oncogene RHO H12</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>RHO12</ns1:Alias>
    <ns1:Alias>rho cDNA clone 12</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/894">
    <ns1:Alias>adaptor protein complex AP-3 subunit beta-2</ns1:Alias>
    <ns1:Alias>AP3B2</ns1:Alias>
    <ns1:Alias>NAPTB</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/B7ZKR7"/>
    <ns1:Description>AP3B2 is the beta 2 subunit of adaptor-related protein complex 3, a neuron-specific complex that is thought to serve neuron-specific functions such as neurotransmitter release.</ns1:Description>
    <ns1:Alias>Neuron-specific vesicle coat protein beta-NAP</ns1:Alias>
    <ns1:Alias>Neuronal adaptin-like protein, beta-subunit</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=567"/>
    <ns1:Alias>clathrin assembly protein complex 3 beta-2 large chain</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:894</ns1:URN>
    <ns1:Alias>adapter-related protein complex 3 subunit beta-2</ns1:Alias>
    <ns1:Alias>Clathrin assembly protein complex 3 beta-2 large chain</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=AP3B2&amp;search=ap3b2"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>Adapter-related protein complex 3 subunit beta-2</ns1:Alias>
    <ns1:Title>AP3B2</ns1:Title>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>Beta-3B-adaptin</ns1:Alias>
    <ns1:Alias>adaptor-related protein complex 3, beta 2 subunit</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Adaptor protein complex AP-3 subunit beta-2</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>neuron-specific vesicle coat protein beta-NAP</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>beta-3B-adaptin</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>AP-3 complex subunit beta-2</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8120"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:HgncName>AP3B2</ns1:HgncName>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/127">
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>FBNL</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=EFEMP1&amp;search=fibulin%3D3"/>
    <ns1:Description>EFEMP1, also known as fibulin-3, binds EGFR, the EGF receptor, inducing EGFR autophosphorylation and the activation of downstream signaling pathways. It may play a role in cell adhesion and migration, and may function as a negative regulator of chondrocyte differentiation. In the olfactory epithelium, it may regulate glial cell migration, differentiation and the ability of glial cells to support neuronal neurite outgrowth. EFEMP1 is up-regulated in malignant gliomas and may play a role in the agressive nature of these tumors by increasing glioma cell adhesiveness and invasive properties.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=3218"/>
    <ns1:Alias>Fibulin-3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q12805"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/2202"/>
    <ns1:Alias>Extracellular protein S1-5</ns1:Alias>
    <ns1:Alias>EFEMP1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/203"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Fibrillin-like protein</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>DHRD</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>fibulin 3</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:127</ns1:URN>
    <ns1:HgncName>EFEMP1</ns1:HgncName>
    <ns1:Alias>EGF containing fibulin-like extracellular matrix protein 1</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Diamandis Mount Sinai Hospital</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>MTLV</ns1:Alias>
    <ns1:Alias>FBLN3</ns1:Alias>
    <ns1:Title>EFEMP1</ns1:Title>
    <ns1:Alias>S1-5</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/541">
    <ns1:Alias>ATSV</ns1:Alias>
    <ns1:Alias>Microtubule-Based Motor KIF1A</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:HgncName>KIF1A</ns1:HgncName>
    <ns1:Alias>Chromosome 2 Open Reading Frame 20</ns1:Alias>
    <ns1:Alias>Axonal Transporter Of Synaptic Vesicles</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Axonal Transport Of Synaptic Vesicles</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q12756"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:541</ns1:URN>
    <ns1:Alias>Kinesin Family Member 1A</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Kinesin, Heavy Chain, Member 1A, Homolog Of Mouse</ns1:Alias>
    <ns1:Alias>UNC104</ns1:Alias>
    <ns1:Alias>HSN2C</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/128"/>
    <ns1:Alias>Spastic Paraplegia 30 (Autosomal Recessive)</ns1:Alias>
    <ns1:Alias>SPG30</ns1:Alias>
    <ns1:Alias>HUnc-104</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Description>From NCBI Entrez Gene: The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]</ns1:Description>
    <ns1:Alias>Unc-104- And KIF1A-Related Protein</ns1:Alias>
    <ns1:Alias>C2orf20</ns1:Alias>
    <ns1:Title>KIF1A</ns1:Title>
    <ns1:Alias>Tmp_locus_27</ns1:Alias>
    <ns1:Alias>KIF1A</ns1:Alias>
    <ns1:Alias>Kinesin-Like Protein KIF1A</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/547"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=KIF1A"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:888"/>
    <ns1:Alias>MRD9</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/858">
    <ns1:Alias>Apo-2L</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Apo-2 ligand</ns1:Alias>
    <ns1:Alias>tumor necrosis factor (ligand) family, member 10</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P50591"/>
    <ns1:Alias>tumor necrosis factor ligand superfamily member 10</ns1:Alias>
    <ns1:Alias>Protein TRAIL</ns1:Alias>
    <ns1:Alias>CD253 antigen</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>chemokine tumor necrosis factor ligand superfamily member 10</ns1:Alias>
    <ns1:Description>tumor necrosis factor (ligand) superfamily, member 10</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=11925"/>
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/603598"/>
    <ns1:Title>TNFSF10</ns1:Title>
    <ns1:URN>urn:edrn:bmdb:biomarker:858</ns1:URN>
    <ns1:Alias>TNF-related apoptosis inducing ligand TRAIL</ns1:Alias>
    <ns1:Alias>TNF-related apoptosis-inducing ligand</ns1:Alias>
    <ns1:Alias>APO2L</ns1:Alias>
    <ns1:Alias>CD253</ns1:Alias>
    <ns1:Alias>TNFSF10</ns1:Alias>
    <ns1:Alias>TL2</ns1:Alias>
    <ns1:Alias>TRAIL</ns1:Alias>
    <ns1:Alias>tumor necrosis factor apoptosis-inducing ligand splice variant delta</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8743"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Phase>One</ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:HgncName>TNFSF10</ns1:HgncName>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>tumor necrosis factor (ligand) superfamily, member 10</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/65">
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:AccessGrantedTo>McIntosh Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>MMP-7</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>Pump-1 protease</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=7174"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/82"/>
    <ns1:Alias>MMP7</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Description>Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades proteoglycans, fibronectin, elastin and casein and differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The enzyme is involved in wound healing, and studies in mice suggest that it regulates the activity of defensins in intestinal mucosa. The gene is part of a cluster of MMP genes which localize to chromosome 11q22.3.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_002414.1"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>PUMP-1</ns1:Alias>
    <ns1:Alias>matrix metalloproteinase 7 (matrilysin, uterine)</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:HgncName>MMP7</ns1:HgncName>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:4316"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P09237"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:65</ns1:URN>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>MPSL1</ns1:Alias>
    <ns1:Title>MMP7</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>Uterine metalloproteinase</ns1:Alias>
    <ns1:Alias>Matrilysin</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/896">
    <ns1:Alias>ephexin-4</ns1:Alias>
    <ns1:Alias>GEF16</ns1:Alias>
    <ns1:Alias>Rho guanine nucleotide exchange factor (GEF) 16</ns1:Alias>
    <ns1:Alias>rho guanine nucleotide exchange factor 16</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q5VV41"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>Ephexin-4</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:896</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/27237"/>
    <ns1:HgncName>ARHGEF16</ns1:HgncName>
    <ns1:Alias>NBR</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ARHGEF16&amp;search=arhgef16"/>
    <ns1:Alias>EPHEXIN4</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Description>ARHGEF16 is a guanine nucleotide exchange factor.  Guanine nucleotide exchange factors regulate the activation of Rho-like GTPases. Guanidine exchange factors promote the GTP activation of Rho GTPase's by catalyzing the exchange of GDP for GTP.</ns1:Description>
    <ns1:Alias>ARHGEF16</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=15515"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Title>ARHGEF16</ns1:Title>
    <ns1:Alias>Rho guanine exchange factor (GEF) 16</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/217"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/25">
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>cancer antigen 19-9</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Description>CA19-9 is a monoclonal antibody that was first discovered in the serum of patients with colon cancer.  Since that time CA19-9 has been used as a tumor marker for a variety of cancers.</ns1:Description>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N3cb4915e36d842a58a10f8d1d4a4b54c">
        <rdf:_5 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/961"/>
        <rdf:_2 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/35"/>
        <rdf:_3 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/917"/>
        <rdf:_6 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/1016"/>
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/34"/>
        <rdf:_4 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/929"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:HgncName></ns1:HgncName>
    <ns1:indicatorForOrgan>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/46">
        <ns1:Alias>Nel-related protein 1</ns1:Alias>
        <ns1:HgncName>NELL1</ns1:HgncName>
        <ns1:Phase></ns1:Phase>
        <ns1:AccessGrantedTo>Meltzer Johns Hopkins University</ns1:AccessGrantedTo>
        <ns1:Security>Public</ns1:Security>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:Description>NELL1 is a cytoplasmic protein that contains epidermal growth factor (EGF)-like repeats. The encoded heterotrimeric protein may be involved in cell growth regulation and differentiation.</ns1:Description>
        <ns1:Title>NELL1</ns1:Title>
        <ns1:QAState>Accepted</ns1:QAState>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
        <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:HopkinsMeltzerBarrettMethylationProfiles"/>
        <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/67"/>
        <ns1:URN>urn:edrn:bmdb:biomarker:46</ns1:URN>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
        <ns1:Alias>NELL1</ns1:Alias>
        <ns1:Alias>NEL-like protein 1</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000165973"/>
        <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=7750"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/52"/>
        <ns1:Alias>NRP1</ns1:Alias>
        <ns1:Type>Genomic</ns1:Type>
        <ns1:Alias>Protein kinase C-binding protein NELL1</ns1:Alias>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:4745"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
        <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q92832"/>
        <ns1:hasBiomarkerStudyDatas>
          <rdf:Bag rdf:nodeID="N7f4750e670404014b24672e000e22a2d">
            <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/46/45"/>
          </rdf:Bag>
        </ns1:hasBiomarkerStudyDatas>
        <ns1:Alias>nel-like 1</ns1:Alias>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
      </ns1:Biomarker>
    </ns1:indicatorForOrgan>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/14"/>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BGWHCramerPLCOPhaseIIIAnalysis"/>
    <ns1:indicatorForOrgan>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/918">
        <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=20731"/>
        <ns1:Alias>guanine nucleotide-binding protein subunit beta-4</ns1:Alias>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:Title>GNB4</ns1:Title>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/59345"/>
        <ns1:HgncName>GNB4</ns1:HgncName>
        <ns1:Security>Public</ns1:Security>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Alias>GNB4</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
        <ns1:Phase>Two</ns1:Phase>
        <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9HAV0"/>
        <ns1:Alias>transducin beta chain 4</ns1:Alias>
        <ns1:Description>GNB4 is the beta subunit of a heterotrimeric guanine nucleotide-binding protein (G protein). These proteins also have alpha and gamma subunits.  GNB4 and other beta subunits are important regulators of alpha subunits, as well as of certain signal transduction receptors and effectors. Each type of subunit is encoded by families of related genes.</ns1:Description>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:Alias>Transducin beta chain 4</ns1:Alias>
        <ns1:Alias>G protein beta-4 subunit</ns1:Alias>
        <ns1:Alias>guanine nucleotide binding protein (G protein), beta polypeptide 4</ns1:Alias>
        <ns1:URN>urn:edrn:bmdb:biomarker:918</ns1:URN>
        <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=GNB4&amp;search=gnb4"/>
        <ns1:Alias>guanine nucleotide binding protein beta subunit 4</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
        <ns1:Type>Protein</ns1:Type>
      </ns1:Biomarker>
    </ns1:indicatorForOrgan>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1118"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/252"/>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1074"/>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>CA19-9</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/13"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/246"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:25</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BGWHCramerPrePLCOPhaseIIAnalysis"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:AccessGrantedTo>Cramer Brigham and Women's Hospital</ns1:AccessGrantedTo>
    <ns1:Alias>carbohydrate antigen 19-9</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:Title>CA19-9</ns1:Title>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/71">
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Title>SPON2</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>FLJ22401</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11253"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Alias>DIL-1</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:71</ns1:URN>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>SPON2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9BUD6"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>spondin 2</ns1:Alias>
    <ns1:Alias>Differentially expressed in cancerous and non-cancerous lung cells 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Description>SPON2, also known as spondin-2, is a cell adhesion protein that promotes adhesion and outgrowth of hippocampal embryonic neurons. It binds directly to bacteria and their components and functions as an opsonin for macrophage phagocytosis of bacteria. Spondin-2 is essential in the initiation of the innate immune response and represents a unique pattern-recognition molecule in the extacellular matrix for microbial pathogens. Spondin-2 also binds bacterial lipopolysaccharide.</ns1:Description>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Spondin-2</ns1:Alias>
    <ns1:Alias>Mindin</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_036577.1"/>
    <ns1:Alias>M-spondin</ns1:Alias>
    <ns1:AccessGrantedTo>McIntosh Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>DIL1</ns1:Alias>
    <ns1:HgncName>SPON2</ns1:HgncName>
    <ns1:Alias>FLJ34460</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:10417"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>spondin 2, extracellular matrix protein</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>FLJ16313</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/956">
    <ns1:Alias>SLP2</ns1:Alias>
    <ns1:Description>STOML2, also known as SLP-2 or stomatin-like 2, is a mitochondrial protein that is thought to  regulate the biogenesis and the activity of mitochondria, and through this regulation play a role in cell activities such as cell migration, cell proliferation, T-cell activation, calcium homeostasis and cellular response to stress.</ns1:Description>
    <ns1:Alias>stomatin-like protein 2</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=STOML2&amp;search=stoml2"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:956</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9UJZ1"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>stomatin-like 2</ns1:Alias>
    <ns1:HgncName>STOML2</ns1:HgncName>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/227"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>HSPC108</ns1:Alias>
    <ns1:Alias>SLP-2</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/30968"/>
    <ns1:Title>STOML2</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=14559"/>
    <ns1:Alias>stomatin (EPB72)-like 2</ns1:Alias>
    <ns1:Alias>STOML2</ns1:Alias>
    <ns1:Alias>EPB72-like protein 2</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/151">
    <ns1:Alias>LU</ns1:Alias>
    <ns1:Title>BCAM</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/191"/>
    <ns1:Alias>basal cell adhesion molecule (Lutheran blood group)</ns1:Alias>
    <ns1:Alias>Basal cell adhesion molecule</ns1:Alias>
    <ns1:Alias>MSK19</ns1:Alias>
    <ns1:Alias>CD_antigen=CD239</ns1:Alias>
    <ns1:Alias>Lutheran antigen</ns1:Alias>
    <ns1:Description>Lutheran blood group glycoprotein is a member of the immunoglobulin superfamily and a receptor for the extracellular matrix protein, laminin alpha-5. The protein contains five, N-terminus, extracellular immunoglobulin domains, a single transmembrane domain, and a short, C-terminal cytoplasmic tail. This protein may play a role in epithelial cell cancer and in vaso-occlusion of red blood cells in sickle cell disease. It may also play a role in intracellular signalling. BCAM has wide tissue distribution (highest in the pancreas and very low in brain) and is closely associated with the basal layer of cells in epithelia and the endothelium of blood vessel walls. Two transcript variants encoding different isoforms have been found for this gene.</ns1:Description>
    <ns1:Alias>Auberger B antigen</ns1:Alias>
    <ns1:Alias>BCAM</ns1:Alias>
    <ns1:Alias>Lutheran blood group glycoprotein</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Diamandis Mount Sinai Hospital</ns1:AccessGrantedTo>
    <ns1:Alias>Lutheran blood group (Auberger b antigen included)</ns1:Alias>
    <ns1:HgncName>BCAM</ns1:HgncName>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>AU</ns1:Alias>
    <ns1:Alias>B-CAM cell surface glycoprotein</ns1:Alias>
    <ns1:Alias>F8/G253 antigen</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>basal cell adhesion molecule (Lu and Au blood groups)</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>CD239</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Skates Massachusetts General Hospital</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:151</ns1:URN>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/236">
    <ns1:Alias>MMP-II</ns1:Alias>
    <ns1:Alias>matrix metalloproteinase-II</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>72 kDa gelatinase</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>EC 3.4.24.24</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>72 kDa type IV collagenase</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Gelatinase A</ns1:Alias>
    <ns1:Alias>Matrix metalloproteinase-2</ns1:Alias>
    <ns1:Alias>MMP-2</ns1:Alias>
    <ns1:Alias>collagenase type IV-A</ns1:Alias>
    <ns1:Alias>matrix metalloproteinase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)</ns1:Alias>
    <ns1:HgncName>MMP2</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Alias>matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)</ns1:Alias>
    <ns1:Alias>CLG4</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P08253"/>
    <ns1:Alias>neutrophil gelatinase</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Description>MMP2 is a member of the matrix metalloproteinase (MMP) family and is involved in many functions, such as remodeling of the vasculature, angiogenesis, tissue repair and remodeling, tumor invasion, inflammation, atherosclerotic plaque rupture, reproduction and embryonic development, as well as in disease processes such as arthritis and metastasis.  In addition to degrading extracellular matrix proteins, MMP2 can also act on several nonmatrix proteins such as big endothelial 1 and beta-type CGRP promoting vasoconstriction and appears to have a role in myocardial cell death pathways.  MMPs are generally secreted as inactive proproteins which are activated when cleaved by extracellular proteinases.  The MMP2 protein degrades gelatin type I and collagen types IV, V, VII, and X.  MMP2 gene mutations have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome.  There are two known isoforms of this gene, encoded by two transcript variants.</ns1:Description>
    <ns1:Title>MMP2</ns1:Title>
    <ns1:Alias>MMP2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_004521.1"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=7166"/>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:236</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:4313"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>TBE-1</ns1:Alias>
    <ns1:Alias>CLG4A</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/56">
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000167751"/>
    <ns1:AccessGrantedTo>Prostate and Urologic</ns1:AccessGrantedTo>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="Nb954093bd4ca4d799e554b7a147ab3a8">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/56/24"/>
        <rdf:_2 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/56/59"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:Alias>Kallikrein-2</ns1:Alias>
    <ns1:Title>KLK2</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/69"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/70"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>hK2</ns1:Alias>
    <ns1:Alias>KLK2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6363"/>
    <ns1:Alias>hGK-1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P20151"/>
    <ns1:Description>The glandular kallikreins are a distinct group of serine proteases with molecular masses of 25,000 to 40,000. The glandular kallikrein gene family comprises 25 to 30 highly homologous genes that encode specific proteases involved in the processing of biologically active peptides (they cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin). Several human kallikrein genes have been isolated.</ns1:Description>
    <ns1:Alias>MGC12201</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:URN>urn:edrn:bmdb:biomarker:56</ns1:URN>
    <ns1:Alias>KLK2A2</ns1:Alias>
    <ns1:Alias>glandular kallikrein 2</ns1:Alias>
    <ns1:HgncName>KLK2</ns1:HgncName>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Glandular kallikrein-1</ns1:Alias>
    <ns1:Alias>Tissue kallikrein-2</ns1:Alias>
    <ns1:Alias>kallikrein-related peptidase 2</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:indicatorForOrgan>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/77">
        <ns1:Alias>SL-1</ns1:Alias>
        <ns1:Alias>MGC126102</ns1:Alias>
        <ns1:Alias>Matrix metalloproteinase-3</ns1:Alias>
        <ns1:Alias>STR1</ns1:Alias>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Instititute</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
        <ns1:Phase></ns1:Phase>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P08254"/>
        <ns1:Alias>STMY</ns1:Alias>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=7173"/>
        <ns1:Alias>MMP3</ns1:Alias>
        <ns1:Alias>Stromelysin-1</ns1:Alias>
        <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
        <ns1:Alias>MGC126104</ns1:Alias>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:URN>urn:edrn:bmdb:biomarker:77</ns1:URN>
        <ns1:Title>MMP3</ns1:Title>
        <ns1:Alias>MGC126103</ns1:Alias>
        <ns1:Alias>STMY1</ns1:Alias>
        <ns1:HgncName>MMP3</ns1:HgncName>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:Type>Protein</ns1:Type>
        <ns1:Alias>MMP-3</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_002413.1"/>
        <ns1:Security>Public</ns1:Security>
        <ns1:Alias>Transin-1</ns1:Alias>
        <ns1:Alias>proteoglycanase</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
        <ns1:Alias>matrix metallopeptidase 3 (stromelysin 1, progelatinase)</ns1:Alias>
        <ns1:Description>Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. MMP3 degrades fibronectin, laminin, collagens III, IV, IX, and X, and cartilage proteoglycans. The enzyme is thought to be involved in wound repair, progression of atherosclerosis, and tumor initiation. The gene is part of a cluster of MMP genes which localize to chromosome 11q22.3.</ns1:Description>
        <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
        <ns1:Alias>CHDS6</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:4314"/>
      </ns1:Biomarker>
    </ns1:indicatorForOrgan>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BethIsraelSandaDataMarkerPerformanceSummary"/>
    <ns1:Alias>kallikrein 2, prostatic</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/395">
    <ns1:Alias>MTSP1</ns1:Alias>
    <ns1:Alias>TADG15</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Q9Y5Y6</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>prostamin</ns1:Alias>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>OTTHUMP00000230931</ns1:Alias>
    <ns1:Alias>OTTHUMP00000230932</ns1:Alias>
    <ns1:Title>ST14</ns1:Title>
    <ns1:HgncName>ST14</ns1:HgncName>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin)</ns1:Alias>
    <ns1:Alias>Serine protease TADG-15</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9Y5Y6"/>
    <ns1:Alias>Tumor-associated differentially-expressed gene 15 protein</ns1:Alias>
    <ns1:Alias>Prostamin</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>suppression of tumorigenicity 14 (colon carcinoma)</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:395</ns1:URN>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>ST14</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ST14&amp;search=st14"/>
    <ns1:Description>ST14 protein is an epithelial-derived, integral membrane serine protease and is found to be activated by sphingosine 1-phosphate. The expression of this protease has been associated with breast, colon, prostate, and ovarian tumors, which implicates its role in cancer invasion, and metastasis.</ns1:Description>
    <ns1:Alias>MT-SP1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Alias>HAI</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>SNC19</ns1:Alias>
    <ns1:Alias>Serine protease 14</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>Membrane-type serine protease 1</ns1:Alias>
    <ns1:Alias>tumor associated differentially expressed gene 15 protein</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>TMPRSS14</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/6768"/>
    <ns1:Alias>EC 3.4.21</ns1:Alias>
    <ns1:Alias>Matriptase</ns1:Alias>
    <ns1:Alias>suppressor of tumorigenicity 14 protein</ns1:Alias>
    <ns1:Alias>EC 3.4.21.109</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=11344"/>
    <ns1:Alias>PRSS14</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/426">
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Tumor suppressor protein DCC</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:426</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=2701"/>
    <ns1:Alias>deleted in colorectal carcinoma</ns1:Alias>
    <ns1:Description>DCC is a receptor for netrin 1, which is required for axon guidance.  DCC is a transmembrane protein and a member of the immunoglobulin superfamily of cell adhesion molecules.  It mediates axon attraction of neuronal growth cones in the developing nervous system upon ligand binding. The cytoplasmic tail of DCC interacts with the tyrosine kinases Src and focal adhesion kinase (FAK, also known as PTK2) to mediate axon attraction. The protein partially localizes to lipid rafts, and induces apoptosis in the absence of
ligand. The protein functions as a tumor suppressor, and is frequently mutated or downregulated in colorectal cancer and esophageal carcinoma.</ns1:Description>
    <ns1:Alias>DCC</ns1:Alias>
    <ns1:Alias>netrin receptor DCC</ns1:Alias>
    <ns1:Alias>CRCR1</ns1:Alias>
    <ns1:Alias>immunoglobulin superfamily, DCC subclass, member 1</ns1:Alias>
    <ns1:Alias>IGDCC1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>immunoglobulin superfamily DCC subclass member 1</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_005206.2"/>
    <ns1:Alias>tumor suppressor protein DCC</ns1:Alias>
    <ns1:Alias>colorectal cancer suppressor</ns1:Alias>
    <ns1:Alias>deleted in colorectal cancer protein</ns1:Alias>
    <ns1:Alias>Colorectal cancer suppressor</ns1:Alias>
    <ns1:Alias>colorectal tumor suppressor</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=DCC&amp;search=dcc"/>
    <ns1:HgncName>DCC</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/121"/>
    <ns1:Title>DCC</ns1:Title>
    <ns1:Alias>Immunoglobulin superfamily DCC subclass member 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P43146"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>CRC18</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/128"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/375">
    <ns1:Alias>FZD10</ns1:Alias>
    <ns1:Alias>FZ-10</ns1:Alias>
    <ns1:Alias>Fz-10</ns1:Alias>
    <ns1:Alias>frizzled-10</ns1:Alias>
    <ns1:Alias>frizzled 10, seven transmembrane spanning receptor</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>frizzled homolog 10</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:HgncName>FZD10</ns1:HgncName>
    <ns1:Title>FZD10</ns1:Title>
    <ns1:Alias>frizzled (Drosophila) homolog 10</ns1:Alias>
    <ns1:Alias>FzE7</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/11211"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>Fz10</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=4039"/>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD10&amp;search=fzd10"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:375</ns1:URN>
    <ns1:Alias>CD350</ns1:Alias>
    <ns1:Alias>frizzled family receptor 10</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/196"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Alias>frizzled homolog 10 (Drosophila)</ns1:Alias>
    <ns1:Alias>Q9ULW2</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>FZD10 is a member of the frizzled gene family.  The frizzled gene family encodes 7-transmembrane domain proteins that are receptors for the Wingless type MMTV integration site family of signaling proteins (WNT signaling proteins).  The highest levels of expression for FZD10 are seen in the placenta and fetal kidney, followed by fetal lung and brain. Using array analysis, expression of this intronless gene is significantly up-regulated in two cases of primary colon cancer.</ns1:Description>
    <ns1:Alias>CD350 antigen</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9ULW2"/>
    <ns1:Alias>hFz10</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/557">
    <ns1:Alias>cytoplasmic aconitate hydratase</ns1:Alias>
    <ns1:Alias>ferritin repressor protein</ns1:Alias>
    <ns1:Alias>IREBP1</ns1:Alias>
    <ns1:Title>ACO1</ns1:Title>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>ACONS</ns1:Alias>
    <ns1:Alias>IRP1</ns1:Alias>
    <ns1:Alias>iron regulatory protein 1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Alias>Iron-responsive element-binding protein 1</ns1:Alias>
    <ns1:Alias>IRE-BP 1</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:557</ns1:URN>
    <ns1:Alias>EC 4.2.1.3</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:HgncName>ACO1</ns1:HgncName>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>IREB1</ns1:Alias>
    <ns1:Alias>IREBP</ns1:Alias>
    <ns1:Alias>Iron regulatory protein 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Description>aconitase 1, soluble</ns1:Description>
    <ns1:Alias>iron-responsive element-binding protein 1</ns1:Alias>
    <ns1:Alias>aconitase 1, soluble</ns1:Alias>
    <ns1:Alias>ACO1</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>aconitate hydratase</ns1:Alias>
    <ns1:Alias>iron-responsive element binding protein 1</ns1:Alias>
    <ns1:Alias>Citrate hydro-lyase</ns1:Alias>
    <ns1:Alias>citrate hydro-lyase</ns1:Alias>
    <ns1:Alias>Aconitase</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Ferritin repressor protein</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Security>Public</ns1:Security>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/374">
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>Human gene expressed in odontoblasts</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>bA203I16.1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>FNDC3A</ns1:Alias>
    <ns1:Alias>Q9Y2H6</ns1:Alias>
    <ns1:Description>Fndc3a is a member of a three-gene family in mice.  Mouse Fndc3a is composed of a proline-rich amino-terminus, nine fibronectin type-III domains, and a hydrophobic carboxy-terminus.  By similarity, human FNDC3A is thought to mediate spermatid-Sertoli adhesion during spermatogenesis.</ns1:Description>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Alias>fibronectin type III domain containing 3A</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=20296"/>
    <ns1:Alias>HUGO</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9Y2H6"/>
    <ns1:Alias>fibronectin type III domain containing 3</ns1:Alias>
    <ns1:Alias>human gene expressed in odontoblasts</ns1:Alias>
    <ns1:Title>FNDC3A</ns1:Title>
    <ns1:Alias>FNDC3</ns1:Alias>
    <ns1:Alias>bA203I16.5</ns1:Alias>
    <ns1:HgncName>FNDC3A</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:374</ns1:URN>
    <ns1:Alias>KIAA0970</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=FNDC3A&amp;search=fndc3a"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/22862"/>
    <ns1:Alias>fibronectin type-III domain-containing protein 3A</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/635">
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1803"/>
    <ns1:Alias>EC 3.4.14.5</ns1:Alias>
    <ns1:Title>DPP4</ns1:Title>
    <ns1:Alias>DPP4</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P27487"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>T-cell activation antigen CD26</ns1:Alias>
    <ns1:Description>From NCBI Gene: The protein encoded by this gene is identical to adenosine deaminase complexing protein-2, and to the T-cell activation antigen CD26. It is an intrinsic membrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. [provided by RefSeq, Jul 2008]</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Alias>TP103</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/102720?search=102720&amp;highlight=102720"/>
    <ns1:Alias>dipeptidyl peptidase 4</ns1:Alias>
    <ns1:Alias>dipeptidylpeptidase 4</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>adenosine deaminase complexing protein 2</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:635</ns1:URN>
    <ns1:Alias>dipeptidyl-peptidase 4</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>ADABP</ns1:Alias>
    <ns1:Alias>ADCP2</ns1:Alias>
    <ns1:HgncName>DPP4</ns1:HgncName>
    <ns1:Alias>Dipeptidyl peptidase IV</ns1:Alias>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>Adenosine deaminase complexing protein 2</ns1:Alias>
    <ns1:Alias>DPP IV</ns1:Alias>
    <ns1:Alias>DPPIV</ns1:Alias>
    <ns1:Alias>CD26 antigen</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3009"/>
    <ns1:Alias>dipeptidyl peptidase IV</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>ADCP-2</ns1:Alias>
    <ns1:Alias>dipeptidylpeptidase IV (CD26, adenosine deaminase complexing protein 2)</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>CD26</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/37">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/36"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_001125.1"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/38"/>
    <ns1:Alias>lectin-bound AFP</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm078610.htm"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=317"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/33"/>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/37"/>
    <ns1:Description>AFP-L3, also known as lectin-bound AFP, is an isoform of AFP, a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatoma or teratoma. The L3 isoform is specific to malignant tumors and its detected presence may serve to identify patients who could benefit from monitoring for the development of HCC in high risk populations (i.e. chronic hepatitis, liver cirrhosis).</ns1:Description>
    <ns1:Alias>AFP-L3</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Title>AFP-L3</ns1:Title>
    <ns1:HgncName>AFP-L3</ns1:HgncName>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P02771"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/132"/>
    <ns1:AccessGrantedTo>G.I. and Other Associated</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:37</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=AFP&amp;search=afp"/>
    <ns1:Alias>Lectin-bound alpha-fetoprotein</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/107">
    <ns1:Alias>Vimentin methylation in stool</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P08670"/>
    <ns1:Alias>Aberrant Vimentin DNA Methylation in Stool</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:107</ns1:URN>
    <ns1:Alias>VIM</ns1:Alias>
    <ns1:Type>Epigenetic</ns1:Type>
    <ns1:HgncName>VIM</ns1:HgncName>
    <ns1:Description>The VIM gene encodes a member of the intermediate filament family.  VIM proteins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells.  These intermediate filaments, along with microtubules and actin microfilaments, make up the cytoskeleton.</ns1:Description>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.cancer.gov/aboutnci/ncicancerbulletin/archive/2005/080905/page2"/>
    <ns1:Title>Aberrant Vimentin DNA Methylation in Stool</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=12692"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/177"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/178"/>
    <ns1:Alias>Vimentin, methylated</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7431"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Markowitz Case Western Reserve University</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/228">
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Follitropin subunit beta</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000501.1"/>
    <ns1:Alias>FSH-beta</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>FSH-B</ns1:Alias>
    <ns1:Title>FSH</ns1:Title>
    <ns1:Description>The pituitary glycoprotein hormone family includes follicle-stimulating hormone, luteinizing hormone, chorionic gonadotropin, and thyroid-stimulating hormone. All of these glycoproteins consist of an identical alpha subunit and a hormone-specific beta subunit. This gene encodes the beta subunit of follicle-stimulating hormone. In conjunction with luteinizing hormone, follicle-stimulating hormone induces egg and sperm production. Alternative splicing results in two transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]  
Defects in FSHB are a cause of isolated follicle-stimulating hormone deficiency. Selective follicle-stimulating hormone deficiency is an uncommon cause of infertility, producing amenorrhea and hypogonadism in women and oligo or azoospermia with normal testosterone levels in normally virilised men. FSHB belongs to the glycoprotein hormones subunit beta family.  There are two transcript variants from alternative splicing that each encode the same protein.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:2488"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>FSHB</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>FSH</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:HgncName>FSHB</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:228</ns1:URN>
    <ns1:Alias>Follitropin beta chain</ns1:Alias>
    <ns1:Alias>follitropin, beta chain</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=3964"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P01225"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>follicle stimulating hormone, beta polypeptide</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/172"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Alias>follicle-stimulating hormone beta subunit</ns1:Alias>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Institute</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/919">
    <ns1:Alias>Protein MOS2 homolog</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>GPATC5</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>G patch domain and KOW motifs-containing protein</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>G patch domain and KOW motifs</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q92917"/>
    <ns1:Alias>GPATCH5</ns1:Alias>
    <ns1:Description>GPKOW is a a putative RNA-binding protein containing G-patch and KOW (Kyprides, Ouzounis, Woese) domains. GPKOW     interacts directly with protein kinase A and protein kinase X and is also found associated with the spliceosome.</ns1:Description>
    <ns1:URN>urn:edrn:bmdb:biomarker:919</ns1:URN>
    <ns1:Title>GPKOW</ns1:Title>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>GPKOW</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=30677"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:HgncName>GPKOW</ns1:HgncName>
    <ns1:Alias>G patch domain-containing protein 5</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>T54</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=GPKOW&amp;search=gpkow"/>
    <ns1:Alias>protein MOS2 homolog</ns1:Alias>
    <ns1:Alias>Protein T54</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/27238"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Spp2</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/126">
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Description>ECM1 is an extracellular protein containing motifs with a cysteine pattern characteristic of the cysteine pattern of the ligand-binding "double-loop" domains of the albumin protein family. It is involved in endochondral bone formation as negative regulator of bone mineralization.  EMC1 stimulates the proliferation of endothelial cells and promotes angiogenesis.  It also inhibits MMP9 proteolytic activity.  ECM1 is expressed in breast cancer tissues, however little or no expression observed in normal breast tissues. It is also expressed in skin; wide expression is observed throughout the dermis with minimal expression in the epidermis.</ns1:Description>
    <ns1:HgncName>ECM1</ns1:HgncName>
    <ns1:Alias>Secretory component p85</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Diamandis Mount Sinai Hospital</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/191"/>
    <ns1:Alias>ECM1</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:126</ns1:URN>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>extracellular matrix protein 1</ns1:Alias>
    <ns1:Title>ECM1</ns1:Title>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/189">
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>CD_antigen=CD358</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>tumor necrosis factor receptor superfamily, member 21</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O75509"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=13469"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:189</ns1:URN>
    <ns1:Alias>UNQ437/PRO868</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>TNFRSF21</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/27242"/>
    <ns1:Alias>death receptor 6</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://http://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF21&amp;search=TNFRSF21"/>
    <ns1:Title>TNFRSF21</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Description>TNFRSF21, a member of the TNF-receptor superfamily and a single-pass type I membrane protein, has been shown to activate NF-kappaB and MAPK8/JNK, and induce cell apoptosis. Through its death domain, this receptor interacts with TRADD protein, which is known to serve as an adaptor that mediates signal transduction of TNF-receptors. TNFRSF21 is required for both normal cell body death and axonal pruning. Knockout studies in mice suggested that this gene plays a role in T-helper cell activation, and may be involved in inflammation and immune regulation.</ns1:Description>
    <ns1:HgncName>TNFRSF21</ns1:HgncName>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/196"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>DR6</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1015">
    <ns1:Alias>tumor differentially expressed 2-like</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:1015</ns1:URN>
    <ns1:Alias>PRO0899</ns1:Alias>
    <ns1:HgncName>SERINC2</ns1:HgncName>
    <ns1:Alias>FKSG84</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Alias>TDE2</ns1:Alias>
    <ns1:Alias>TDE2L</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>SERINC2</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/347735"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>serine incorporator 2</ns1:Description>
    <ns1:Title>SERINC2</ns1:Title>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/614549?search=614549&amp;highlight=614549"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=23231"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q96SA4"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>serine incorporator 2</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1010">
    <ns1:Alias>Histone H2B.G</ns1:Alias>
    <ns1:Alias>Histone H2B.A</ns1:Alias>
    <ns1:Alias>H2B.h</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:1010</ns1:URN>
    <ns1:Alias>Histone Cluster 1, H2be</ns1:Alias>
    <ns1:Alias>Histone H2B.L</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Histone H2B Type 1-C/E/F/G/I</ns1:Alias>
    <ns1:Alias>H2B Histone Family, Member H</ns1:Alias>
    <ns1:Alias>Histone H2B.H</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:HgncName>HIST1H2BE</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=4753"/>
    <ns1:Alias>Histone 1, H2be</ns1:Alias>
    <ns1:Alias>Histone H2B.1 A</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8344"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>H2B/l</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>H2BFA</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>H2BFH</ns1:Alias>
    <ns1:Description>H2B histone family, member H</ns1:Description>
    <ns1:Alias>H2B/h</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>dJ221C16.8</ns1:Alias>
    <ns1:Alias>H2BFK</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>HIST1H2BE</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/602805"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>H2B/a</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P62807"/>
    <ns1:Alias>H2BFG</ns1:Alias>
    <ns1:Alias>H2B/k</ns1:Alias>
    <ns1:Alias>H2BFL</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Title>HIST1H2BE</ns1:Title>
    <ns1:Alias>H2B/g</ns1:Alias>
    <ns1:Alias>Histone H2B.K</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/944">
    <ns1:Alias>ras-related protein Rab-24</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/53917"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>RAB24, member RAS oncogene family</ns1:Alias>
    <ns1:Description>RAB24 is a small GTPase of the Rab subfamily of Ras-related proteins that regulate intracellular protein trafficking.  RAB24 may be involved in autophagy-related processes.</ns1:Description>
    <ns1:HgncName>RAB24</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q969Q5"/>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:944</ns1:URN>
    <ns1:Alias>RAB24</ns1:Alias>
    <ns1:Title>RAB24</ns1:Title>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=RAB24&amp;search=rab24"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=9765"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/948">
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>zinc finger protein 183 (RING finger, C3HC4 type)</ns1:Alias>
    <ns1:Alias>ZNF183</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=12974"/>
    <ns1:Alias>Zinc finger protein 183</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=RNF113A&amp;search=rnf113a"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O15541"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7737"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Title>RNF113A</ns1:Title>
    <ns1:Alias>RNF113</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Description>RNF113A is a member of the RNF family, or RING-type zinc finger proteins.  The RNF proteins are a subset of the larger family of zinc finger proteins. Members of the RNF family have an enzyme activity known as E3 ubiquitin-protein ligase which  targets other proteins to be degraded within cells. RNF113A contains   a C3H1-type zinc finger domain and a C3HC4 Ring-type (Really Interesting New Gene-type) zinc finger domain. The Ring-type zinc finger domain is present in various tumor suppressors, DNA repair genes and cytokine receptor-associated molecules, and is implicated in mediating protein-protein interactions.</ns1:Description>
    <ns1:Alias>RING finger protein 113A</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>RNF113A</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>Cwc24</ns1:Alias>
    <ns1:Alias>ring finger protein 113A</ns1:Alias>
    <ns1:HgncName>RNF113A</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:948</ns1:URN>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/907">
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=DGCR6&amp;search=dgcr6"/>
    <ns1:Alias>protein DGCR6</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q14129"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8214"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>DiGeorge syndrome critical region 6</ns1:Alias>
    <ns1:HgncName>DGCR6</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:907</ns1:URN>
    <ns1:Alias>DiGeorge syndrome critical region protein 6</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>DGCR6</ns1:Alias>
    <ns1:Description>DGCR6 is located on chromosome 22q11.21.  Microdeletions in this region are associated with DiGeorge syndrome, and more widely, the CATCH 22 syndrome.  DGCR6, also known as DiGeorge syndrome critical region 6, is thought to be involved in DiGeorge syndrome pathology and in schizophrenia.  Another function attributed to this gene is a role in neural crest cell migration into the third and fourth pharyngeal pouches. The DGCR6 protein shares homology with the Drosophila melanogaster gonadal protein, which participates in gonadal and germ cell development, and with the gamma-1 subunit of human laminin.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=2846"/>
    <ns1:Alias>DiGeorge syndrome critical region gene 6</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Title>DGCR6</ns1:Title>
    <ns1:Type>Protein</ns1:Type>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/646">
    <ns1:Alias>ERBB3</ns1:Alias>
    <ns1:Alias>EC 2.7.10.1</ns1:Alias>
    <ns1:Alias>p180-ErbB3</ns1:Alias>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>erbB3-S</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>HER3</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:HgncName>ERBB3</ns1:HgncName>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P21860"/>
    <ns1:Alias>p85-sErbB3</ns1:Alias>
    <ns1:Alias>Proto-oncogene-like protein c-ErbB-3</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>ErbB-3</ns1:Alias>
    <ns1:Alias>LCCS2</ns1:Alias>
    <ns1:Alias>c-erbB3</ns1:Alias>
    <ns1:Alias>Tyrosine kinase-type cell surface receptor HER3</ns1:Alias>
    <ns1:Alias>v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)</ns1:Alias>
    <ns1:Alias>lethal congenital contracture syndrome 2</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>c-erbB-3</ns1:Alias>
    <ns1:Description>From NCBI Gene: This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized. [provided by RefSeq, Jul 2008]</ns1:Description>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>MDA-BF-1</ns1:Alias>
    <ns1:Alias>tyrosine kinase-type cell surface receptor HER3</ns1:Alias>
    <ns1:Alias>p45-sErbB3</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3431"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Alias>receptor tyrosine-protein kinase erbB-3</ns1:Alias>
    <ns1:Alias>proto-oncogene-like protein c-ErbB-3</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Title>ERBB3</ns1:Title>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/2065"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:646</ns1:URN>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/190151"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/909">
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>EC 3.1.3.16,EC 3.1.3.48</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Description>DUSP9 is a member of the dual specificity protein phosphatase subfamily. DUSP9 is specific for members of the ERK family of MAP kinases, is expressed only in placenta, kidney, and fetal liver, and is localized to the cytoplasm and nucleus.</ns1:Description>
    <ns1:HgncName>DUSP9</ns1:HgncName>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Mitogen-activated protein kinase phosphatase 4</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q99956"/>
    <ns1:Alias>dual specificity protein phosphatase 9</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1852"/>
    <ns1:Alias>serine/threonine specific protein phosphatase</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>dual specificity phosphatase 9</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3076"/>
    <ns1:Alias>MKP4</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=DUSP9&amp;search=dusp9"/>
    <ns1:Title>DUSP9</ns1:Title>
    <ns1:Alias>mitogen-activated protein kinase phosphatase 4</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>DUSP9</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:909</ns1:URN>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>MAP kinase phosphatase 4</ns1:Alias>
    <ns1:Alias>MKP-4</ns1:Alias>
    <ns1:Alias>map kinase phosphatase 4</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/463">
    <ns1:Security>Public</ns1:Security>
    <ns1:Type>Proteomic</ns1:Type>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:463</ns1:URN>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Title>Pecot MALDI MS signature + clinical and imaging data</ns1:Title>
    <ns1:Description>A serum proteomic signature of seven features identified by MALDI MS was previously identified (see "Yildiz MALDI MS signature for lung cancer").  The serum signature was associated with the diagnosis of lung cancer independently of gender, smoking status, smoking pack-years, and C-reactive protein levels.  Here the signature is applied to cohorts presenting with one or more lung nodules discovered by clinical evaluation and chest CT.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:HgncName></ns1:HgncName>
    <ns1:Alias>Pecot MALDI MS signature + clinical and imaging data</ns1:Alias>
    <ns1:IsPanel>1</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/152"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/928">
    <ns1:Title>MAP2K1</ns1:Title>
    <ns1:Alias>MEK 1</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>MAP2K1, or mitogen-activated protein kinase kinase 1, is a dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. MAP2K1 is located upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals.  MAP2K1 is thought to be involved in binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors, as well as     cellular processes such as proliferation, differentiation, transcription regulation and development.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q02750"/>
    <ns1:Alias>MAPK/ERK kinase 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MAP2K1&amp;search=map2k1"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>MKK1</ns1:Alias>
    <ns1:Alias>PRKMK1</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>mitogen-activated protein kinase kinase 1</ns1:Alias>
    <ns1:Alias>MAPKK 1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>MAPKK1</ns1:Alias>
    <ns1:Alias>MAP2K1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>protein kinase, mitogen-activated, kinase 1 (MAP kinase kinase 1)</ns1:Alias>
    <ns1:Alias>EC 2.7.12.2</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>MAP kinase kinase 1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Alias>MEK1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/5604"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:928</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6840"/>
    <ns1:HgncName>MAP2K1</ns1:HgncName>
    <ns1:Alias>dual specificity mitogen-activated protein kinase kinase 1</ns1:Alias>
    <ns1:Alias>ERK activator kinase 1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/384">
    <ns1:Alias>Lectin galactoside-binding soluble 3-binding protein</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Tumor-associated antigen 90K</ns1:Alias>
    <ns1:Alias>lectin, galactoside-binding, soluble, 3 binding protein</ns1:Alias>
    <ns1:Alias>MAC-2-BP</ns1:Alias>
    <ns1:Alias>MAC2BP</ns1:Alias>
    <ns1:Alias>LGALS3BP</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>Godwin University of Kansas Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>Mac-2 BP</ns1:Alias>
    <ns1:Alias>M2BP</ns1:Alias>
    <ns1:Alias>Mac-2-binding protein</ns1:Alias>
    <ns1:Alias>Basement membrane autoantigen p105</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>serum protein 90K</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:384</ns1:URN>
    <ns1:Alias>L3 antigen</ns1:Alias>
    <ns1:Alias>lectin galactoside-binding soluble 3-binding protein</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=LGALS3BP&amp;search=lgals3bp"/>
    <ns1:Title>LGALS3BP</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6564"/>
    <ns1:Description>LGALS3BP is a secreted protein that binds to a human macrophage-associated lectin known as Mac-2 and also binds galectin 1.  Elevated levels of LGALS3BP have been found in the serum of patients with cancer and in those infected by the human immunodeficiency virus (HIV).</ns1:Description>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:HgncName>LGALS3BP</ns1:HgncName>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>BTBD17B</ns1:Alias>
    <ns1:Alias>tumor-associated antigen 90K</ns1:Alias>
    <ns1:Alias>Q08380</ns1:Alias>
    <ns1:Alias>90K</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>mac-2 BP</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>basement membrane autoantigen p105</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/3959"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q08380"/>
    <ns1:Alias>galectin-3-binding protein</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/865">
    <ns1:Alias>TNFRSF1A-associated via death domain</ns1:Alias>
    <ns1:Title>TRADD</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Alias>TNFR1-associated DEATH domain protein</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Hs.89862</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>TNFR1-associated death domain protein</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Description>TNFRSF1A-associated via death domain</ns1:Description>
    <ns1:Alias>tumor necrosis factor receptor type 1 associated death domain protein</ns1:Alias>
    <ns1:Alias>TRADD</ns1:Alias>
    <ns1:Alias>tumor necrosis factor receptor type 1-associated DEATH domain protein</ns1:Alias>
    <ns1:Phase>One</ns1:Phase>
    <ns1:HgncName>TRADD</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:865</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>tumor necrosis factor receptor-1-associated protein</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/88">
    <ns1:Alias>VCAM1</ns1:Alias>
    <ns1:Title>VCAM1</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>L1CAM</ns1:Alias>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:Alias>INCAM-100</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:88</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Alias>CD106</ns1:Alias>
    <ns1:Description>VCAM1, a single-pass type I membrane protein belonging to the Ig superfamily, is a cell surface sialoglycoprotein expressed by cytokine-activated endothelium. It mediates leukocyte-endothelial cell adhesion and signal transduction.  VCAM1 interacts with the beta-1 integrin VLA4 on leukocytes, and mediates both adhesion and signal transduction. The VCAM1/VLA4 interaction may play a pathophysiologic role both in immune responses and in leukocyte emigration to sites of inflammation. VCAM1 may play a role in the development of artherosclerosis and rheumatoid arthritis. VCAM1 is expressed on inflamed vascular endothelium, as well as on macrophage-like and dendritic cell types in both normal and inflammed tissue.</ns1:Description>
    <ns1:HgncName>VCAM1</ns1:HgncName>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>MGC99561</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_001069.1"/>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Instititute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=12663"/>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P19320"/>
    <ns1:Alias>sV-CAM</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>DKFZp779G2333</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>serum vascular cell adhesion protein 1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>vascular cell adhesion molecule 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:7412"/>
    <ns1:Alias>CD_antigen=CD106</ns1:Alias>
    <ns1:Alias>sVCAM-1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/932">
    <ns1:Alias>NADH-ubiquinone oxidoreductase 42 kDa subunit</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/4705"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Complex I-42kD</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:Title>NDUFA10</ns1:Title>
    <ns1:Alias>NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10 (42kD)</ns1:Alias>
    <ns1:Alias>CI-42KD</ns1:Alias>
    <ns1:Description>NDUFA10 is an accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Mammalian complex I is the first enzyme complex in the electron transport chain of mitochondria. It is composed of 45 different subunits. This protein is a component of the hydrophobic protein fraction and has NADH dehydrogenase activity and oxidoreductase activity. It transfers electrons from NADH to the respiratory chain.</ns1:Description>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>CI-42k</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:HgncName>NDUFA10</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=NDUFA10&amp;search=ndufa10"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O95299"/>
    <ns1:Alias>NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>complex I 42kDa subunit</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:932</ns1:URN>
    <ns1:Alias>CI-42kD</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>NDUFA10</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=7684"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/641">
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>rev-binding factor</ns1:Alias>
    <ns1:Alias>eukaryotic translation initiation factor 5A-1</ns1:Alias>
    <ns1:Alias>eIF-5A-1</ns1:Alias>
    <ns1:Alias>eIF5AI</ns1:Alias>
    <ns1:Alias>eIF-5A</ns1:Alias>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>EIF5A</ns1:Alias>
    <ns1:Description>From UniProtKB/Swiss-Prot: mRNA-binding protein involved in translation elongation. Has an important function at the level of mRNA turnover, probably acting downstream of decapping. Involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity. With syntenin SDCBP, functions as a regulator of p53/TP53 and p53/TP53-dependent apoptosis. Regulates also TNF-alpha-mediated apoptosis. Mediates effects of polyamines on neuronal process extension and survival. May play an important role in brain development and function, and in skeletal muscle stem cell differentiation. Also described as a cellular cofactor of human T-cell leukemia virus type I (HTLV-1) Rex protein and of human immunodeficiency virus type 1 (HIV-1) Rev protein, essential for mRNA export of retroviral transcripts.</ns1:Description>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=3300"/>
    <ns1:Alias>MGC104255</ns1:Alias>
    <ns1:Alias>EIF5A1</ns1:Alias>
    <ns1:HgncName>EIF5A</ns1:HgncName>
    <ns1:Alias>eIF-4D</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1984"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>Eukaryotic initiation factor 5A isoform 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P63241"/>
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/600187"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>eukaryotic initiation factor 5A</ns1:Alias>
    <ns1:Alias>MGC99547</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Alias>EIF-5A</ns1:Alias>
    <ns1:Alias>eukaryotic translation initiation factor 5A</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:URN>urn:edrn:bmdb:biomarker:641</ns1:URN>
    <ns1:Alias>Rev-binding factor</ns1:Alias>
    <ns1:Title>EIF5A</ns1:Title>
    <ns1:Alias>eIF-5A1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/942">
    <ns1:Alias>EC 3.1.3.48</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>receptor-type tyrosine-protein phosphatase epsilon</ns1:Alias>
    <ns1:Description>PTPRE is a member of the protein tyrosine phosphatase (PTP) family.  Members of the PTP family are signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitosis, and oncogenic transformation. The PTPRE gene encodes two isoforms, one of which is a receptor-type PTP, and the other which is not a receptor-type PTP.	Both isoforms act as negative regulators of FceRI-mediated signal transduction leading to cytokine production and degranulation.</ns1:Description>
    <ns1:Alias>PTPE</ns1:Alias>
    <ns1:Alias>R-PTP-EPSILON</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>R-PTP-epsilon</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/5791"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P23469"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>HPTPE</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=9669"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PTPRE&amp;search=ptpre"/>
    <ns1:Alias>protein tyrosine phosphatase, receptor type, E</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>PTPRE</ns1:Alias>
    <ns1:Title>PTPRE</ns1:Title>
    <ns1:Alias>Protein-tyrosine phosphatase epsilon</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:942</ns1:URN>
    <ns1:Alias>protein tyrosine phosphatase, receptor type, epsilon polypeptide</ns1:Alias>
    <ns1:Phase>Two</ns1:Phase>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:HgncName>PTPRE</ns1:HgncName>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/538">
    <ns1:Alias>HSCR2</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P24530"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>ETB</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/128"/>
    <ns1:Alias>Endothelin Receptor Type B</ns1:Alias>
    <ns1:Alias>Endothelin B Receptor</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=EDNRB"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1910"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>ETBR</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:3180"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>HSCR</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>WS4A</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Description>From Entrez Gene:
The protein encoded by this gene is a G protein-coupled receptor which activates a phosphatidylinositol-calcium second messenger system. Its ligand, endothelin, consists of a family of three potent vasoactive peptides: ET1, ET2, and ET3. Studies suggest that the multigenic disorder, Hirschsprung disease type 2, is due to mutations in the endothelin receptor type B gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. (provided by RefSeq, Jan 2011)</ns1:Description>
    <ns1:Title>EDNRB</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>ETRB</ns1:Alias>
    <ns1:Alias>ET-BR</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>ABCDS</ns1:Alias>
    <ns1:HgncName>EDNRB</ns1:HgncName>
    <ns1:Alias>EDNRB</ns1:Alias>
    <ns1:Alias>ET-B</ns1:Alias>
    <ns1:Alias>Endothelin Receptor Non-Selective Type</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:538</ns1:URN>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/553">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/155"/>
    <ns1:Title>Showe 29-gene signature for lung cancer</ns1:Title>
    <ns1:Alias>Showe 29-gene signature for lung cancer</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:HgncName></ns1:HgncName>
    <ns1:Security>Public</ns1:Security>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:553</ns1:URN>
    <ns1:Description>A 29-gene peripheral blood gene expression signature that separates patients with non-small cell lung cancer (NSCLC) tumors and patient controls with 86% accuracy (91% sensitivity, 80% specificity).  Subjects were primarily smokers and former smokers.  The 29 genes, minus one that did not match a gene symbol in the naming database: RSF1,  DYRK2,  YY1,  C19orf12,  THEM2,  TRIO,  MYADM,  BAIAP2,  ROGDI,  DNAJB14,  BRE,  TMEM41A,  C9orf64,  FAM110A,  PCNXL2,  REST,  C19orf62,  C13orf27,  ASCC3,  SLC1A5,  PTPLAD1,  MRE11A,  GTPBP10,  SERPINI2,  CREB1,  CCDC53,  USP48,  ZSCAN2</ns1:Description>
    <ns1:IsPanel>1</ns1:IsPanel>
    <ns1:Type>Gene</ns1:Type>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/62">
    <ns1:AccessGrantedTo>Prostate and Urologic</ns1:AccessGrantedTo>
    <ns1:Alias>kallikrein-related peptidase 11</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/80"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/79"/>
    <ns1:Title>KLK11</ns1:Title>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>kallikrein 11</ns1:Alias>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N4eea242c00004925801e3b8fc4fe7d89">
        <rdf:_2 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/62/58"/>
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/62/29"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>TLSP</ns1:Alias>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:Alias>hk11</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:indicatorForOrgan>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/80">
        <ns1:Alias>OB</ns1:Alias>
        <ns1:Alias>OBS</ns1:Alias>
        <ns1:Security>Public</ns1:Security>
        <ns1:Alias>obesity factor</ns1:Alias>
        <ns1:Alias>leptin (obesity homolog, mouse)</ns1:Alias>
        <ns1:Type>Protein</ns1:Type>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
        <ns1:Alias>obese, mouse, homolog of</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:3952"/>
        <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/254"/>
        <ns1:Description>Leptin (LEP) is secreted by white adipocytes and plays a major role in the regulation of body weight. This protein, which acts through the leptin receptor, functions as part of a signaling pathway that can inhibit food intake and/or regulate energy expenditure to maintain constancy of the adipose mass.  Leptin has also been implicated in the regulation of reproduction, glucose homeostasis, bone formation, wound healing and the immune system. Leptin has several endocrine functions and is also involved in the regulation of immune and inflammatory responses, hematopoiesis, angiogenesis and wound healing. Mutations in the leptin gene and/or its regulatory regions cause severe obesity and morbid obesity with hypogonadism. The leptin gene has also been linked to type 2 diabetes mellitus development.</ns1:Description>
        <ns1:Phase></ns1:Phase>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000221.1"/>
        <ns1:HgncName>LEP</ns1:HgncName>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
        <ns1:AccessGrantedTo>Mor Yale University</ns1:AccessGrantedTo>
        <ns1:Alias>leptin</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/222"/>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:Alias>leptin (murine obesity homolog)</ns1:Alias>
        <ns1:URN>urn:edrn:bmdb:biomarker:80</ns1:URN>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
        <ns1:Title>LEP</ns1:Title>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
        <ns1:Alias>LEP</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P41159"/>
        <ns1:Alias>FLJ94114</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6553"/>
        <ns1:QAState>Curated</ns1:QAState>
      </ns1:Biomarker>
    </ns1:indicatorForOrgan>
    <ns1:Description>The glandular kallikreins are a distinct group of serine proteases with molecular masses of 25,000 to 40,000. Kallikreins are a subgroup of serine proteases having diverse physiological functions. hk11 is a possible multifunctional protease which efficiently cleaves 'bz-Phe-Arg-4-methylcoumaryl-7-amide', a kallikrein substrate, and weakly cleaves other substrates for kallikrein and trypsin. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Several human kallikrein genes have been isolated. Expressed in brain, skin and prostate. Isoform 1 is expressed preferentially in brain. Isoform 2 is expressed in prostate.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9UBX7"/>
    <ns1:Alias>PRSS20</ns1:Alias>
    <ns1:Alias>Serine protease 20</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000167757"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6359"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:62</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:11012"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:HgncName>KLK11</ns1:HgncName>
    <ns1:Alias>KLK11</ns1:Alias>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BethIsraelSandaDataMarkerPerformanceSummary"/>
    <ns1:Alias>Hippostasin</ns1:Alias>
    <ns1:Alias>Kallikrein-11</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/494">
    <ns1:IsPanel>1</ns1:IsPanel>
    <ns1:hasBiomarker>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1087">
        <ns1:Alias>Leukocyte Receptor Cluster (LRC) Member 7</ns1:Alias>
        <ns1:Alias>EF-Tu</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=EEF1A1"/>
        <ns1:Alias>EF1A</ns1:Alias>
        <ns1:Alias>Eukaryotic Translation Elongation Factor 1 Alpha 1</ns1:Alias>
        <ns1:Alias>GRAF-1EF</ns1:Alias>
        <ns1:Alias>Elongation Factor 1-Alpha 1</ns1:Alias>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:Alias>CCS3</ns1:Alias>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/494"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/133"/>
        <ns1:Description>From NCBI Entrez Gene: This gene encodes an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas, and the other isoform (alpha 2) is expressed in brain, heart and skeletal muscle. This isoform is identified as an autoantigen in 66% of patients with Felty syndrome. This gene has been found to have multiple copies on many chromosomes, some of which, if not all, represent different pseudogenes. [provided by RefSeq, Jul 2008]</ns1:Description>
        <ns1:Alias>eEF1A-1</ns1:Alias>
        <ns1:Alias>LENG7</ns1:Alias>
        <ns1:Alias>Cervical Cancer Suppressor 3</ns1:Alias>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Alias>Eukaryotic Elongation Factor 1 A-1</ns1:Alias>
        <ns1:Alias>EEF-1</ns1:Alias>
        <ns1:Alias>CTCL Tumor Antigen</ns1:Alias>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:Alias>Elongation Factor 1 Alpha Subunit</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P68104"/>
        <ns1:Alias>EF1a-Like Protein</ns1:Alias>
        <ns1:Alias>EEF1A</ns1:Alias>
        <ns1:Alias>HNGC:16303</ns1:Alias>
        <ns1:HgncName>EEF1A1</ns1:HgncName>
        <ns1:Alias>Translation Elongation Factor 1 Alpha 1-Like 14</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1915"/>
        <ns1:Alias>Glucocorticoid Receptor AF-1 Specific Elongation Factor</ns1:Alias>
        <ns1:Title>EEF1A1</ns1:Title>
        <ns1:Phase></ns1:Phase>
        <ns1:Alias>EF-1-alpha-1</ns1:Alias>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:Alias>Prostate Tumor-Inducing Protein 1</ns1:Alias>
        <ns1:Alias>EE1A1</ns1:Alias>
        <ns1:Security>Public</ns1:Security>
        <ns1:Alias>Eukaryotic Translation Elongation Factor 1 Alpha 1-Like 14</ns1:Alias>
        <ns1:Alias>PTI1</ns1:Alias>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:URN>urn:edrn:bmdb:biomarker:1087</ns1:URN>
        <ns1:Alias>Elongation Factor Tu</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:3189"/>
        <ns1:Type>Protein</ns1:Type>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:Alias>Leukocyte Receptor Cluster Member 7</ns1:Alias>
        <ns1:Alias>CCS-3</ns1:Alias>
        <ns1:Alias>EEF1A1</ns1:Alias>
      </ns1:Biomarker>
    </ns1:hasBiomarker>
    <ns1:hasBiomarker>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1081">
        <ns1:URN>urn:edrn:bmdb:biomarker:1081</ns1:URN>
        <ns1:Alias>SEC15-Like 2 (S. Cerevisiae)</ns1:Alias>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/494"/>
        <ns1:Alias>SEC15 Homolog B (S. Cerevisiae)</ns1:Alias>
        <ns1:Type>Protein</ns1:Type>
        <ns1:Security>Public</ns1:Security>
        <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:17085"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/115"/>
        <ns1:Title>EXOC6B</ns1:Title>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:HgncName>EXOC6B</ns1:HgncName>
        <ns1:Description>From NCBI Entrez Gene: In yeast and rat, Sec15 is part of a multiprotein complex that is required for targeted exocytosis.[supplied by OMIM, Apr 2004]</ns1:Description>
        <ns1:Alias>SEC15-Like 2</ns1:Alias>
        <ns1:Alias>Exocyst Complex Component 6B</ns1:Alias>
        <ns1:Alias>SEC15 Homolog B</ns1:Alias>
        <ns1:Alias>SEC15-Like Protein 2</ns1:Alias>
        <ns1:Alias>SEC15L2</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/23233"/>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:Alias>SEC15B</ns1:Alias>
        <ns1:Alias>EXOC6B</ns1:Alias>
        <ns1:Alias>WUGSC:H_NH0343N14.1</ns1:Alias>
        <ns1:Alias>KIAA0919</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=EXOC6B"/>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9Y2D4"/>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:Phase></ns1:Phase>
        <ns1:Alias>Exocyst Complex Component Sec15B</ns1:Alias>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/505"/>
      </ns1:Biomarker>
    </ns1:hasBiomarker>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Title>Zhong TAA signature</ns1:Title>
    <ns1:Alias>Zhong TAA signature</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:494</ns1:URN>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:hasBiomarker>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1084">
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/nuccore/ac108477"/>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/505"/>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/494"/>
        <ns1:Phase></ns1:Phase>
        <ns1:URN>urn:edrn:bmdb:biomarker:1084</ns1:URN>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:Alias>BAC clone RP11-499F19</ns1:Alias>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Security>Public</ns1:Security>
        <ns1:HgncName></ns1:HgncName>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:Type>Protein</ns1:Type>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:Description>BAC clone RP11-499F19 is available in Genbank as accession number AC108477.  There is no associated protein sequence and no known protein function.</ns1:Description>
        <ns1:Alias>GI:23132689</ns1:Alias>
        <ns1:Title>BAC clone RP11-499F19</ns1:Title>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/115"/>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:Alias>AC108477</ns1:Alias>
      </ns1:Biomarker>
    </ns1:hasBiomarker>
    <ns1:hasBiomarker>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1086">
        <ns1:Alias>Postmeiotic Segregation Increased 2-Like 15</ns1:Alias>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/4239954"/>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:HgncName>PMS2P7</ns1:HgncName>
        <ns1:Title>PMS2P7</ns1:Title>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:Alias>PMS2L15</ns1:Alias>
        <ns1:Type>Protein</ns1:Type>
        <ns1:Phase></ns1:Phase>
        <ns1:Alias>PMS2LP2</ns1:Alias>
        <ns1:Security>Public</ns1:Security>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:URN>urn:edrn:bmdb:biomarker:1086</ns1:URN>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:Alias>Postmeiotic Segregation Increased 2-Like Pseudogene 2</ns1:Alias>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/494"/>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/nuccore/AB017006"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/133"/>
        <ns1:Alias>PMSR7</ns1:Alias>
        <ns1:Alias>Postmeiotic Segregation Increased 2 Pseudogene 7</ns1:Alias>
        <ns1:Description>PMS2P7, previously known as PMS2L15, was thought to be part of a multigene family found on chromosome bands 7p22, 7p12-p13, 7q11, and 7q22.  These genes have since been labeled  pseudogenes.</ns1:Description>
        <ns1:Alias>PMS2P7</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/239"/>
      </ns1:Biomarker>
    </ns1:hasBiomarker>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Description>The TAA signature is a diagnostic array of five markers capable of distinguishing patients with non-small cell lung cancer (NSCLC) from normal control subjects.  The diagnostic array was developed by enriching and screening phage-expressed tumor-associated proteins, and using these in a fluorescent protein microarray to identify and measure multiple non-small cell lung cancer-associated antibodies and show how simultaneous measurements can be combined into a single diagnostic assay. Although the identity of the phage-expressed proteins is not critical for use in a diagnostic assay, the sequences were compared with the GenBank database to obtain possible identity.  The five proteins in the final diagnostic array are GAGE7, BAC clone RP11-499F19, SEC15L2, PMS2P7 (PMS2L15), and EEF1A.</ns1:Description>
    <ns1:HgncName></ns1:HgncName>
    <ns1:Security>Public</ns1:Security>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/133"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:hasBiomarker>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1085">
        <ns1:Type>Protein</ns1:Type>
        <ns1:Phase></ns1:Phase>
        <ns1:Security>Public</ns1:Security>
        <ns1:Alias>GAGE7</ns1:Alias>
        <ns1:Alias>GAGE-12I</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/2579"/>
        <ns1:Alias>GAGE7B</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=GAGE7&amp;search=868c201b9308d02f9eacb236c7ebbd73"/>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:Alias>AL4</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/238"/>
        <ns1:Alias>Cancer/Testis Antigen Family 4</ns1:Alias>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/494"/>
        <ns1:Alias>Cancer/Testis Antigen 4.7</ns1:Alias>
        <ns1:Title>GAGE7</ns1:Title>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:Description>GAGE7 is a member of a family of genes that code for an antigenic peptide, YRPRPRRY.  These genes are thought to be expressed in a variety of tumors but not in normal tissues, except for the testis.</ns1:Description>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/133"/>
        <ns1:Alias>GAGE12I</ns1:Alias>
        <ns1:HgncName>GAGE7</ns1:HgncName>
        <ns1:Alias>GAGE-8</ns1:Alias>
        <ns1:Alias>Cancer/Testis Antigen Family 4, Member 7</ns1:Alias>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:Alias>Member 7</ns1:Alias>
        <ns1:Alias>G Antigen 12G</ns1:Alias>
        <ns1:Alias>GAGE-7B</ns1:Alias>
        <ns1:URN>urn:edrn:bmdb:biomarker:1085</ns1:URN>
        <ns1:Alias>CT4.7</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O76087"/>
        <ns1:Alias>G Antigen 7</ns1:Alias>
        <ns1:Alias>GAGE-7</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:4104"/>
      </ns1:Biomarker>
    </ns1:hasBiomarker>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/26">
    <ns1:URN>urn:edrn:bmdb:biomarker:26</ns1:URN>
    <ns1:Alias>Medullary Cystic Kidney Disease, Autosomal Dominant</ns1:Alias>
    <ns1:Alias>CD227</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BGWHCramerPLCOPhaseIIIAnalysis"/>
    <ns1:Alias>Tumor-Associated Epithelial Membrane Antigen</ns1:Alias>
    <ns1:Alias>Breast Carcinoma-Associated Antigen DF3</ns1:Alias>
    <ns1:Alias>PUM</ns1:Alias>
    <ns1:Alias>Mucin 1, Cell Surface Associated</ns1:Alias>
    <ns1:Alias>Episialin</ns1:Alias>
    <ns1:Title>CA15-3</ns1:Title>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>DF3 Antigen</ns1:Alias>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="Nbd0f9ffdd5544ca19184a5ced8120636">
        <rdf:_5 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/26/1021"/>
        <rdf:_4 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/26/960"/>
        <rdf:_2 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/26/38"/>
        <rdf:_3 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/26/915"/>
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/26/37"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P15941"/>
    <ns1:indicatorForOrgan>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1106">
        <ns1:Type></ns1:Type>
        <ns1:HgncName></ns1:HgncName>
        <ns1:Security></ns1:Security>
        <ns1:Title>ThisIsATest</ns1:Title>
        <ns1:URN>urn:edrn:bmdb:biomarker:1106</ns1:URN>
        <ns1:Alias>ThisIsATest</ns1:Alias>
        <ns1:Description></ns1:Description>
        <ns1:QAState></ns1:QAState>
        <ns1:Phase></ns1:Phase>
        <ns1:IsPanel>0</ns1:IsPanel>
      </ns1:Biomarker>
    </ns1:indicatorForOrgan>
    <ns1:Alias>MCKD</ns1:Alias>
    <ns1:Alias>MUC1/ZD</ns1:Alias>
    <ns1:Alias>Carcinoma-Associated Mucin</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_002447"/>
    <ns1:Alias>ADMCKD</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/16"/>
    <ns1:Alias>Mucin-1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/17"/>
    <ns1:Alias>EMA</ns1:Alias>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1072"/>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/89">
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
        <ns1:HgncName></ns1:HgncName>
        <ns1:Security>Public</ns1:Security>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
        <ns1:Phase></ns1:Phase>
        <ns1:URN>urn:edrn:bmdb:biomarker:89</ns1:URN>
        <ns1:Type>Protein</ns1:Type>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/23"/>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/20"/>
        <ns1:Title>Cramer 5-marker panel for ovarian cancer</ns1:Title>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/22"/>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Description>The PLCO phase III specimens (test half) revealed marker panels produced only marginal improvement over CA 125 alone and, in some case, worse performance. Besides searching for new markers, some ways to improve detection might include: 1) Add epidemiologic variables, and 2) Add in prior markers values.</ns1:Description>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/24"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/26"/>
        <ns1:Alias>Cramer 5-marker panel for ovarian cancer</ns1:Alias>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:Alias>MUC-1/SEC</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:Alias>CA 15-3</ns1:Alias>
    <ns1:Alias>Medullary Cystic Kidney Disease 1 (Autosomal Dominant)</ns1:Alias>
    <ns1:Alias>Peanut-Reactive Urinary Mucin</ns1:Alias>
    <ns1:Alias>PEM</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Cancer Antigen 15-3</ns1:Alias>
    <ns1:Alias>Polymorphic Epithelial Mucin</ns1:Alias>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1098"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/4582"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>MCD</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>PEMT</ns1:Alias>
    <ns1:Alias>MUC-1</ns1:Alias>
    <ns1:Alias>CA15.3</ns1:Alias>
    <ns1:Alias>Krebs Von Den Lungen-6</ns1:Alias>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:Description>From NCBI Gene: This gene encodes a membrane-bound protein that is a member of the mucin family. Mucins are O-glycosylated proteins that play an essential role in forming protective mucous barriers on epithelial surfaces. These proteins also play a role in intracellular signaling. This protein is expressed on the apical surface of epithelial cells that line the mucosal surfaces of many different tissues including lung, breast stomach and pancreas. This protein is proteolytically cleaved into alpha and beta subunits that form a heterodimeric complex. The N-terminal alpha subunit functions in cell-adhesion and the C-terminal beta subunit is involved in cell signaling. Overexpression, aberrant intracellular localization, and changes in glycosylation of this protein have been associated with carcinomas. This gene is known to contain a highly polymorphic variable number tandem repeats (VNTR) domain. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Feb 2011]</ns1:Description>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BGWHCramerPrePLCOPhaseIIAnalysis"/>
    <ns1:Alias>H23AG</ns1:Alias>
    <ns1:AccessGrantedTo>Cramer Brigham and Women's Hospital</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/116"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>CD227 Antigen</ns1:Alias>
    <ns1:Alias>MUC-1/X</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>CA15-3</ns1:Alias>
    <ns1:Alias>Tumor Associated Epithelial Mucin</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/15"/>
    <ns1:Alias>MUC1</ns1:Alias>
    <ns1:Alias>MCKD1</ns1:Alias>
    <ns1:indicatorForOrgan>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/47">
        <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:HopkinsMeltzerBarrettMethylationProfiles"/>
        <ns1:Title>TAC1</ns1:Title>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
        <ns1:Alias>neurokinin 2</ns1:Alias>
        <ns1:Alias>neurokinin 1</ns1:Alias>
        <ns1:Alias>tachykinin</ns1:Alias>
        <ns1:Alias>neurokinin alpha</ns1:Alias>
        <ns1:QAState>Accepted</ns1:QAState>
        <ns1:Alias>neuromedin L</ns1:Alias>
        <ns1:Type>Genomic</ns1:Type>
        <ns1:Alias>TAC1</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/60"/>
        <ns1:Alias>PPT</ns1:Alias>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:Alias>tachykinin-1</ns1:Alias>
        <ns1:URN>urn:edrn:bmdb:biomarker:47</ns1:URN>
        <ns1:Alias>neuropeptide gamma</ns1:Alias>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:hasBiomarkerStudyDatas>
          <rdf:Bag rdf:nodeID="N6ce165f718774c7599a05baa6947a905">
            <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/47/46"/>
          </rdf:Bag>
        </ns1:hasBiomarkerStudyDatas>
        <ns1:Description>The tachykinin gene encodes four products of the tachykinin peptide hormone family, substance P and neurokinin A, as well as the related peptides, neuropeptide K and neuropeptide gamma. These active peptides are thought to function as neurotransmitters which interact with nerve receptors and smooth muscle cells. They are known to induce behavioral responses and function as vasodilators and secretagogues, and contract (directly or indirectly) many smooth muscles. Multiple transcript variants encoding different isoforms have been found for this gene.</ns1:Description>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P20366"/>
        <ns1:Alias>Protachykinin-1</ns1:Alias>
        <ns1:Phase></ns1:Phase>
        <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/68"/>
        <ns1:HgncName>TAC1</ns1:HgncName>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
        <ns1:Alias>tachykinin, precursor 1</ns1:Alias>
        <ns1:Alias>NPK</ns1:Alias>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:Alias>TAC2</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:6863"/>
        <ns1:Security>Public</ns1:Security>
        <ns1:AccessGrantedTo>GI and Other Associated</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/62"/>
        <ns1:Alias>TKN1</ns1:Alias>
        <ns1:Alias>neuropeptide K</ns1:Alias>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:Alias>substance P</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/63"/>
        <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000006128"/>
        <ns1:Alias>NKNA</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11517"/>
        <ns1:Alias>substance K</ns1:Alias>
      </ns1:Biomarker>
    </ns1:indicatorForOrgan>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:HgncName>MUC1</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MUC1"/>
    <ns1:Alias>KL-6</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:7508"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>Tumor-Associated Mucin</ns1:Alias>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:Alias>MAM6</ns1:Alias>
    <ns1:Alias>H23 Antigen</ns1:Alias>
    <ns1:Alias>ADMCKD1</ns1:Alias>
    <ns1:Alias>Mucin 1, Transmembrane</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/249"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/41">
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/44"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q99497"/>
    <ns1:Alias>Parkinson disease protein 7</ns1:Alias>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>PARK7</ns1:Alias>
    <ns1:Alias>Parkinson disease (autosomal recessive, early onset) 7</ns1:Alias>
    <ns1:Alias>Protein DJ-1</ns1:Alias>
    <ns1:AccessGrantedTo>Hanash Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Description>DJ-1, also known as PARK-7, belongs to the peptidase C56 family of proteins. It acts as a positive regulator of androgen receptor-dependent transcription. It may also function as a redox-sensitive chaperone, as a sensor for oxidative stress, and it apparently protects neurons against oxidative stress and cell death. DJ-1 is highly expressed in pancreas, kidney, skeletal muscle, liver, testis and heart and is detected at slightly lower levels in placenta and brain.</ns1:Description>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:HgncName>PARK7</ns1:HgncName>
    <ns1:Alias>DJ1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/27"/>
    <ns1:Alias>DJ-1</ns1:Alias>
    <ns1:Title>PARK7</ns1:Title>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/62"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/73"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/74"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=16369"/>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N774120051de1445792cfe6155bdced00">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/41/998"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:11315"/>
    <ns1:Alias>Oncogene DJ-1</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:41</ns1:URN>
    <ns1:Security>Public</ns1:Security>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/779">
    <ns1:URN>urn:edrn:bmdb:biomarker:779</ns1:URN>
    <ns1:Alias>Sutherland-Haan X-linked mental retardation syndrome</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:HgncName>PQBP1</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/10084"/>
    <ns1:Description>From NCBI Gene: This gene encodes a nuclear polyglutamine-binding protein that is involved with transcription activation. The encoded protein contains a WW domain. Mutations in this gene have been found in patients with Renpenning syndrome 1 and other syndromes with X-linked mental retardation. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene.[provided by RefSeq, Nov 2009]</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O60828"/>
    <ns1:Alias>polyglutamine-binding protein 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>MRXS8</ns1:Alias>
    <ns1:Alias>NPW38</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Phase>One</ns1:Phase>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>PQBP1</ns1:Alias>
    <ns1:Alias>MRX55</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>38 kDa nuclear protein containing a WW domain</ns1:Alias>
    <ns1:Alias>nuclear protein containing WW domain 38 kD</ns1:Alias>
    <ns1:Alias>RENS1</ns1:Alias>
    <ns1:Alias>polyglutamine tract-binding protein 1</ns1:Alias>
    <ns1:Alias>SHS</ns1:Alias>
    <ns1:Title>PQBP1</ns1:Title>
    <ns1:Alias>Polyglutamine tract-binding protein 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/300463"/>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1013">
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/868"/>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:HgncName>Mercola 7-gene signature for prostate cancer</ns1:HgncName>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
        <ns1:Security>Public</ns1:Security>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:Title>Mercola 7-gene signature for prostate cancer</ns1:Title>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/683"/>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Description>Significance Analysis of Microarray (SAM) was used to develop a 7-gene classifier. The overall prediction accuracy and sensitivity is 71% and 76%, respectively. The inclusion of the Gleason sum to the seven-gene classifier raised the prediction accuracy and sensitivity to 83% and 76% respectively This prognostic signature is closely associated with biochemical recurrence in patients after radical prostatectomy.  The seven genes are: RRAGD, PQBP1, HIST1H2BC, ALDH1A2, TRIM22, RBPMS, HSPB8.</ns1:Description>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
        <ns1:Phase></ns1:Phase>
        <ns1:Alias>Mercola 7-gene signature for prostate cancer</ns1:Alias>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/793"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/698"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/802"/>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/564"/>
        <ns1:Type>Gene</ns1:Type>
        <ns1:URN>urn:edrn:bmdb:biomarker:1013</ns1:URN>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/779"/>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:Alias>Marks 7-gene signature for prostate cancer</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:Alias>MRXS3</ns1:Alias>
    <ns1:Alias>mental retardation, X-linked 55</ns1:Alias>
    <ns1:Alias>Npw38</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=9330"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Alias>polyglutamine binding protein 1</ns1:Alias>
    <ns1:Alias>PQBP-1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/477">
    <ns1:Alias>heparin-binding neurite outgrowth-promoting factor 1</ns1:Alias>
    <ns1:Alias>pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1)</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PTN&amp;search=pleiotrophin"/>
    <ns1:Alias>PTN</ns1:Alias>
    <ns1:Alias>NEGF1</ns1:Alias>
    <ns1:Alias>HBGF8</ns1:Alias>
    <ns1:Alias>heparin affin regulatory protein</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P21246"/>
    <ns1:Alias>HARP</ns1:Alias>
    <ns1:Description>Pleiotrophin, or PTN, is a secreted growth factor found in osteoblasts and brain tissue.  PTN induces neurite outgrowth and is mitogenic for fibroblasts, epithelial, and endothelial cells. It binds anaplastic lymphoma kinase (ALK) which induces MAPK pathway activation, an important step in the anti-apoptotic signaling of PTN and regulation of cell proliferation.</ns1:Description>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>HBNF</ns1:Alias>
    <ns1:Alias>Heparin-binding neurite outgrowth-promoting factor 1</ns1:Alias>
    <ns1:Alias>HBGF-8</ns1:Alias>
    <ns1:Alias>neurite growth-promoting factor 1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>heparin binding growth factor 8</ns1:Alias>
    <ns1:Alias>HB-GAM</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_002816.1"/>
    <ns1:Alias>osteoblast-specific factor 1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>Osteoblast-specific factor 1</ns1:Alias>
    <ns1:Alias>OSF-1</ns1:Alias>
    <ns1:HgncName>PTN</ns1:HgncName>
    <ns1:Alias>heparin-binding brain mitogen</ns1:Alias>
    <ns1:Alias>HBNF1</ns1:Alias>
    <ns1:Alias>Heparin-binding growth factor 8</ns1:Alias>
    <ns1:Alias>pleiotrophin</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=9630"/>
    <ns1:Alias>heparin-binding growth factor 8</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:477</ns1:URN>
    <ns1:Alias>HBNF-1</ns1:Alias>
    <ns1:Alias>HBBM</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
    <ns1:Alias>Heparin-binding brain mitogen</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972">
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/444"/>
        <ns1:Alias>Aptamer-based markers</ns1:Alias>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/429"/>
        <ns1:Phase></ns1:Phase>
        <ns1:Title>Somalogic 12-marker panel for lung cancer</ns1:Title>
        <ns1:HgncName></ns1:HgncName>
        <ns1:Security>Public</ns1:Security>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/454"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/114"/>
        <ns1:Type>Protein</ns1:Type>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/413"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/450"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/477"/>
        <ns1:URN>urn:edrn:bmdb:biomarker:972</ns1:URN>
        <ns1:Alias>Ostroff 12-marker panel for lung cancer</ns1:Alias>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/479"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/501"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/492"/>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Alias>Somalogic 12-marker panel for lung cancer</ns1:Alias>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/483"/>
        <ns1:Description>The sensitivity and specificity of our 12-biomarker panel improves upon published protein and gene expression panels.  The 12-protein panel consists of cadherin-1 (CDH1), CD30 ligand (TNFSF8), endostatin, HSP90a, LRIG3, MIP-4 (CCL18), pleiotrophin, PRKCI, RGM-C (HFE2), SCF-sR (KIT), sL-selectin (SELL), and YES. The panel discriminates NSCLC from controls with 91% sensitivity and 84% specificity in cross-validated training and 89% sensitivity and 83% specificity in a separate verification set, with similar performance for early and late stage NSCLC.</ns1:Description>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/488"/>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>heparin-binding growth-associated molecule</ns1:Alias>
    <ns1:Alias>Heparin-binding growth-associated molecule</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Title>pleiotrophin</ns1:Title>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/479">
    <ns1:Alias>aPKC-lambda/iota</ns1:Alias>
    <ns1:Description>PRKCI is a member of the protein kinase C (PKC) family of serine/threonine protein kinases.  It is a calcium- and diacylglycerol-independent serine/threonine-protein kinase that plays a general protective role against apoptotic stimuli, is involved in NF-kappa-B activation, cell survival, differentiation and polarity, and contributes to the regulation of microtubule dynamics in the early secretory pathway. Is necessary for BCR-ABL oncogene-mediated resistance to apoptotic drug in leukemia cells, protecting leukemia cells against drug-induced apoptosis.</ns1:Description>
    <ns1:Alias>PKCI</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>DXS1179E</ns1:Alias>
    <ns1:HgncName>PRKCI</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_002731.4"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>EC 2.7.11.13</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Title>PRKCI</ns1:Title>
    <ns1:Alias>PRKC-lambda/iota</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=9404"/>
    <ns1:Alias>PRKCI</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972"/>
    <ns1:Alias>nPKC-iota</ns1:Alias>
    <ns1:Alias>Atypical protein kinase C-lambda/iota</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PRKCI&amp;search=prkci"/>
    <ns1:Alias>protein kinase C iota type</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P41743"/>
    <ns1:Phase></ns1:Phase>
    <ns1:URN>urn:edrn:bmdb:biomarker:479</ns1:URN>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>atypical protein kinase C-lambda/iota</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>protein kinase C, iota</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/49">
    <ns1:Alias>SL3/AKV core-binding factor alpha C subunit</ns1:Alias>
    <ns1:Alias>PEA2-alpha C</ns1:Alias>
    <ns1:Alias>PEBP2-alpha C</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/54"/>
    <ns1:Title>RUNX3</ns1:Title>
    <ns1:Alias>RUNX3</ns1:Alias>
    <ns1:Alias>CBFA3</ns1:Alias>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53">
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/49"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/49"/>
        <ns1:Alias>8-gene Panel for Barrett's Esophagus</ns1:Alias>
        <ns1:QAState>Accepted</ns1:QAState>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/48"/>
        <ns1:HgncName></ns1:HgncName>
        <ns1:Phase></ns1:Phase>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/52"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/46"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/54"/>
        <ns1:Alias>Meltzer 8-marker panel for Esophageal Adenocarcinoma</ns1:Alias>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/45"/>
        <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/74"/>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/56"/>
        <ns1:Description>Eight methylation biomarkers - p16, RUNX3, HPP1 (HGNC name TMEFF2), NELL1, TAC1, SST, AKAP12 and CDH13 - were tested in a restrospective multicenter double-blinded validation study for their accuracy in predicting neoplastic progression in Barretts Esophagus. Hypermethylation of p16, RUNX3 and HPP1 has been show to occur in early Barretts Esophagus-related neoplastic progression and predicts progression risk. Several of the panel (NELL1, TAC1, SST, AKAP12 and CDH13) were also shown to be methylated early and often in Barretts Esophagus-related neoplastic progression.</ns1:Description>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/51"/>
        <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:HopkinsMeltzerBarrettMethylationProfiles"/>
        <ns1:AccessGrantedTo>Meltzer Johns Hopkins University</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:Alias>8 Gene Panel for Barretts Esophagus</ns1:Alias>
        <ns1:Title>8 Gene Panel for Barretts Esophagus</ns1:Title>
        <ns1:URN>urn:edrn:bmdb:biomarker:53</ns1:URN>
        <ns1:hasBiomarkerStudyDatas>
          <rdf:Bag rdf:nodeID="N245ac2c55fbe46a496be72e883f5a04b">
            <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/53/52"/>
          </rdf:Bag>
        </ns1:hasBiomarkerStudyDatas>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/47"/>
        <ns1:Type>Genomic</ns1:Type>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/50"/>
        <ns1:Security>Public</ns1:Security>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:Alias>Oncogene AML-2</ns1:Alias>
    <ns1:Description>RUNX3 is a member of the runt domain-containing family of transcription factors. A heterodimer of this protein and a beta subunit forms a complex that binds to the core DNA sequence 5'-PYGPYGGT-3' found in a number of enhancers and promoters, and can either activate or suppress transcription. It also interacts with other transcription factors. It functions as a tumor suppressor, and the gene is frequently deleted or transcriptionally silenced in cancer. Multiple transcript variants encoding different isoforms have been found for this gene.</ns1:Description>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/90"/>
    <ns1:Alias>Runt-related transcription factor 3</ns1:Alias>
    <ns1:Alias>Polyomavirus enhancer-binding protein 2 alpha C subunit</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:indicatorForOrgan>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/69">
        <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6169"/>
        <ns1:HgncName>ITIH4</ns1:HgncName>
        <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:3700"/>
        <ns1:Title>ITIH4</ns1:Title>
        <ns1:Alias>Gp120</ns1:Alias>
        <ns1:Alias>PK-120</ns1:Alias>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:Alias>ITIH4</ns1:Alias>
        <ns1:Alias>Plasma kallikrein sensitive glycoprotein 120</ns1:Alias>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Alias>PRO1851</ns1:Alias>
        <ns1:Security>Public</ns1:Security>
        <ns1:URN>urn:edrn:bmdb:biomarker:69</ns1:URN>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:Phase></ns1:Phase>
        <ns1:Alias>IHRP</ns1:Alias>
        <ns1:Alias>ITIHL1</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
        <ns1:Alias>H4P</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_002209.2"/>
        <ns1:Alias>Inter-alpha-trypsin inhibitor family heavy chain-related protein</ns1:Alias>
        <ns1:Alias>ITI heavy chain H4</ns1:Alias>
        <ns1:Alias>Inter-alpha-trypsin inhibitor heavy chain H4</ns1:Alias>
        <ns1:Alias>Inter-alpha-inhibitor heavy chain 4</ns1:Alias>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:Description>The inter-alpha-trypsin inhibitors (ITI) are a family of plasma protease inhibitors, assembled from a light chain - bikunin, encoded by AMBP - and five homologous heavy chains (encoded by ITIH1, ITIH2, ITIH3, ITIH4, and ITIH5), contributing to extracellular matrix stability by covalent linkage to hyaluronan. ITIH4 is secreted into the blood, where it is cleaved by plasma kallikrein into two smaller forms. Expression of the ITIH4 gene has been detected only in liver, and it seems to be upregulated during surgical trauma. This gene is part of a cluster of similar genes on chromosome 3. Two transcript variants encoding different isoforms have been found for this gene.</ns1:Description>
        <ns1:Type>Protein</ns1:Type>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:Alias>ITI-HC4</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q14624"/>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:Alias>PK120</ns1:Alias>
        <ns1:AccessGrantedTo>Bast MD Anderson</ns1:AccessGrantedTo>
      </ns1:Biomarker>
    </ns1:indicatorForOrgan>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/332"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/91"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Acute myeloid leukemia 2 protein</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:49</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=RUNX3&amp;search=runx3"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <ns1:Alias>Core-binding factor subunit alpha-3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/864"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/109"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/49"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>PEBP2A3</ns1:Alias>
    <ns1:HgncName>RUNX3</ns1:HgncName>
    <ns1:Alias>SL3-3 enhancer factor 1 alpha C subunit</ns1:Alias>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N34f7346a959d434cb500fa16e60c2eaa">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/49/48"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:864"/>
    <ns1:Alias>AML2</ns1:Alias>
    <ns1:Type>Genomic</ns1:Type>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:HopkinsMeltzerBarrettMethylationProfiles"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/53"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q13761"/>
    <ns1:Alias>CBF-alpha-3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000020633"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=10473"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/70">
    <ns1:Alias>thromboglobulin, beta-1</ns1:Alias>
    <ns1:Alias>leukocyte-derived growth factor</ns1:Alias>
    <ns1:Alias>MDGF</ns1:Alias>
    <ns1:Alias>CXCL7</ns1:Alias>
    <ns1:Alias>beta-thromboglobulin</ns1:Alias>
    <ns1:Alias>b-TG1</ns1:Alias>
    <ns1:HgncName>PPBP</ns1:HgncName>
    <ns1:Alias>neutrophil-activating peptide-2</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>TGB</ns1:Alias>
    <ns1:Alias>small inducible cytokine B7</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:70</ns1:URN>
    <ns1:Alias>thrombocidin 2</ns1:Alias>
    <ns1:Alias>connective tissue-activating peptide III</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>platelet basic protein</ns1:Alias>
    <ns1:Alias>pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_002695.1"/>
    <ns1:Alias>NAP-2-L1</ns1:Alias>
    <ns1:Alias>small inducible cytokine subfamily B, member 7</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/173"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=9240"/>
    <ns1:Title>PPBP</ns1:Title>
    <ns1:Alias>LDGF</ns1:Alias>
    <ns1:Alias>Beta-TG</ns1:Alias>
    <ns1:Alias>macrophage-derived growth factor</ns1:Alias>
    <ns1:Alias>TGB1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>LA-PF4</ns1:Alias>
    <ns1:Alias>PBP</ns1:Alias>
    <ns1:Alias>CTAP3</ns1:Alias>
    <ns1:Alias>CTAP-III</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>TC2</ns1:Alias>
    <ns1:Alias>thrombocidin 1</ns1:Alias>
    <ns1:Alias>neutrophil-activating peptide 2</ns1:Alias>
    <ns1:Description>CTAP-III (officially named PPBP) is a platelet-derived growth factor that belongs to the CXC chemokine family. This growth factor is a potent chemoattractant and activator of neutrophils. It has been shown to stimulate various cellular processes including DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and sythesis of hyaluronic acid and sulfated glycosaminoglycan. It also stimulates the formation and secretion of plasminogen activator by synovial cells.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:5473"/>
    <ns1:Alias>NAP-2</ns1:Alias>
    <ns1:Alias>low-affinity platelet factor IV</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>SCYB7</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>pro-platelet basic protein</ns1:Alias>
    <ns1:Alias>THBGB1</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>CTAPIII</ns1:Alias>
    <ns1:AccessGrantedTo>Bast MD Anderson</ns1:AccessGrantedTo>
    <ns1:Alias>THBGB</ns1:Alias>
    <ns1:Alias>TC1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P02775"/>
    <ns1:Alias>B-TG1</ns1:Alias>
    <ns1:Alias>CXC chemokine ligand 7</ns1:Alias>
    <ns1:Alias>PPBP</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/86">
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=15451"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Security>Public</ns1:Security>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>GOLM1</ns1:Alias>
    <ns1:Alias>PSEC0257</ns1:Alias>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/970">
        <ns1:Title>Laxman 7-marker panel for prostate cancer</ns1:Title>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:HgncName></ns1:HgncName>
        <ns1:Type>Gene</ns1:Type>
        <ns1:Alias>Laxman 7-marker panel for prostate cancer</ns1:Alias>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:Security>Public</ns1:Security>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/86"/>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Phase></ns1:Phase>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/545"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/119"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/544"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/546"/>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:URN>urn:edrn:bmdb:biomarker:970</ns1:URN>
        <ns1:Description>This 7-marker multiplex panel of urine transcripts outperforms PCA3 transcript alone for the detection of prostate cancer. The panel consists of PCA3, AMACR, ERG, GP73 (GOLPH2), SPINK1, TFF3, and TMPRSS2:ERG fusion.</ns1:Description>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/543"/>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/129"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/63"/>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:Alias>golgi membrane protein 1</ns1:Alias>
    <ns1:Alias>FLJ22634</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/89"/>
    <ns1:Alias>FLJ23608</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:86</ns1:URN>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Chinnaiyan University of Michigan</ns1:AccessGrantedTo>
    <ns1:Alias>chromosome 9 open reading frame 155</ns1:Alias>
    <ns1:HgncName>GOLM1</ns1:HgncName>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>GOLPH2</ns1:Alias>
    <ns1:Alias>C9orf155</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/129"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/90"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/91"/>
    <ns1:Alias>GP73</ns1:Alias>
    <ns1:Title>GOLM1</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/51280"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q8NBJ4"/>
    <ns1:Description>The Golgi complex plays a key role in the sorting and modification of proteins exported from the endoplasmic reticulum. GP73 is a type II Golgi transmembrane protein. It processes proteins synthesized in the rough endoplasmic reticulum and assists in the transport of protein cargo through the Golgi apparatus. The expression of the GP73 gene has been observed to be upregulated in response to viral infection. Alternatively spliced transcript variants encoding the same protein have been described for this gene.
Kladeny, RD. et al. 2000, found significant up-regulation of GOLPH2 expression in human hepatocyte cells infected with a recombinant adenovirus. EDRN investigator Block, TM et al. 2005, found that GP73 over-expression in serum correlate with liver cancer in woodchucks and humans. Chinnayian's lab reported that GP73 transcript was over-expressed in prostate cancer patients urine sediment (Laxman B. et al. 2008).</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/180"/>
    <ns1:Alias>golgi phosphoprotein 2</ns1:Alias>
    <ns1:Alias>bA379P1.3</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/456">
    <ns1:Description>From NCBI Gene: microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding.
miRNAs bind to complementary sequences in the 3' UTR of multiple target mRNAs, usually silencing the targeted mRNA.  miRNAs may trigger the cleavage of their target molecules or act as translational repressors. miRNAs are thought to target approximatley 60% of all genes and are able to repress hundreds of targets each.</ns1:Description>
    <ns1:Alias>microRNA 21</ns1:Alias>
    <ns1:Alias>MIRN21</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>mir-21</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Phase></ns1:Phase>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:HgncName>MIR21</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:456</ns1:URN>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/406991"/>
    <ns1:Title>MIR21</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/136"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=31586"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MIR21&amp;search=mirna21"/>
    <ns1:Alias>miR-21</ns1:Alias>
    <ns1:Alias>miRNA21</ns1:Alias>
    <ns1:Alias>hsa-mir-21</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/137"/>
    <ns1:Type>Genomic</ns1:Type>
    <ns1:Alias>MIR21</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/135"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/555">
        <ns1:Security>Public</ns1:Security>
        <ns1:Type>Genomic</ns1:Type>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:Phase></ns1:Phase>
        <ns1:HgncName></ns1:HgncName>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/462"/>
        <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
        <ns1:URN>urn:edrn:bmdb:biomarker:555</ns1:URN>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/398"/>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/460"/>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/135"/>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:Title>Shen 4-marker miRNA panel for lung cancer</ns1:Title>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/456"/>
        <ns1:Description>We initially validated expressions of a set of miRNAs in paired lung tumor tissues and plasma specimens from 28 stage I NSCLC patients by real-time quantitative reverse transcription PCR, and then evaluated diagnostic value of the plasma miRNAs in a cohort of 58 NSCLC patients and 29 healthy individuals. The altered miRNA expressions were reproducibly confirmed in the tumor tissues. The miRNAs were stably present and reliably measurable in plasma. A logistic regression model with the best prediction was defined on the basis of the four genes (miRNA-21, -126, -210, and 486-5p), yielding 86.22% sensitivity and 96.55% specificity in distinguishing NSCLC patients from the healthy controls. (Lab Invest. 2011 Apr;91(4):579-87, PMID:    21116241)</ns1:Description>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Alias>Shen 4-marker miRNA panel for lung cancer</ns1:Alias>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1080">
    <ns1:URN>urn:edrn:bmdb:biomarker:1080</ns1:URN>
    <ns1:HgncName>PXN</ns1:HgncName>
    <ns1:Type>Protein</ns1:Type>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P49023"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:9718"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/505">
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:Type>Protein</ns1:Type>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:URN>urn:edrn:bmdb:biomarker:505</ns1:URN>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Description>A potential autoantibody profile was developed to screen for non-small cell lung cancer.  212 immunogenic phage-expressed proteins were statistically ranked for their individual reactivity with 23 stage I cancer patient and 23 risk-matched control samples.  Measurements of the five most predictive antibody markers in 46 cases and controls were combined.  While the identity of these phage-expressed proteins is not critical for use in a diagnostic assay, the identities were determined through a nucleotide search of GenBank.  Markers are: paxillin, SEC 15L2, BAC clone RP11-499F19, XRCC5, and MALAT1.</ns1:Description>
        <ns1:Security>Public</ns1:Security>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1083"/>
        <ns1:Alias>Zhong 5-antibody panel for Lung Cancer</ns1:Alias>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1081"/>
        <ns1:Phase></ns1:Phase>
        <ns1:HgncName></ns1:HgncName>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/115"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1082"/>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1080"/>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1084"/>
        <ns1:Title>Zhong 5-antibody panel for Lung Cancer</ns1:Title>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:Title>PXN</ns1:Title>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/115"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/5829"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>PXN</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Description>From NCBI Entrez Gene: This gene encodes a cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion). Alternatively spliced transcript variants encoding different isoforms have been described for this gene. These isoforms exhibit different expression pattern, and have different biochemical, as well as physiological properties (PMID:9054445). [provided by RefSeq, Aug 2011]</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PXN"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>Paxillin</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1089">
    <ns1:referencesResource rdf:resource="http://ncit.nci.nih.gov/ncitbrowser/pages/concept_details.jsf?dictionary=NCI_Thesaurus&amp;version=14.10d&amp;code=C17227&amp;type=all&amp;key=1823952639&amp;b=1&amp;n=0&amp;vse=null"/>
    <ns1:Alias>UBC</ns1:Alias>
    <ns1:Description>The ubiquitin protein was named due to its ubiquitous presence in the human body.  This small protein, comprised of 76 amino acids, is coded for by a family of genes whose translation products are fusion proteins.  The four genes that are known to code for ubiquitin are UBB, UBC, UBA52, and RPS27A.  Ubiquitin molecules are often bound to other proteins as a marker for degradation.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.rcsb.org/pdb/101/motm.do?momID=60&amp;evtc=Suggest&amp;evta=Moleculeof%20the%20Month&amp;evtl=OtherOptions"/>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/504">
        <ns1:URN>urn:edrn:bmdb:biomarker:504</ns1:URN>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/81"/>
        <ns1:Phase></ns1:Phase>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/424"/>
        <ns1:Security>Public</ns1:Security>
        <ns1:HgncName></ns1:HgncName>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/427"/>
        <ns1:Type>Proteomic</ns1:Type>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/402"/>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1089"/>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/421"/>
        <ns1:Description>This panel was derived from the proteomic analysis of bronchial lesions that could predict the diagnosis of lung cancer. Nine matrix-assisted laser desorption ionization mass spectrometry (MALDI MS) mass to charge ratio features were selected to build a prediction model diagnostic of lung cancer.  One signature was  not able to be associated with a particular protein.  The remaining eight signatures are derived from: Thymosin beta-4 (TMSB4X), Macrophage migration inhibitory factor (MIF), Des-ubiquitin (Ubiquitin-Gly-Gly), Ubiquitin, Acyl-coA binding protein (ACBP, also known as DBI), Cystatin A (CSTA),  and Cytochrome c.</ns1:Description>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Title>Rahman 9-marker MALDI MS panel for Lung Cancer</ns1:Title>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/495"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/114"/>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:Alias>Rahman 9-marker MALDI MS panel for Lung Cancer</ns1:Alias>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:Alias>Ubiquitin</ns1:Alias>
    <ns1:Alias>UBB</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>RPS27A</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:1089</ns1:URN>
    <ns1:Title>Ubiquitin</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/114"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:HgncName></ns1:HgncName>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/240"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>UBA52</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/466">
    <ns1:Alias>bHLHe39</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/503">
        <ns1:Phase></ns1:Phase>
        <ns1:Alias>Massion 4-marker FISH panel for lung cancer</ns1:Alias>
        <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/466"/>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/416"/>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:Description>The combination of these 4 probes, TP63, MYC, CEP3, and CEP6, offered a sensitivity of 82% for lung cancer and a specificity of 58%. These results indicate that specific cytogenetic alterations present in preinvasive lung lesions are closely associated with the diagnosis of lung cancer and may therefore have value in assessing lung cancer risk.</ns1:Description>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:Title>Massion 4-marker FISH panel for lung cancer</ns1:Title>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/497"/>
        <ns1:Security>Public</ns1:Security>
        <ns1:Type>Genomic</ns1:Type>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:URN>urn:edrn:bmdb:biomarker:503</ns1:URN>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/101"/>
        <ns1:HgncName></ns1:HgncName>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/415"/>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/101"/>
    <ns1:Alias>Myc proto-oncogene protein</ns1:Alias>
    <ns1:Alias>v-myc avian myelocytomatosis viral oncogene homolog</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:466</ns1:URN>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Massion Vanderbilt University Medical Center</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>myc proto-oncogene protein</ns1:Alias>
    <ns1:HgncName>MYC</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/116"/>
    <ns1:Title>MYC</ns1:Title>
    <ns1:Alias>avian myelocytomatosis viral oncogene homolog</ns1:Alias>
    <ns1:Alias>v-myc myelocytomatosis viral oncogene homolog (avian)</ns1:Alias>
    <ns1:Alias>Proto-oncogene c-Myc</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>Class E basic helix-loop-helix protein 39</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>c-Myc</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MYC&amp;search=myc"/>
    <ns1:Alias>MYC</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>cmyc</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Description>The oncogenic protein MYC, previously known as c-MYC, is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation.  It participates in the regulation of gene transcription of specific target genes.  MYC binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3'. Mutations, overexpression, rearrangement and translocation of the MYC gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. Evidence shows that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/4609"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>BHLHE39</ns1:Alias>
    <ns1:Alias>MRTL</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P01106"/>
    <ns1:Alias>Transcription factor p64</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=7553"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>myc-related translation/localization regulatory factor</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/444">
    <ns1:Alias>HSPCA</ns1:Alias>
    <ns1:Alias>heat shock 90kD protein, alpha-like 4</ns1:Alias>
    <ns1:Alias>HSP90A</ns1:Alias>
    <ns1:Alias>HSP 86</ns1:Alias>
    <ns1:Alias>Heat shock 86 kDa</ns1:Alias>
    <ns1:Alias>HSP89A</ns1:Alias>
    <ns1:Alias>renal carcinoma antigen NY-REN-38</ns1:Alias>
    <ns1:Alias>heat shock 86 kDa</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>heat shock 90kD protein 1, alpha-like 4</ns1:Alias>
    <ns1:Alias>Renal carcinoma antigen NY-REN-38</ns1:Alias>
    <ns1:Alias>Hsp90</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_001017963.2"/>
    <ns1:Alias>HSPCAL4</ns1:Alias>
    <ns1:Alias>Hsp89</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>LAP2</ns1:Alias>
    <ns1:Description>The HSP90AA1 protein, also known as HSP90a, is a molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved in cell cycle control and signal transduction.  HSP90AA1 is a homodimer that assists in the proper folding of specific target proteins by use of an ATPase activity that is modulated by co-chaperones. Two transcript variants encoding different isoforms have been found for this gene.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>HSP86</ns1:Alias>
    <ns1:Title>HSP90a</ns1:Title>
    <ns1:Alias>HSPCAL1</ns1:Alias>
    <ns1:Alias>heat shock 90kD protein 1, alpha</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=HSP90AA1&amp;search=hsp90alpha"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>heat shock protein HSP 90-alpha</ns1:Alias>
    <ns1:HgncName>HSP90AA1</ns1:HgncName>
    <ns1:Alias>HSPC1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>HSP90N</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.mupnet.com/JOCM%203%284%29%20107-112.pdf"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>HSPN</ns1:Alias>
    <ns1:Alias>FLJ31884</ns1:Alias>
    <ns1:Alias>HSP90AA1</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:444</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=5253"/>
    <ns1:Alias>HSP90a</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>heat shock 90kDa protein 1, alpha</ns1:Alias>
    <ns1:Alias>heat shock protein 90kDa alpha (cytosolic), class A member 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P07900"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1083">
    <ns1:Alias>HCN</ns1:Alias>
    <ns1:Alias>LINC00047</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Long Intergenic Non-Protein Coding RNA 47</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>PRO1073</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:29665"/>
    <ns1:Alias>NEAT2</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:1083</ns1:URN>
    <ns1:Alias>PRO2853</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Phase></ns1:Phase>
    <ns1:HgncName>MALAT1</ns1:HgncName>
    <ns1:Security>Public</ns1:Security>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/505"/>
    <ns1:Description>MALAT1 is a non-protein coding RNA known to be associated with lung adenocarcinoma.</ns1:Description>
    <ns1:Alias>MALAT1</ns1:Alias>
    <ns1:Alias>Metastasis Associated Lung Adenocarcinoma Transcript 1 (Non-Protein Coding)</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9UHZ2"/>
    <ns1:Alias>Nuclear Enriched Abundant Transcript 2</ns1:Alias>
    <ns1:Alias>MALAT-1</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>hepcarcin</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>Nuclear Paraspeckle Assembly Transcript 2 (Non-Protein Coding)</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/115"/>
    <ns1:Alias>NCRNA00047</ns1:Alias>
    <ns1:Alias>Metastasis Associated In Lung Adenocarcinoma Transcript 1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Non-Protein Coding RNA 47</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/378938"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MALAT1"/>
    <ns1:Alias>mascRNA</ns1:Alias>
    <ns1:Title>MALAT1</ns1:Title>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/119">
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9UHK6"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:HgncName>AMACR</ns1:HgncName>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>2-methylacyl-CoA racemase</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=451"/>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=AMACR&amp;search=amacr"/>
    <ns1:Alias>CBAS4</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/249"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>AMACR</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/88"/>
    <ns1:Description>AMACR, a racemase, is an enzyme that interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from the gene locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis.  Frequent overexpression of AMACR has been detected in prostate cancer tumors.</ns1:Description>
    <ns1:URN>urn:edrn:bmdb:biomarker:119</ns1:URN>
    <ns1:Alias>RACE</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/23600"/>
    <ns1:Alias>RM</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Title>AMACR</ns1:Title>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>AMACRD</ns1:Alias>
    <ns1:AccessGrantedTo>Chinnaiyan University of Michigan</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/129"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>alpha-methylacyl-CoA racemase</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/970"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1088">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/118"/>
    <ns1:Title>OLFM1</ns1:Title>
    <ns1:URN>urn:edrn:bmdb:biomarker:1088</ns1:URN>
    <ns1:Alias>OLFM1</ns1:Alias>
    <ns1:Alias>NOEL1</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>Olfactomedin 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>Olfactomedin Related ER Localized Protein</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:HgncName>OLFM1</ns1:HgncName>
    <ns1:Alias>olfactomedin-1</ns1:Alias>
    <ns1:Alias>Pancortin 1</ns1:Alias>
    <ns1:Alias>NOELIN1</ns1:Alias>
    <ns1:Alias>pancortin</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/507">
        <ns1:Type>Protein</ns1:Type>
        <ns1:Security>Public</ns1:Security>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:Alias>Wu 6-marker phage peptide panel for Lung Cancer</ns1:Alias>
        <ns1:Title>Wu 6-marker phage peptide panel for Lung Cancer</ns1:Title>
        <ns1:HgncName></ns1:HgncName>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/118"/>
        <ns1:Phase></ns1:Phase>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:Description>The six-phage peptide detector stands out as a promising diagnostic biomarker for NSCLC.  The peptide panel could be used to diagnose non-small cell lung cancer and to differentiate between non-small cell lung cancer and chronic obstructive pulmonary diseases.  One of the six phage peptides shows 100% homology to olfactomedin 1. (Clin Cancer Res. 2010 Jul 15;16(14):3760-8. doi: 10.1158/1078-0432.CCR-10-0193)  The other five peptides were homologous to proteins in a blastp search, but the homology was not high enough to positively identify the peptides.</ns1:Description>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:URN>urn:edrn:bmdb:biomarker:507</ns1:URN>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1088"/>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>OlfA</ns1:Alias>
    <ns1:Alias>noelin</ns1:Alias>
    <ns1:Alias>Olfactomedin-1</ns1:Alias>
    <ns1:Alias>NOE1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Neuroblastoma Protein</ns1:Alias>
    <ns1:Alias>AMY</ns1:Alias>
    <ns1:Alias>Neuronal Olfactomedin-Related ER Localized Protein</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>From NCBI Entrez Gene: This gene product shares extensive sequence similarity with the rat neuronal olfactomedin-related ER localized protein. While the exact function of the encoded protein is not known, its abundant expression in brain suggests that it may have an essential role in nerve tissue. Several alternatively spliced transcripts encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</ns1:Description>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/23">
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Title>VTCN1</ns1:Title>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/44"/>
    <ns1:Alias>B7X</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>DD-0110</ns1:Alias>
    <ns1:Alias>B7 family member, H4</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000134258"/>
    <ns1:Alias>B7-H4</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.expasy.org/uniprot/Q7Z7D3"/>
    <ns1:Phase></ns1:Phase>
    <ns1:URN>urn:edrn:bmdb:biomarker:23</ns1:URN>
    <ns1:Alias>FLJ22418</ns1:Alias>
    <ns1:Alias>VTCN1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/11"/>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:Alias>V-set domain containing T cell activation inhibitor 1</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/89"/>
    <ns1:Alias>B7S1</ns1:Alias>
    <ns1:Alias>T-cell costimulatory molecule B7x</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=28873"/>
    <ns1:Alias>Protein B7S1</ns1:Alias>
    <ns1:Alias>B7h.5</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:79679"/>
    <ns1:Alias>PRO1291</ns1:Alias>
    <ns1:Alias>Immune costimulatory protein B7-H4</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>B7 superfamily member 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Description>Highly glycosylated sialomucin; expressed on immune cells.  Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells (Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation. Overexpressed in breast, ovarian, endometrial, renal cell (RCC) and non-small-cell lung cancers (NSCLC).  Belongs to the B7 family of costimulatory proteins.</ns1:Description>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BGWHCramerPrePLCOPhaseIIAnalysis"/>
    <ns1:Alias>B7H4</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Cramer Brigham and Women's Hospital</ns1:AccessGrantedTo>
    <ns1:Alias>OV110</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N48888654406a467f8180d3d9010ad64c">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/23/39"/>
        <rdf:_2 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/23/40"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:HgncName>VTCN1</ns1:HgncName>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BGWHCramerPLCOPhaseIIIAnalysis"/>
    <ns1:Alias>VCTN1</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/67">
    <ns1:Alias>WAP four-disulfide core domain protein 4</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P03973"/>
    <ns1:Alias>Mucus proteinase inhibitor</ns1:Alias>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1076">
        <ns1:Title>Proteomic Panel for Lung Cancer</ns1:Title>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/236"/>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Description>An immunoaffinity-mass spectrometry-based quantification approach was used to develop an assay for verifying the expression of potential biomarkers in patient serum samples from lung cancer patients.</ns1:Description>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1077"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/104"/>
        <ns1:URN>urn:edrn:bmdb:biomarker:1076</ns1:URN>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/224"/>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:Alias>Proteomic Panel for Lung Cancer</ns1:Alias>
        <ns1:Phase></ns1:Phase>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/67"/>
        <ns1:Security>Public</ns1:Security>
        <ns1:HgncName></ns1:HgncName>
        <ns1:Type>Proteomic</ns1:Type>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:Alias>secretory leukocyte protease inhibitor (antileukoproteinase)</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/236"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>ALP</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Description>SLPI is a secreted inhibitor which protects epithelial tissues from serine proteases. It is found in various secretions including seminal plasma, cervical mucus, and bronchial secretions, and has affinity for trypsin, leukocyte elastase, and cathepsin G. Its inhibitory effect contributes to the immune response by protecting epithelial surfaces from attack by endogenous proteolytic enzymes; the protein is also thought to have broad-spectrum anti-biotic activity.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/84"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Seminal proteinase inhibitor</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>WAP4</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>MPI</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:6590"/>
    <ns1:Alias>HUSI-I</ns1:Alias>
    <ns1:Alias>WFDC4</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>BLPI</ns1:Alias>
    <ns1:Alias>secretory leukocyte peptidase inhibitor</ns1:Alias>
    <ns1:Alias>SLPI</ns1:Alias>
    <ns1:AccessGrantedTo>Urban Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>McIntosh Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:HgncName>SLPI</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11092"/>
    <ns1:Title>SLPI</ns1:Title>
    <ns1:Security>Public</ns1:Security>
    <ns1:URN>urn:edrn:bmdb:biomarker:67</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_003055.1"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>ALK1</ns1:Alias>
    <ns1:Alias>antileukoproteinase</ns1:Alias>
    <ns1:Alias>HUSI</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/73">
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Bast MD Anderson</ns1:AccessGrantedTo>
    <ns1:Alias>TRF</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:7018"/>
    <ns1:Alias>PRO2086</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P02787"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/547">
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/223"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/74"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/143"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/73"/>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/20"/>
        <ns1:URN>urn:edrn:bmdb:biomarker:547</ns1:URN>
        <ns1:Type>Protein</ns1:Type>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/72"/>
        <ns1:Phase></ns1:Phase>
        <ns1:Description>The OVA1 diagnostic test is comprised of five biomarkers: CA125, transthyretin (prealbumin), apolipprotein A1 (Apo A-1), beta-2 microglobulin, and transferrin.  OVA1 is an In Vitro Diagnostic Multivariate Index Assay (IVDMIA) of Proteomic Biomarkers test that analyzes the serum levels of these five proteomic biomarkers.  OVA1 is the first FDA approved test for assessing ovarian cancer risk in women previously diagnosed with an ovarian mass, and already scheduled for surgery. The OVA1 algorithm combines the results of these levels with information on the menopause status of the patient to classify the patient into a low- or high-risk group.  The results of the OVA1 test can help determine patients needing referral to a gynecologic oncologist for their surgery.</ns1:Description>
        <ns1:Title>OVA1</ns1:Title>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:referencesResource rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm182057.htm"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/167"/>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:Alias>OVA1</ns1:Alias>
        <ns1:HgncName></ns1:HgncName>
        <ns1:Security>Public</ns1:Security>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:referencesResource rdf:resource="http://www.medicalnewstoday.com/releases/225318.php"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/144"/>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:HgncName>TF</ns1:HgncName>
    <ns1:Alias>transferrin</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/190000"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:URN>urn:edrn:bmdb:biomarker:73</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Alias>TF</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>PRO1557</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11740"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Description>TF, or transferrin, a glycoprotein with an approximate molecular weight of 76.5 kDa, is thought to have been created as a result of an ancient gene duplication event that led to generation of homologous C and N-terminal domains each of which binds one ion of ferric iron. The function of this protein is to transport iron from the intestine, reticuloendothelial system, and liver parenchymal cells to all proliferating cells in the body. This protein may also have a physiologic role as granulocyte/pollen-binding protein (GPBP) involved in the removal of certain organic matter and allergens from serum.</ns1:Description>
    <ns1:Title>TF</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_001054.1"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/546">
    <ns1:Alias>Trefoil Factor 3 (Intestinal)</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/129"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>TFI</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:546</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11757"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/970"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Description>TFF3 is a member of the trefoil factor family.  The trefoil factors are secreted peptides produced by normal intestinal mucosa, characterized by having at least one copy of the trefoil motif, a 40-amino acid domain that contains three conserved disulfides.</ns1:Description>
    <ns1:Alias>HP1.B</ns1:Alias>
    <ns1:Alias>Trefoil Factor 3</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7033"/>
    <ns1:Title>TFF3</ns1:Title>
    <ns1:Alias>ITF</ns1:Alias>
    <ns1:Alias>HITF</ns1:Alias>
    <ns1:HgncName>TFF3</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/182"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/181"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=TFF3&amp;search=tff3"/>
    <ns1:Alias>Trefoil Factor 3, HITF, Human Intestinal Trefoil Factor11</ns1:Alias>
    <ns1:Alias>TFF3</ns1:Alias>
    <ns1:Alias>Polypeptide P1.B</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q07654"/>
    <ns1:Alias>Intestinal Trefoil Factor</ns1:Alias>
    <ns1:Alias>P1B</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/421">
    <ns1:Phase></ns1:Phase>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>CSTA</ns1:Alias>
    <ns1:Type>Proteomic</ns1:Type>
    <ns1:Alias>cystatin-A</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CSTA&amp;search=csta"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=2481"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P01040"/>
    <ns1:Alias>cystatin A (stefin A)</ns1:Alias>
    <ns1:Alias>AREI</ns1:Alias>
    <ns1:Title>CSTA</ns1:Title>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>Stefin-A</ns1:Alias>
    <ns1:Alias>STF1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>Cystatin-AS</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:421</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/114"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1475"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>STFA</ns1:Alias>
    <ns1:Alias>cystatin AS</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Description>CSTA, or cystatin-A, is a member of the cystatin superfamily, which includes proteins that contain multiple cystatin-like sequences.  Some members of the cystatin superfamily are active cysteine protease inhibitors, of which there are three families: type 1 cystatins (stefins), type 2 cystatins, and kininogens.  CSTA is a stefin     that functions as a cysteine protease inhibitor, forming tight complexes with papain and the cathepsins B, H, and L. Stefins have been proposed as prognostic and diagnostic biomarkers for cancer.</ns1:Description>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/504"/>
    <ns1:HgncName>CSTA</ns1:HgncName>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/868">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>GPSTAF50</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/10346"/>
    <ns1:Alias>RNF94</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Description>From NCBI Gene: The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This protein localizes to the cytoplasm and its expression is induced by interferon. The protein down-regulates transcription from the HIV-1 LTR promoter region, suggesting that function of this protein may be to mediate interferon's antiviral effects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2010]</ns1:Description>
    <ns1:URN>urn:edrn:bmdb:biomarker:868</ns1:URN>
    <ns1:Alias>E3 ubiquitin-protein ligase TRIM22</ns1:Alias>
    <ns1:Alias>RING finger protein 94</ns1:Alias>
    <ns1:Alias>50 kDa-stimulated trans-acting factor</ns1:Alias>
    <ns1:Alias>tripartite motif containing 22</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>tripartite motif-containing 22</ns1:Alias>
    <ns1:Alias>Tripartite motif-containing protein 22</ns1:Alias>
    <ns1:Alias>tripartite motif-containing protein 22</ns1:Alias>
    <ns1:Phase>One</ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Title>TRIM22</ns1:Title>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/606559"/>
    <ns1:Alias>EC 6.3.2.-</ns1:Alias>
    <ns1:Alias>tripartite motif protein TRIM22</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>tripartite binding motif 22</ns1:Alias>
    <ns1:Alias>staf-50</ns1:Alias>
    <ns1:Alias>TRIM22</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q8IYM9"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>stimulated trans-acting factor (50 kDa)</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>STAF50</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1013"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=16379"/>
    <ns1:Alias>Staf-50</ns1:Alias>
    <ns1:HgncName>TRIM22</ns1:HgncName>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/424">
    <ns1:Title>Cytochrome C</ns1:Title>
    <ns1:Alias>CYC</ns1:Alias>
    <ns1:Alias>HCS</ns1:Alias>
    <ns1:Alias>Cytochrome C, Somatic</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/54205"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/114"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/205"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/504"/>
    <ns1:HgncName>CYCS</ns1:HgncName>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=19986"/>
    <ns1:Description>CYCS, or cytochrome C, is an electron carrier protein that is an important part of the electron transport chain in mitochondria. The cytochrome C protein is a small heme protein that associates with the inner membrane of the mitochondrion where it accepts electrons from cytochrome b and transfers them to the cytochrome oxidase complex.  Cytochrome C also plays a role in apoptosis.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>THC4</ns1:Alias>
    <ns1:Alias>cyto C</ns1:Alias>
    <ns1:Alias>CYCS</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Cytochrome C</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:424</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P99999"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CYCS&amp;search=cycs"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/683">
    <ns1:Title>HIST1H2BC</ns1:Title>
    <ns1:Alias>histone 1, H2bc</ns1:Alias>
    <ns1:Alias>Histone H2B.g</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Histone H2B.l</ns1:Alias>
    <ns1:Alias>H2BFK</ns1:Alias>
    <ns1:Alias>histone H2B.1 A</ns1:Alias>
    <ns1:Alias>H2BFH</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>H2B histone family, member L</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8347"/>
    <ns1:Alias>H2B/l</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=4757"/>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>H2B/a</ns1:Alias>
    <ns1:Alias>dJ221C16.3</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Alias>histone cluster 1, H2bc</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P62807"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Histone H2B.h</ns1:Alias>
    <ns1:Alias>histone H2B type 1-C/E/F/G/I</ns1:Alias>
    <ns1:Alias>HIST1H2BC</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Alias>H2B.1</ns1:Alias>
    <ns1:HgncName>HIST1H2BC</ns1:HgncName>
    <ns1:Alias>H2B/k</ns1:Alias>
    <ns1:Alias>H2BFL</ns1:Alias>
    <ns1:Alias>histone H2B.l</ns1:Alias>
    <ns1:Alias>H2B/g</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Histone H2B.a</ns1:Alias>
    <ns1:Alias>H2B/h</ns1:Alias>
    <ns1:Alias>Histone H2B.k</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:683</ns1:URN>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/602847"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>H2BFG</ns1:Alias>
    <ns1:Alias>H2BFA</ns1:Alias>
    <ns1:Alias>Histone H2B.1 A</ns1:Alias>
    <ns1:Description>From NCBI Gene: Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Two molecules of each of the four core histones (H2A, H2B, H3, and H4) form an octamer, around which approximately 146 bp of DNA is wrapped in repeating units, called nucleosomes. The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a member of the histone H2B family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element. This gene is found in the large histone gene cluster on chromosome 6. [provided by RefSeq, Jul 2008]</ns1:Description>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1013"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/22">
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="Nfc79f77b52584ef7bfd0ffe33e6ecd66">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/22/32"/>
        <rdf:_2 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/22/33"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/89"/>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:HgncName></ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:22</ns1:URN>
    <ns1:Alias>Cancer-associated Antigen 72-4</ns1:Alias>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:Title>CA72-4</ns1:Title>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/10"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Cramer Brigham and Women's Hospital</ns1:AccessGrantedTo>
    <ns1:Alias>TAG-72</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>tumor-associated glycoprotein 72</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Description>High-MW mucin-type glycoprotein expressed on epithelial cancer cells.</ns1:Description>
    <ns1:Alias>CA72-4</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/43"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/398">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/135"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:398</ns1:URN>
    <ns1:Type>Genomic</ns1:Type>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>486-5p</ns1:Alias>
    <ns1:Alias>MIR-486</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.microrna.org/microrna/linkFromMirbase.do?mirbase=MIMAT0002177"/>
    <ns1:HgncName></ns1:HgncName>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>hsa-miR-486-5p</ns1:Alias>
    <ns1:Alias>MIR486-5p</ns1:Alias>
    <ns1:Alias>MIR486</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MIR486"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/619554"/>
    <ns1:Title>MIR486-5p</ns1:Title>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:32342"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/555"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>From NCBI Gene: MicroRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding.
miRNAs bind to complementary sequences in the 3' UTR of multiple target mRNAs, usually silencing the targeted mRNA.  miRNAs may trigger the cleavage of their target molecules or act as translational repressors. miRNAs are thought to target approximately 60% of all genes and are able to repress hundreds of targets each.	
MIR486-5p is a variant of MIR486.</ns1:Description>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/454">
    <ns1:Alias>chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)</ns1:Alias>
    <ns1:Alias>chemokine (C-C), dendritic</ns1:Alias>
    <ns1:Description>From NCBI Gene: This antimicrobial gene is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 17. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for naive T cells, CD4+ and CD8+ T cells and nonactivated lymphocytes, but not for monocytes or granulocytes. This chemokine attracts naive T lymphocytes toward dendritic cells and activated macrophages in lymph nodes. It may play a role in both humoral and cell-mediated immunity responses. [provided by RefSeq, Sep 2014]</ns1:Description>
    <ns1:Alias>macrophage inflammatory protein 4</ns1:Alias>
    <ns1:Alias>AMAC1</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>DCCK1</ns1:Alias>
    <ns1:Alias>Dendritic cell chemokine 1</ns1:Alias>
    <ns1:Alias>CKb7</ns1:Alias>
    <ns1:Alias>Pulmonary and activation-regulated chemokine</ns1:Alias>
    <ns1:Alias>small inducible cytokine subfamily A (Cys-Cys), member 18, pulmonary and activation-regulated</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_002979.1"/>
    <ns1:Alias>CC chemokine ligand 18</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:454</ns1:URN>
    <ns1:Alias>pulmonary and activation-regulated chemokine</ns1:Alias>
    <ns1:Alias>AMAC-1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>Macrophage inflammatory protein 4</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=10616"/>
    <ns1:Alias>small inducible cytokine A18</ns1:Alias>
    <ns1:Title>CCL18</ns1:Title>
    <ns1:Alias>alternative macrophage activation-associated CC chemokine 1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL18&amp;search=mip-4"/>
    <ns1:Alias>Alternative macrophage activation-associated CC chemokine 1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>MIP4</ns1:Alias>
    <ns1:Alias>Small-inducible cytokine A18</ns1:Alias>
    <ns1:Alias>PARC</ns1:Alias>
    <ns1:HgncName>CCL18</ns1:HgncName>
    <ns1:Alias>MIP-4</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>small-inducible cytokine A18</ns1:Alias>
    <ns1:Alias>CC chemokine PARC</ns1:Alias>
    <ns1:Alias>C-C motif chemokine 18</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P55774"/>
    <ns1:Alias>CCL18</ns1:Alias>
    <ns1:Alias>SCYA18</ns1:Alias>
    <ns1:Alias>dendritic cell chemokine 1</ns1:Alias>
    <ns1:Alias>DC-CK1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/402">
    <ns1:Alias>ACBP</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=2690"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/504"/>
    <ns1:Alias>DBI</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Diazepam-Binding Inhibitor</ns1:Alias>
    <ns1:Alias>endozepine</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Acyl-Coenzyme A Binding Domain Containing 1</ns1:Alias>
    <ns1:Alias>EP</ns1:Alias>
    <ns1:Alias>ACBD1</ns1:Alias>
    <ns1:Alias>Endozepine</ns1:Alias>
    <ns1:Alias>CCK-RP</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:402</ns1:URN>
    <ns1:Alias>Cholecystokinin-Releasing Peptide, Trypsin-Sensitive</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1622"/>
    <ns1:Alias>GABA Receptor Modulator</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Title>ACBP</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Acyl-CoA-Binding Protein</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/114"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P07108"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Description>DBI, diazepam binding inhibitor, was previously known as ACBP, acyl-coA binding protein.  This protein is regulated by hormones, is involved in lipid metabolism, and is thought to act as a neuropeptide to regulate the action of the GABA receptor.  DBI is conserved across species.  The most highly conserved domain is the hydrophobic binding site for medium- and long-chain acyl-coA esters.  DBI is involved in the regulation of pancreatic secretion and release of cholecystokinin.  There are three pseudogenes for DBI on separate chromosomes.  DBI has multiple transcript variants encoding different isoforms.</ns1:Description>
    <ns1:Alias>diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)</ns1:Alias>
    <ns1:HgncName>DBI</ns1:HgncName>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/564">
    <ns1:Alias>RALDH 2</ns1:Alias>
    <ns1:Alias>aldehyde dehydrogenase 1 family, member A2</ns1:Alias>
    <ns1:Title>ALDH1A2</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O94788"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Description>From NCBI Gene: This protein belongs to the aldehyde dehydrogenase family of proteins. The product of this gene is an enzyme that catalyzes the synthesis of retinoic acid (RA) from retinaldehyde. Retinoic acid, the active derivative of vitamin A (retinol), is a hormonal signaling molecule that functions in developing and adult tissues. The studies of a similar mouse gene suggest that this enzyme and the cytochrome CYP26A1, concurrently establish local embryonic retinoic acid levels which facilitate posterior organ development and prevent spina bifida. Four transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, May 2011]</ns1:Description>
    <ns1:Alias>retinaldehyde-specific dehydrogenase type 2</ns1:Alias>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>RALDH2-T</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>retinal dehydrogenase 2</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1013"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Retinaldehyde-specific dehydrogenase type 2</ns1:Alias>
    <ns1:Alias>Aldehyde dehydrogenase family 1 member A2</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>RalDH2</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:URN>urn:edrn:bmdb:biomarker:564</ns1:URN>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/602847"/>
    <ns1:Alias>RALDH(II)</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=15472"/>
    <ns1:Alias>ALDH1A2</ns1:Alias>
    <ns1:Alias>EC 1.2.1.36</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/8854"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:HgncName>ALDH1A2</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/235"/>
    <ns1:Alias>RALDH2</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/488">
    <ns1:Alias>PBT</ns1:Alias>
    <ns1:HgncName>KIT</ns1:HgncName>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>p145 c-kit</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:Alias>mast/stem cell growth factor receptor Kit</ns1:Alias>
    <ns1:Alias>CD117</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>C-Kit</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:488</ns1:URN>
    <ns1:Alias>SCF-sR</ns1:Alias>
    <ns1:Alias>Piebald trait</ns1:Alias>
    <ns1:Alias>soluble KIT variant 1</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6342"/>
    <ns1:Alias>proto-oncogene c-Kit</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene-like protein</ns1:Alias>
    <ns1:Description>SCF-sR, also known as KIT, is the human homolog of the proto-oncogene c-kit. C-kit was first identified as the cellular homolog of the feline sarcoma viral oncogene v-kit.  Human KIT is a tyrosine-protein kinase that acts as cell-surface receptor for the cytokine KITLG/SCF and plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis.  KIT is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous lukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene.</ns1:Description>
    <ns1:Alias>proto-oncogene tyrosine-protein kinase Kit</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/221"/>
    <ns1:Alias>KIT</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/p10721"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/220"/>
    <ns1:Alias>Piebald trait protein</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000213.1"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>tyrosine-protein kinase Kit</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
    <ns1:Title>KIT</ns1:Title>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=KIT&amp;search=kit"/>
    <ns1:Alias>v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:Alias>CD117 antigen</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>SCFR</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/34">
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000134308"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:34</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=12854"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/137"/>
    <ns1:Description>YWHAQ, also known as 14-3-3 theta, belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. This highly conserved protein family is found in both plants and mammals, and this protein is 99% identical to the mouse and rat orthologs. The 14-3-3 proteins have a wide range of ligands, are involved in a variety of biological pathways, and are known to be overexpressed in some human lung cancers, suggesting that they may play a role in tumorigenesis. 14-3-3 theta is an adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathway. It binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner.  14-3-3 theta antigens have been found to be targets of autoantibodies in subjects newly diagnosed with lung cancer.</ns1:Description>
    <ns1:Alias>1C5</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>14-3-3 theta</ns1:Alias>
    <ns1:Title>YWHAQ</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/30"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>14-3-3 protein theta</ns1:Alias>
    <ns1:Alias>protein tau</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:HgncName>YWHAQ</ns1:HgncName>
    <ns1:AccessGrantedTo>Hanash Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:indicatorForOrgan>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/54">
        <ns1:Alias>TSP-1</ns1:Alias>
        <ns1:AccessGrantedTo>Haab Van Andel Research Institute</ns1:AccessGrantedTo>
        <ns1:Alias>TSP</ns1:Alias>
        <ns1:QAState>Accepted</ns1:QAState>
        <ns1:Phase></ns1:Phase>
        <ns1:Alias>THBS-1</ns1:Alias>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:Title>THBS1</ns1:Title>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:HgncName>THBS1</ns1:HgncName>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/250"/>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:hasBiomarkerStudyDatas>
          <rdf:Bag rdf:nodeID="Ne1e7d63a3b1f4969867831f84c070cb5">
            <rdf:_2 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/54/23"/>
            <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/54/22"/>
            <rdf:_3 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/54/1041"/>
          </rdf:Bag>
        </ns1:hasBiomarkerStudyDatas>
        <ns1:Alias>THBS</ns1:Alias>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:Type>Protein</ns1:Type>
        <ns1:Alias>Thrombospondin-1</ns1:Alias>
        <ns1:URN>urn:edrn:bmdb:biomarker:54</ns1:URN>
        <ns1:Alias>THBS1</ns1:Alias>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Prostate and Urologic</ns1:AccessGrantedTo>
        <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000137801"/>
        <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11785"/>
        <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BethIsraelSandaTSPPreval"/>
        <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/75"/>
        <ns1:Description>TSP is an adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. TSP can bind to fibrinogen, fibronectin, laminin, type V collagen and integrins alpha-V/beta-1. It has been shown to play roles in platelet aggregation, angiogenesis, and tumorigenesis.</ns1:Description>
        <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:7057"/>
        <ns1:Alias>thrombospondin-1p180</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P07996"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/66"/>
        <ns1:Security>Public</ns1:Security>
      </ns1:Biomarker>
    </ns1:indicatorForOrgan>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:10971"/>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N740e821dd50d4841b2662f0286baac50">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/34/19"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:Security>Public</ns1:Security>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/39">
        <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:FHCRCHanashAnnexinLamr"/>
        <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/60"/>
        <ns1:Type>Protein</ns1:Type>
        <ns1:Phase></ns1:Phase>
        <ns1:Security>Public</ns1:Security>
        <ns1:HgncName></ns1:HgncName>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/27"/>
        <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
        <ns1:Description>The EDRN validation study ("Validation of Protein Markers for Lung Cancer Using CARET Sera and Proteomics Techniques") presents evidence for the occurrence in lung cancer sera of autoantibodies to annexin 1, 14-3-3 theta and LAMR1, which precede the onset of symptoms and diagnosis.  The combined AUC for these three antigens in CARET pre-clinical lung cancer sera vs. matched controls was 0.73. While autoantibodies to various cancer antigens have been reported in newly diagnosed lung cancer patient sera, an important aspect of this study is testing for occurrence of autoantibodies in pre-diagnostic sera and demonstration of significant autoantibody reactivity against LAMR1, annexin 1 and 14-3-3 theta.</ns1:Description>
        <ns1:hasBiomarkerStudyDatas>
          <rdf:Bag rdf:nodeID="Na293263d46c040e498fb47d045914b1c">
            <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/39/1000"/>
          </rdf:Bag>
        </ns1:hasBiomarkerStudyDatas>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:URN>urn:edrn:bmdb:biomarker:39</ns1:URN>
        <ns1:Alias>Hanash 3-marker panel for Lung Cancer</ns1:Alias>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/35"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/34"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/73"/>
        <ns1:Alias>Hanash 3 marker panel for Lung Cancer</ns1:Alias>
        <ns1:Title>Hanash 3 marker panel for Lung Cancer</ns1:Title>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Hanash Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/32"/>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:QAState>Accepted</ns1:QAState>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>Protein HS1</ns1:Alias>
    <ns1:Alias>14-3-3 protein tau</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://ca.expasy.org/uniprot/P27348"/>
    <ns1:Alias>14-3-3 protein T-cell</ns1:Alias>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:FHCRCHanashAnnexinLamr"/>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/27"/>
    <ns1:Alias>YWHAQ</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/29"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/28"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/73"/>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1051">
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Gamma-seminoprotein</ns1:Alias>
    <ns1:Alias>kallikrein-3</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>EC 3.4.21.77</ns1:Alias>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:URN>urn:edrn:bmdb:biomarker:1051</ns1:URN>
    <ns1:Alias>kallikrein 3, (prostate specific antigen)</ns1:Alias>
    <ns1:Alias>Seminin</ns1:Alias>
    <ns1:Alias>PSA</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/176820"/>
    <ns1:Alias>prostate-specific antigen</ns1:Alias>
    <ns1:AccessGrantedTo>Chan Johns Hopkins Medical Institutions</ns1:AccessGrantedTo>
    <ns1:Alias>KLK2A1</ns1:Alias>
    <ns1:Alias>prostate specific antigen</ns1:Alias>
    <ns1:Alias>seminin</ns1:Alias>
    <ns1:Alias>gamma-seminoprotein</ns1:Alias>
    <ns1:Title>PSA</ns1:Title>
    <ns1:Type>Protein</ns1:Type>
    <ns1:HgncName>KLK3</ns1:HgncName>
    <ns1:Alias>Semenogelase</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/87"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Kallikrein-3</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>APS</ns1:Alias>
    <ns1:Alias>hK3</ns1:Alias>
    <ns1:Description>KLK3, also known as PSA, or prostate specific antigen, a member of the kallikrein subgroup of serine proteases, is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19.  Kallikreins are increasingly thought to be involved in carcinogenesis, and many act as cancer biomarkers.  The product of the KLK3 gene is a protease present in seminal plasma. It is thought to function normally in the liquefaction of seminal coagulum.  KLK3, or PSA, is well known for its role in diagnosing and monitoring prostate cancer.  There are several isoforms of KLK3, generated by alternate splicing and transcript variants.</ns1:Description>
    <ns1:Alias>KLK3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6364"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/250"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P07288"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/97"/>
    <ns1:Alias>semenogelase</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/354"/>
    <ns1:Alias>kallikrein-related peptidase 3</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/249"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1075">
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/130"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/543"/>
        <ns1:referencesResource rdf:resource="http://www.mlabs.umich.edu/files/pdfs/MiPS_FAQ.pdf"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/140"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/97"/>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1051"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/63"/>
        <ns1:URN>urn:edrn:bmdb:biomarker:1075</ns1:URN>
        <ns1:HgncName></ns1:HgncName>
        <ns1:Phase></ns1:Phase>
        <ns1:Security>Public</ns1:Security>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/141"/>
        <ns1:AccessGrantedTo>Wei University of Michigan</ns1:AccessGrantedTo>
        <ns1:Alias>MiPS (Mi Prostate Score Urine test)</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/188"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/147"/>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:Type>Gene</ns1:Type>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/95"/>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Chinnaiyan University of Michigan</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/247"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/129"/>
        <ns1:referencesResource rdf:resource="http://www.pcf.org/site/c.leJRIROrEpH/b.8833993/k.EC93/New_Urine_Test_for_Prostate_Cancer_Available_Unlike_PSA_Test_is_UltraSpecific_for_Prostate_Cancer.htm"/>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/253"/>
        <ns1:AccessGrantedTo>Prostate and Urologic</ns1:AccessGrantedTo>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:Description>The MiPS assay is a multiplex analysis of T2-ERG gene fusion, PCA3, and serum PSA (KLK3).  It is commercially available through the University of Michigan MLabs.  The MiPS assay tests for the presence of two prostate cancer biomarkers: a piece of RNA made from the PCA3 gene, found to be overactive in 95 percent of all prostate cancers, and another RNA marker that is found only when TMPRSS2 and ERG abnormally fuse. TMPRSS2:ERG, or T2-ERG, is a strong indicator of prostate cancer.</ns1:Description>
        <ns1:Title>MiPS (Mi Prostate Score Urine test)</ns1:Title>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:Alias>P-30 antigen</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/492">
    <ns1:Alias>CD62L</ns1:Alias>
    <ns1:Alias>selectin L</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/127"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972"/>
    <ns1:Alias>hLHRc</ns1:Alias>
    <ns1:Description>From NCBI Gene and UniProtKB/Swiss-Prot:  sL-selectin, also known as SELL, is a cell surface adhesion molecule that belongs to a family of adhesion/homing receptors.  SELL mediates the adherence of lymphocytes to endothelial cells of high endothelial venules in peripheral lymph nodes and promotes initial tethering and rolling of leukocytes in endothelia, facilitating their migration into secondary lymphoid organs and inflammation sites.  SELL contains a C-type lectin-like domain, a calcium-binding epidermal growth factor-like domain, and two short complement-like repeats. Alternatively spliced transcript variants have been found for this gene.</ns1:Description>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>LEU8</ns1:Alias>
    <ns1:Alias>LSEL</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:492</ns1:URN>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=10720"/>
    <ns1:Alias>Lyam-1</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>LAM-1</ns1:Alias>
    <ns1:Alias>Leukocyte adhesion molecule 1</ns1:Alias>
    <ns1:Alias>CD62 antigen-like family member L</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P14151"/>
    <ns1:Alias>lymphocyte adhesion molecule 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000646.2"/>
    <ns1:Alias>Leukocyte surface antigen Leu-8</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>CD62L antigen</ns1:Alias>
    <ns1:Alias>Leu-8</ns1:Alias>
    <ns1:Title>SELL</ns1:Title>
    <ns1:Security>Public</ns1:Security>
    <ns1:HgncName>SELL</ns1:HgncName>
    <ns1:AccessGrantedTo>Anderson Dana-Farber Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>leukocyte-endothelial cell adhesion molecule 1</ns1:Alias>
    <ns1:Alias>LYAM1</ns1:Alias>
    <ns1:Alias>pln homing receptor</ns1:Alias>
    <ns1:Alias>L-selectin</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
    <ns1:Alias>LNHR</ns1:Alias>
    <ns1:AccessGrantedTo>Anderson Arizona State University</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>lymph node homing receptor</ns1:Alias>
    <ns1:Alias>Leukocyte-endothelial cell adhesion molecule 1</ns1:Alias>
    <ns1:Alias>TQ1</ns1:Alias>
    <ns1:Alias>LAM1</ns1:Alias>
    <ns1:Alias>PLNHR</ns1:Alias>
    <ns1:Alias>sL-selectin</ns1:Alias>
    <ns1:Alias>LECAM1</ns1:Alias>
    <ns1:Alias>Lymph node homing receptor</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SELL&amp;search=sell"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>gp90-MEL</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>SELL</ns1:Alias>
    <ns1:Alias>leukocyte surface antigen Leu-8</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/68">
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:57817"/>
    <ns1:Alias>PLTR</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>HEPC</ns1:Alias>
    <ns1:HgncName>HAMP</ns1:HgncName>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Putative liver tumor regressor</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Description>HEPC, also known as HAMP, is involved in the maintenance of iron homeostasis, and it is necessary for the regulation of iron storage in macrophages, and for intestinal iron absorption. The preproprotein is post-translationally cleaved into mature peptides of 20, 22 and 25 amino acids, and these active peptides are rich in cysteines, which form intramolecular bonds that stabilize their beta-sheet structures. These peptides exhibit antimicrobial activity. Mutations in this gene cause hemochromatosis type 2B, also known as juvenile hemochromatosis, a disease caused by severe iron overload that results in cardiomyopathy, cirrhosis, and endocrine failure.</ns1:Description>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>hepcidin antimicrobial peptide</ns1:Alias>
    <ns1:AccessGrantedTo>Bast MD Anderson</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=15598"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>HEPCIDIN</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P81172"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:68</ns1:URN>
    <ns1:Title>HAMP</ns1:Title>
    <ns1:Alias>HAMP</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/173"/>
    <ns1:Alias>LEAP-1</ns1:Alias>
    <ns1:Alias>LEAP1</ns1:Alias>
    <ns1:Alias>hepcidin-25</ns1:Alias>
    <ns1:Alias>Liver-expressed antimicrobial peptide 1</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>hepcidin</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_066998.1"/>
    <ns1:Alias>HFE2B</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/54/1041">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/287"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/21/43">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
  </ns1:BiomarkerStudyData>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/429">
    <ns1:Phase></ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Description>COL18A1, also known as endostatin, is the alpha chain of type XVIII collagen.  COL18A1 is one of the multiplexins, extracellular matrix proteins that contain multiple triple-helix domains (collagenous domains) interrupted by non-collagenous domains. COLA18A probably plays a major role in determining the retinal structure as well as in the closure of the neural tube.  It also inhibits endothelial cell proliferation and angiogenesis, and  may inhibit angiogenesis by binding to the heparan sulfate proteoglycans involved in growth factor signaling.</ns1:Description>
    <ns1:Alias>antiangiogenic agent</ns1:Alias>
    <ns1:HgncName>COL18A1</ns1:HgncName>
    <ns1:Alias>Endostatin</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/185"/>
    <ns1:Alias>collagen alpha-1(XVIII) chain</ns1:Alias>
    <ns1:Alias>KS</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
    <ns1:Title>Endostatin</ns1:Title>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_085059.2"/>
    <ns1:Alias>COL18A1</ns1:Alias>
    <ns1:Alias>multi-functional protein MFP</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P39060"/>
    <ns1:Alias>collagen, type XVIII, alpha 1</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>human type XVIII collagen</ns1:Alias>
    <ns1:Alias>KNO</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=COL18A1&amp;search=endostatin"/>
    <ns1:Alias>Knobloch syndrome, type 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=2195"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:429</ns1:URN>
    <ns1:Alias>KNO1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/545">
    <ns1:Alias>Spink3</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/970"/>
    <ns1:Description>SPINK1 is a trypsin inhibitor, which is secreted from pancreatic acinar cells into pancreatic juice.  Its physiological function is to prevent the trypsin-catalyzed premature activation of zymogens within the pancreas.  Mutations in SPINK1 are associated with hereditary pancreatitis and tropical calcific pancreatitis.</ns1:Description>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P00995"/>
    <ns1:Alias>Serine Protease Inhibitor, Kazal Type 1</ns1:Alias>
    <ns1:Alias>Serine Peptidase Inhibitor, Kazal Type 1</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>PCTT</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=SPINK1&amp;search=spink1"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11244"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>SPINK1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/6690"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>Pancreatic Secretory Trypsin Inhibitor</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/129"/>
    <ns1:Alias>PSTI</ns1:Alias>
    <ns1:Alias>TCP</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:545</ns1:URN>
    <ns1:Alias>Serine Protease Inhibitor, Kazal-Type 1</ns1:Alias>
    <ns1:Title>SPINK1</ns1:Title>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/179"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>TATI</ns1:Alias>
    <ns1:Alias>Tumor-Associated Trypsin Inhibitor</ns1:Alias>
    <ns1:HgncName>SPINK1</ns1:HgncName>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/966">
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.womenandinfants.org/news/FDA-Clears-Biomarker-Test.cfm"/>
    <ns1:hasBiomarker>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/24">
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:Alias>WAP5</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=15939"/>
        <ns1:Alias>WFDC2</ns1:Alias>
        <ns1:URN>urn:edrn:bmdb:biomarker:24</ns1:URN>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:Alias>WAP domain containing protein HE4-V4</ns1:Alias>
        <ns1:Alias>Putative protease inhibitor WAP5</ns1:Alias>
        <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Cramer Brigham and Women's Hospital</ns1:AccessGrantedTo>
        <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BGWHCramerPLCOPhaseIIIAnalysis"/>
        <ns1:Type>Protein</ns1:Type>
        <ns1:Phase></ns1:Phase>
        <ns1:Alias>HE4</ns1:Alias>
        <ns1:Security>Public</ns1:Security>
        <ns1:Alias>epididymis-specific, whey-acidic protein type, four-disulfide core</ns1:Alias>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/12"/>
        <ns1:Alias>WAP four-disulfide core domain 2</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/204"/>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/966"/>
        <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000101443"/>
        <ns1:Alias>EDDM4</ns1:Alias>
        <ns1:Title>HE4</ns1:Title>
        <ns1:HgncName>WFDC2</ns1:HgncName>
        <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BGWHCramerPrePLCOPhaseIIAnalysis"/>
        <ns1:Alias>WAP four-disulfide core domain 2 [Precursor]</ns1:Alias>
        <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/45"/>
        <ns1:Alias>Epididymal secretory protein E4</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:10406"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/137"/>
        <ns1:QAState>Accepted</ns1:QAState>
        <ns1:Alias>epididymal protein 4</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:hasBiomarkerStudyDatas>
          <rdf:Bag rdf:nodeID="Ne4acb2dbf7024d0bab0f47d2e2b02081">
            <rdf:_4 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/24/740"/>
            <rdf:_2 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/24/42"/>
            <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/24/41"/>
            <rdf:_3 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/24/155"/>
          </rdf:Bag>
        </ns1:hasBiomarkerStudyDatas>
        <ns1:Alias>Major epididymis-specific protein E4</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
        <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/466"/>
        <ns1:Alias>dJ461P17.6</ns1:Alias>
        <ns1:Description>11 kDa protein that is a precursor to the epididymal secretory protein HE4; an inhibitor of an as yet unidentified protease.  Highly expressed in a number of tumors cells lines, such ovarian, colon, breast, lung and renal cells lines.</ns1:Description>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/89"/>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:referencesResource rdf:resource="http://www.expasy.org/uniprot/Q14508"/>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
      </ns1:Biomarker>
    </ns1:hasBiomarker>
    <ns1:IsPanel>1</ns1:IsPanel>
    <ns1:hasBiomarker>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/20">
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/547"/>
        <ns1:Alias>mucin 16, cell surface associated</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:Alias>CA-125</ns1:Alias>
        <ns1:Description>MUC16 (CA125) is a highly glycosylated sialomucin that is expressed on epithelial cell surface, especially on ovarian cancer cells.  MUC16 is anchored to the epithelium by a transmembrane domain and is released into the extracellular space by enzymatic cleavage. It is thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces.</ns1:Description>
        <ns1:QAState>Accepted</ns1:QAState>
        <ns1:HgncName>MUC16</ns1:HgncName>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/89"/>
        <ns1:Alias>Ovarian cancer-related tumor marker CA125</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
        <ns1:Alias>Ovarian carcinoma antigen CA125</ns1:Alias>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/966"/>
        <ns1:AccessGrantedTo>Cramer Brigham and Women's Hospital</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Crichton Jet Propulsion Laboratory</ns1:AccessGrantedTo>
        <ns1:Alias>Mucin 16</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000181143"/>
        <ns1:Alias>MUC16</ns1:Alias>
        <ns1:Title>CA125</ns1:Title>
        <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BGWHCramerPrePLCOPhaseIIAnalysis"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
        <ns1:Security>Public</ns1:Security>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/94025"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/254"/>
        <ns1:Phase></ns1:Phase>
        <ns1:Type>Protein</ns1:Type>
        <ns1:hasBiomarkerStudyDatas>
          <rdf:Bag rdf:nodeID="Nbfcba62419d34c8faf936f79c90d1258">
            <rdf:_6 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/959"/>
            <rdf:_3 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/152"/>
            <rdf:_2 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/30"/>
            <rdf:_4 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/257"/>
            <rdf:_7 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/1010"/>
            <rdf:_5 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/916"/>
            <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/55"/>
          </rdf:Bag>
        </ns1:hasBiomarkerStudyDatas>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/8"/>
        <ns1:referencesResource rdf:resource="http://www.genome.ad.jp/dbget-bin/www_bget?hsa+94025"/>
        <ns1:Alias>CA125 ovarian cancer antigen</ns1:Alias>
        <ns1:Alias>Mucin-16</ns1:Alias>
        <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1073"/>
        <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=MUC16"/>
        <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/41"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/35"/>
        <ns1:Alias>MUC-16</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://ca.expasy.org/uniprot/Q8WXI7"/>
        <ns1:URN>urn:edrn:bmdb:biomarker:20</ns1:URN>
        <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:BGWHCramerPLCOPhaseIIIAnalysis"/>
        <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
        <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=15582"/>
        <ns1:Alias>FLJ14303</ns1:Alias>
        <ns1:Alias>CA125</ns1:Alias>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
      </ns1:Biomarker>
    </ns1:hasBiomarker>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Description>The Risk of Ovarian Malignancy Algorithm (ROMA) algorithm was approved by the FDA in 2011.  Research demonstrates that examining levels of HE4 and CA125 using the ROMA algorithm shows the highest accuracy in determining ovarian cancer risk in pre- and post-menopausal women who have an ovarian mass present.</ns1:Description>
    <ns1:HgncName></ns1:HgncName>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/167"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/166"/>
    <ns1:Title>ROMA</ns1:Title>
    <ns1:Alias>ROMA</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:966</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.accessdata.fda.gov/cdrh_docs/reviews/K103358.pdf"/>
  </ns1:Biomarker>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/24/740">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/1000199"/>
  </ns1:BiomarkerStudyData>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/66">
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>IBP2</ns1:Alias>
    <ns1:Alias>IBP-2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P18065"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>IGFBP-2</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=5471"/>
    <ns1:Title>IGFBP2</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>IGF-binding protein 2</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>BP2</ns1:Alias>
    <ns1:Alias>IGFBP2</ns1:Alias>
    <ns1:Description>IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Insulin-like growth factor binding protein 2 (IGFBP2) is overexpressed in ovarian malignant tissues and in the serum and cystic fluid of ovarian cancer patients, suggesting an important role of IGFBP2 in the biology of ovarian cancer.</ns1:Description>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:3485"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000588.2"/>
    <ns1:Alias>IGF-BP53</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>McIntosh Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:HgncName>IGFBP2</ns1:HgncName>
    <ns1:URN>urn:edrn:bmdb:biomarker:66</ns1:URN>
    <ns1:Alias>Insulin-like growth factor-binding protein 2</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/83"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
  </ns1:Biomarker>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/54/23">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/286"/>
  </ns1:BiomarkerStudyData>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/802">
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9NQL2"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:802</ns1:URN>
    <ns1:Phase>One</ns1:Phase>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Description>From NCBI Gene: RRAGD is a monomeric guanine nucleotide-binding protein, or G protein. By binding GTP or GDP, small G proteins act as molecular switches in numerous cell processes and signaling pathways.[supplied by OMIM, Apr 2004]</ns1:Description>
    <ns1:Alias>Ras-related GTP binding D</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1013"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>RagD</ns1:Alias>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=RRAGD&amp;search=rragd"/>
    <ns1:Alias>Rag D</ns1:Alias>
    <ns1:Alias>Rag D protein</ns1:Alias>
    <ns1:Alias>DKFZP761H171</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=19903"/>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/608268"/>
    <ns1:Alias>RRAGD</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:HgncName>RRAGD</ns1:HgncName>
    <ns1:Alias>bA11D8.2.1</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>ras-related GTP-binding protein D</ns1:Alias>
    <ns1:Alias>RAGD</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/58528"/>
    <ns1:Title>RRAGD</ns1:Title>
    <ns1:IsPanel>0</ns1:IsPanel>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/501">
    <ns1:HgncName>YES1</ns1:HgncName>
    <ns1:Alias>Cellular Yes-1 Protein</ns1:Alias>
    <ns1:Alias>Yamaguchi Sarcoma Oncogene</ns1:Alias>
    <ns1:Alias>Proto-Oncogene C-Yes</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_005424.1"/>
    <ns1:Alias>P61-YES</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=12841"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=YES1&amp;search=yes"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P07947"/>
    <ns1:Alias>C-YES</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:URN>urn:edrn:bmdb:biomarker:501</ns1:URN>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>YES</ns1:Alias>
    <ns1:Alias>HsT441</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
    <ns1:Title>YES</ns1:Title>
    <ns1:Description>YES1, also known as YES, is a non-receptor protein tyrosine kinase that is involved in the regulation of cell growth and survival, apoptosis, cell-cell adhesion, cytoskeleton remodeling, and differentiation.  It is the cellular homolog of the Yamaguchi sarcoma virus oncogene and belongs to the src family of proteins.  YES1 is involved in many phosphorylation reactions, including a role in cell cycle progression by phosphorylating the cyclin-dependent kinase 4/CDK4 thus regulating the G1 phase. Also involved in G2/M progression and cytokinesis.</ns1:Description>
    <ns1:Alias>Proto-Oncogene Tyrosine-Protein Kinase YES</ns1:Alias>
    <ns1:Alias>YES1</ns1:Alias>
    <ns1:Alias>V-Yes-1 Yamaguchi Sarcoma Viral Oncogene Homolog 1</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>Tyrosine-Protein Kinase Yes</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/52">
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="Nb7f06701d87944bda1015defe1b6663c">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/52/51"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:AccessGrantedTo>Meltzer Johns Hopkins University</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/59"/>
    <ns1:HgncName>AKAP12</ns1:HgncName>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:Title>AKAP12</ns1:Title>
    <ns1:Alias>Gravin</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/61"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:Description>AKAP12 is a member of the A-kinase anchor protein (AKAP) family, a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. AKAP12 is expressed in endothelial cells, cultured fibroblasts, and osteosarcoma cells. It associates with protein kinases A and C and phosphatase, and serves as a scaffold protein in signal transduction. This protein and RII PKA colocalize at the cell periphery. AKAP12 is a cell growth-related protein. Antibodies to this protein can be produced by patients with myasthenia gravis. Alternative splicing of this gene results in two transcript variants encoding different isoforms.</ns1:Description>
    <ns1:Type>Genomic</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:9590"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:52</ns1:URN>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/73"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q02952"/>
    <ns1:Alias>A-kinase anchor protein 250 kDa</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=370"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>AKAP12</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000131016"/>
    <ns1:Alias>AKAP250</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/60"/>
    <ns1:Alias>Myasthenia gravis autoantigen</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <ns1:Alias>A-kinase anchor protein 12</ns1:Alias>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:HopkinsMeltzerBarrettMethylationProfiles"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/32">
    <ns1:Alias>Phospholipase A2 inhibitory protein</ns1:Alias>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1071"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:Alias>Chromobindin-9</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/27"/>
    <ns1:Title>ANXA1</ns1:Title>
    <ns1:Alias>Lipocortin I</ns1:Alias>
    <ns1:Alias>Annexin-1</ns1:Alias>
    <ns1:Alias>Annexin I</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N0f0520eed7b1478cab57387e308dda16">
        <rdf:_2 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/32/914"/>
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/32/18"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:Alias>Calpactin II</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/119"/>
    <ns1:Description>Annexin 1 belongs to a family of calcium-dependent phospholipid binding proteins which are preferentially located on the cytosolic face of the plasma membrane. Annexin I protein has an apparent relative molecular mass of 40 kDa, with phospholipase A2 inhibitory activity.  Since phospholipase A2 is required for the biosynthesis of the potent mediators of inflammation, prostaglandins and leukotrienes, annexin I may have potential anti-inflammatory activity. Annexin 1 also promotes membrane fusion and is involved in exocytosis. It seems to bind from two to four calcium ions with high affinity.</ns1:Description>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:Alias>ANXA1</ns1:Alias>
    <ns1:Alias>Annexin 1</ns1:Alias>
    <ns1:AccessGrantedTo>Hanash Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:301"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:FHCRCHanashAnnexinLamr"/>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000135046"/>
    <ns1:referencesResource rdf:resource="http://ca.expasy.org/uniprot/P04083"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:HgncName>ANXA1</ns1:HgncName>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>ANX1</ns1:Alias>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <ns1:Alias>p35</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&amp;id=4502101"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/25"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:32</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:Alias>LPC1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/73"/>
    <ns1:memberOfPanel>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/508">
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/115"/>
        <ns1:Type>Protein</ns1:Type>
        <ns1:Alias>Farlow 6-marker panel for Lung Cancer</ns1:Alias>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/32"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/443"/>
        <ns1:Security>Public</ns1:Security>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/119"/>
        <ns1:Title>Farlow 6-marker panel for Lung Cancer</ns1:Title>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/446"/>
        <ns1:HgncName></ns1:HgncName>
        <ns1:URN>urn:edrn:bmdb:biomarker:508</ns1:URN>
        <ns1:Phase></ns1:Phase>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:Description>This study aimed to develop a serum test that could be used to discern NSCLC patients from cancer-free controls and may provide a means to indicate who should have spiral CT done. A large number of potential tumor autoantibodies for NSCLC were identified and validated.  The six-analyte blood test that resulted from this study (consisting of IMPDH, phosphoglycerate mutase, ubiquilin, Annexin I, Annexin II, and HSP70-9B) possessed excellent test performance characteristics when tested against our 196 patient cohort that was composed of four clinically distinct groups, with only 13 patients misclassified overall.</ns1:Description>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/153"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
        <ns1:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/474"/>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:IsPanel>1</ns1:IsPanel>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
      </ns1:Biomarker>
    </ns1:memberOfPanel>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Annexin A1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=533"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/137"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/26"/>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/39"/>
  </ns1:Biomarker>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/257">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/1000205"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/38/999">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/138"/>
  </ns1:BiomarkerStudyData>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/543">
    <ns1:Security>Public</ns1:Security>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/129"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P11308"/>
    <ns1:Title>TMPRSS2:ERG</ns1:Title>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/147"/>
    <ns1:HgncName></ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=ERG&amp;search=erg"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/970"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/130"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/141"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1075"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Description>TMPRSS2:ERG gene fusions are a common genetic event in prostate cancer.  These fusions are specific for prostate cancer and have also been observed in precursor lesions.  Since TMPRSS2:ERG fusions are not seen in every prostate cancer, their utility is in assays combined with other biomarkers, such as PCA3.</ns1:Description>
    <ns1:URN>urn:edrn:bmdb:biomarker:543</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/2078"/>
    <ns1:Alias>T2S:ERG</ns1:Alias>
    <ns1:Alias>TMPRSS2:ERG</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/140"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/O15393"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7113"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/188"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=TMPRSS2&amp;search=tmprss2"/>
  </ns1:Biomarker>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/23/39">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/929">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/114"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/62/58">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/127"/>
  </ns1:BiomarkerStudyData>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/495">
    <ns1:Title>TMSB4X</ns1:Title>
    <ns1:Alias>TMSB4</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/504"/>
    <ns1:Alias>THYB4</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>TMSB4X</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>thymosin beta-4</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11881"/>
    <ns1:Description>TMSB4X, or thymosin beta-4, belongs to the thymosin beta family.  It is an actin sequestering protein which plays an important role in the regulation of actin polymerization.  TMSB4X binds to and sequesters actin monomers (G actin) and therefore inhibits actin polymerization.  It is also involved in cell proliferation, migration, and differentiation. This gene escapes X inactivation and has a homolog on chromosome Y.</ns1:Description>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>T beta-4</ns1:Alias>
    <ns1:Alias>prothymosin beta-4</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=TMSB4X&amp;search=tmsb4x"/>
    <ns1:Alias>FX</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_066932.1"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:495</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P62328"/>
    <ns1:Alias>thymosin 4</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>TB4X</ns1:Alias>
    <ns1:Alias>Fx</ns1:Alias>
    <ns1:Alias>PTMB4</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/114"/>
    <ns1:HgncName>TMSB4X</ns1:HgncName>
    <ns1:Alias>thymosin beta 4, X-linked</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>thymosin, beta 4, X chromosome</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/81">
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>L-dopachrome tautomerase</ns1:Alias>
    <ns1:Alias>MIF</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Alias>macrophage migration inhibitory factor</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/114"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Title>MIF</ns1:Title>
    <ns1:AccessGrantedTo>Mor Yale University</ns1:AccessGrantedTo>
    <ns1:HgncName>MIF</ns1:HgncName>
    <ns1:Alias>L-dopachrome isomerase</ns1:Alias>
    <ns1:Description>MIF, a lymphokine involved in cell-mediated immunity, immunoregulation, and inflammation, plays a role in the regulation of macrophage function in host defense through the suppression of anti-inflammatory effects of glucocorticoids. This lymphokine and the JAB1 protein form a complex in the cytosol near the peripheral plasma membrane, which may indicate an additional role in integrin signaling pathways. MIF is also closely related to tumorigenesis.</ns1:Description>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/504"/>
    <ns1:Alias>GLIF</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/254"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>macrophage migration inhibitory factor (glycosylation-inhibiting factor)</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>phenylpyruvate tautomerase</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:81</ns1:URN>
    <ns1:Alias>MMIF</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P14174"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_002406.1"/>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:4282"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=7097"/>
    <ns1:Alias>GIF</ns1:Alias>
    <ns1:Alias>Glycosylation-inhibiting factor</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1082">
    <ns1:Alias>Thyroid-Lupus Autoantigen</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=XRCC5"/>
    <ns1:Phase></ns1:Phase>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Ku80</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>KUB2</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/505"/>
    <ns1:Alias>X-Ray Repair Complementing Defective Repair In Chinese Hamster Cells 5 (Double-Strand-Break Rejoining)</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/115"/>
    <ns1:Alias>86 KDa Subunit Of Ku Antigen</ns1:Alias>
    <ns1:Alias>KARP1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>Nuclear Factor IV</ns1:Alias>
    <ns1:Alias>Ku Autoantigen, 80kDa</ns1:Alias>
    <ns1:HgncName>XRCC5</ns1:HgncName>
    <ns1:Alias>KU80</ns1:Alias>
    <ns1:Alias>80kDa</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>CTCBF</ns1:Alias>
    <ns1:Alias>X-Ray Repair Cross-Complementing Protein 5</ns1:Alias>
    <ns1:Alias>X-Ray Repair Complementing Defective Repair In Chinese Hamster Cells 5 (Double-Strand-Break Rejoining; Ku Autoantigen, 80kD)</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/7520"/>
    <ns1:Alias>Ku Autoantigen</ns1:Alias>
    <ns1:Alias>ATP-Dependent DNA Helicase II 80 KDa Subunit</ns1:Alias>
    <ns1:Alias>CTC Box-Binding Factor 85 KDa Subunit</ns1:Alias>
    <ns1:Description>From NCBI Entrez Gene: The protein encoded by this gene is the 80-kilodalton subunit of the Ku heterodimer protein which is also known as ATP-dependant DNA helicase II or DNA repair protein XRCC5. Ku is the DNA-binding component of the DNA-dependent protein kinase, and it functions together with the DNA ligase IV-XRCC4 complex in the repair of DNA double-strand break by non-homologous end joining and the completion of V(D)J recombination events. This gene functionally complements Chinese hamster xrs-6, a mutant defective in DNA double-strand break repair and in ability to undergo V(D)J recombination. A rare microsatellite polymorphism in this gene is associated with cancer in patients of varying radiosensitivity. [provided by RefSeq, Jul 2008]</ns1:Description>
    <ns1:Alias>XRCC5</ns1:Alias>
    <ns1:Alias>G22P2</ns1:Alias>
    <ns1:Alias>DNA Repair Protein XRCC5</ns1:Alias>
    <ns1:Alias>KARP-1</ns1:Alias>
    <ns1:Alias>Lupus Ku Autoantigen Protein P86</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Ku86</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P13010"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>ATP-Dependent DNA Helicase 2 Subunit 2</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:1082</ns1:URN>
    <ns1:Alias>EC 3.6.4.-</ns1:Alias>
    <ns1:Alias>CTC85</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:12833"/>
    <ns1:Title>XRCC5</ns1:Title>
    <ns1:Alias>TLAA</ns1:Alias>
    <ns1:Alias>Ku86 Autoantigen Related Protein 1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>NFIV</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/74">
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>HDCMA22P</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:HgncName>B2M</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=914"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Type>Protein</ns1:Type>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Description>B2M, a secreted protein belonging to the beta-2-microglobulin family, is a component of the class I major histocompatibility complex (MHC) on the surface of nearly all nucleated cells and involved in the presentation of peptide antigens to the immune system. A mutation in this gene has been shown to result in hypercatabolic hypoproteinemia. B2M is detected in serum and urine.</ns1:Description>
    <ns1:Title>B2M</ns1:Title>
    <ns1:Alias>CDABP0092</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_004039.1"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:Alias>B2M</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/547"/>
    <ns1:Alias>beta-2-microglobulin</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P61769"/>
    <ns1:AccessGrantedTo>Bast MD Anderson</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:567"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:74</ns1:URN>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/114">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/121"/>
    <ns1:Type>Genomic</ns1:Type>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>CDH1</ns1:Alias>
    <ns1:Title>CDH1</ns1:Title>
    <ns1:Description>From NCBI Gene: This gene is a classical cadherin from the cadherin superfamily. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function is thought to contribute to progression in cancer by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. Identified transcript variants arise from mutation at consensus splice sites. [provided by RefSeq, Jul 2008]</ns1:Description>
    <ns1:Alias>cadherin 1, type 1, E-cadherin (epithelial)</ns1:Alias>
    <ns1:Alias>CDHE</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P12830"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:114</ns1:URN>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/999"/>
    <ns1:Alias>UVO</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_004351.1"/>
    <ns1:AccessGrantedTo>Sidransky Johns Hopkins University</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>E-Cadherin</ns1:Alias>
    <ns1:Alias>uvomorulin</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:HgncName>CDH1</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/183"/>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=1748"/>
    <ns1:Alias>CAM 120/80</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>Cadherin-1</ns1:Alias>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=CDH1&amp;search=cdh1"/>
    <ns1:Alias>CD324</ns1:Alias>
  </ns1:Biomarker>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/32/18">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/138"/>
  </ns1:BiomarkerStudyData>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/793">
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>heart and RRM expressed sequence</ns1:Alias>
    <ns1:Alias>Hermes</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q93062"/>
    <ns1:HgncName>RBPMS</ns1:HgncName>
    <ns1:Alias>RBP-MS</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=19097"/>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/601558"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>RBPMS</ns1:Alias>
    <ns1:Alias>RNA-binding protein with multiple splicing</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/11030"/>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>RNA binding protein with multiple splicing</ns1:Alias>
    <ns1:Description>From NCBI Gene: This gene encodes a member of the RNA recognition motif family of RNA-binding proteins. The RNA recognition motif is between 80-100 amino acids in length and family members contain one to four copies of the motif. The RNA recognition motif consists of two short stretches of conserved sequence, as well as a few highly conserved hydrophobic residues. The encoded protein has a single, putative RNA recognition motif in its N-terminus. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2013]</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Heart and RRM expressed sequence</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:Title>RBPMS</ns1:Title>
    <ns1:Alias>HERMES</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:793</ns1:URN>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1013"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/45">
    <ns1:Description>CDH13 is a member of the cadherin superfamily. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region but, unlike the typical cadherin superfamily member, lacks the highly conserved cytoplasmic region. This particular cadherin is a putative mediator of cell-cell interaction in the heart and may act as a negative regulator of neural cell growth. The gene locus is hypermethylated or deleted in breast, ovarian and lung cancers.</ns1:Description>
    <ns1:Alias>H-cadherin</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:45</ns1:URN>
    <ns1:Alias>H-cadherin (heart)</ns1:Alias>
    <ns1:Alias>T-cadherin</ns1:Alias>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/331"/>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:HopkinsMeltzerBarrettMethylationProfiles"/>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P55290"/>
    <ns1:Alias>CDH13</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:AccessGrantedTo>Meltzer Johns Hopkins University</ns1:AccessGrantedTo>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N918aa9acf0e14a84b26a698c400206f5">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/45/44"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Type>Genomic</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>cadherin 13</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/66"/>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000140945"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/50"/>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:1012"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=1753"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/109"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>truncated-cadherin</ns1:Alias>
    <ns1:Alias>T-cad</ns1:Alias>
    <ns1:Alias>heart-cadherin</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/49"/>
    <ns1:Title>CDH13</ns1:Title>
    <ns1:Security>Public</ns1:Security>
    <ns1:HgncName>CDH13</ns1:HgncName>
    <ns1:Alias>P105</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/698">
    <ns1:Alias>H11</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=30171"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/160"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:698</ns1:URN>
    <ns1:Alias>protein kinase H11</ns1:Alias>
    <ns1:Alias>heat shock 27kDa protein 8</ns1:Alias>
    <ns1:Alias>Alpha-crystallin C chain</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>DHMN2</ns1:Alias>
    <ns1:Alias>HSPB8</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/26353"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>HMN2</ns1:Alias>
    <ns1:Alias>E2-induced gene 1 protein</ns1:Alias>
    <ns1:Alias>HMN2A</ns1:Alias>
    <ns1:Alias>HspB8</ns1:Alias>
    <ns1:Alias>CMT2L</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1013"/>
    <ns1:Phase>One</ns1:Phase>
    <ns1:Alias>HSP22</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://omim.org/entry/608014"/>
    <ns1:Title>HSPB8</ns1:Title>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>Protein kinase H11</ns1:Alias>
    <ns1:Alias>heat shock protein beta-8</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>heat shock 22kDa protein 8</ns1:Alias>
    <ns1:Alias>alpha-crystallin C chain</ns1:Alias>
    <ns1:Alias>Small stress protein-like protein HSP22</ns1:Alias>
    <ns1:Alias>E2IG1</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>small stress protein-like protein HSP22</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/159"/>
    <ns1:Description>From NCBI Gene: The protein encoded by this gene belongs to the superfamily of small heat-shock proteins containing a conservative alpha-crystallin domain at the C-terminal part of the molecule. The expression of this gene in induced by estrogen in estrogen receptor-positive breast cancer cells, and this protein also functions as a chaperone in association with Bag3, a stimulator of macroautophagy. Thus, this gene appears to be involved in regulation of cell proliferation, apoptosis, and carcinogenesis, and mutations in this gene have been associated with different neuromuscular diseases, including Charcot-Marie-Tooth disease. [provided by RefSeq, Jul 2008]</ns1:Description>
    <ns1:Alias>CRYAC</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/162"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:HgncName>HSPB8</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9UJY1"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/51">
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:HopkinsMeltzerBarrettMethylationProfiles"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/55"/>
    <ns1:indicatorForOrgan>
      <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/72">
        <ns1:IsPanel>0</ns1:IsPanel>
        <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/547"/>
        <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P02766"/>
        <ns1:URN>urn:edrn:bmdb:biomarker:72</ns1:URN>
        <ns1:HgncName>TTR</ns1:HgncName>
        <ns1:Alias>transthyretin</ns1:Alias>
        <ns1:Title>transthyretin</ns1:Title>
        <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
        <ns1:Alias>prealbumin, amyloidosis type I</ns1:Alias>
        <ns1:Alias>TTR</ns1:Alias>
        <ns1:AccessGrantedTo>Bast MD Anderson</ns1:AccessGrantedTo>
        <ns1:Phase></ns1:Phase>
        <ns1:Alias>ATTR</ns1:Alias>
        <ns1:Type>Protein</ns1:Type>
        <ns1:Description>Transthyretin, one of the three prealbumins including alpha-1-antitrypsin, transthyretin and orosomucoid, is a carrier protein that transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. TT consists of a tetramer of identical subunits. More than 80 different mutations in this gene have been reported; most mutations are related to amyloid deposition, affecting predominantly peripheral nerve and/or the heart, and a small portion of the gene mutations is non-amyloidogenic. The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis, and carpal tunnel syndrome.</ns1:Description>
        <ns1:Alias>TBPA</ns1:Alias>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
        <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000362.1"/>
        <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
        <ns1:Alias>TT</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=12405"/>
        <ns1:Alias>Prealbumin</ns1:Alias>
        <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:7276"/>
        <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
        <ns1:Security>Public</ns1:Security>
        <ns1:QAState>Curated</ns1:QAState>
        <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
        <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
        <ns1:Alias>PALB</ns1:Alias>
      </ns1:Biomarker>
    </ns1:indicatorForOrgan>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:Alias>Somatostatin-14</ns1:Alias>
    <ns1:Type>Genomic</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/60"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11329"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Meltzer Johns Hopkins University</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>somatostatin</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000157005"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Phase></ns1:Phase>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P61278"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:HgncName>SST</ns1:HgncName>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Somatostatin-28</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Title>SST</ns1:Title>
    <ns1:Alias>SST</ns1:Alias>
    <ns1:Description>The hormone somatostatin (SST) has active 14 aa and 28 aa forms that are produced by alternate cleavage of the single preproprotein encoded by this gene. Somatostatin is expressed throughout the body and inhibits the release of numerous secondary hormones by binding to high-affinity G-protein-coupled somatostatin receptors. This hormone is an important regulator of the endocrine system through its interactions with pituitary growth hormone, thyroid stimulating hormone, and most hormones of the gastrointestinal tract. Somatostatin also affects rates of neurotransmission in the central nervous system and proliferation of both normal and tumorigenic cells. The promoter of somatostatin, a primary inhibitor of gastrin-stimulated gastric acid secretion, is hypermethylated in 80% of human colon cancers. A synthetic analog of SST, known as octreotide or SMS 201-995, is available under the name Sandostatin (Novartis). It is used for the treatment of a variety of disorders including acromegaly and the symptomatic treatment of carcinoid tumors and vasoactive intestinal peptide tumors.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:6750"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:51</ns1:URN>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N3d02ee5543b54f50a2d129946b9c3ea5">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/51/50"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:Alias>Growth hormone release-inhibiting factor</ns1:Alias>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/35">
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="N6534015fe8eb435dad5e26658794699a">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/35/20"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/55"/>
    <ns1:Alias>p40</ns1:Alias>
    <ns1:Alias>37LRP</ns1:Alias>
    <ns1:Alias>40S ribosomal protein SA</ns1:Alias>
    <ns1:Alias>LRP</ns1:Alias>
    <ns1:Alias>Laminin-binding protein precursor p40</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:HgncName>RPSA</ns1:HgncName>
    <ns1:Alias>67kD, ribosomal protein SA</ns1:Alias>
    <ns1:Alias>RPSA</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6502"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:35</ns1:URN>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/77"/>
    <ns1:referencesResource rdf:resource="http://ca.expasy.org/cgi-bin/niceprot.pl?Q86VC0"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/27"/>
    <ns1:Alias>67LR</ns1:Alias>
    <ns1:Alias>NEM/1CHD4</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>LAMR1</ns1:Alias>
    <ns1:Description>Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes.  They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Many of the effects of laminin are mediated through interactions with cell surface receptors. These receptors include members of the integrin family, as well as non-integrin laminin-binding proteins. The amino acid sequence of laminin receptor 1 is highly through evolution, suggesting a key biological function. It has been observed that the level of the laminin receptor transcript is higher in colon carcinoma tissue and lung cancer cell line than their normal counterparts. Also, there is a correlation between the upregulation of this polypeptide in cancer cells and their invasive and metastatic phenotype.  Cell-adhesive protein LAMR1 plays an important role in the processes of cancer proliferation, invasion and metastasis.  LAMR1 antigens have been found to be targets of autoantibodies in subjects newly diagnosed with lung cancer.</ns1:Description>
    <ns1:Alias>LAMBR</ns1:Alias>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:FHCRCHanashAnnexinLamr"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/73"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/28"/>
    <ns1:Alias>LBP</ns1:Alias>
    <ns1:Alias>LBP/p40</ns1:Alias>
    <ns1:Alias>laminin receptor 1 (67kD, ribosomal protein SA)</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:Title>RPSA</ns1:Title>
    <ns1:Alias>LRP/LR</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:3921"/>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:Alias>34/67 kDa laminin receptor</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/39"/>
    <ns1:Alias>Multidrug resistance-associated protein MGr1-Ag</ns1:Alias>
    <ns1:Alias>RSSA</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>ribosomal protein SA</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/78"/>
    <ns1:Alias>Colon carcinoma laminin-binding protein</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>LamR</ns1:Alias>
    <ns1:AccessGrantedTo>Hanash Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/76"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>laminin receptor 1</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000168028"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/450">
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>leucine-rich repeats and immunoglobulin-like domains 3</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>LIG-3</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:URN>urn:edrn:bmdb:biomarker:450</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q6UXM1"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>KIAA3016</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>LIRG3</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>leucine-rich repeats and immunoglobulin-like domains protein 3</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=LRIG3&amp;search=lrig3"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/186"/>
    <ns1:Alias>LIG3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_700356.2"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
    <ns1:HgncName>LRIG3</ns1:HgncName>
    <ns1:Alias>FLJ90440</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:Title>LRIG3</ns1:Title>
    <ns1:Alias>LRIG3</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Description>The LRIG3 protein is a widely expressed type I membrane protein.  It contains three Ig-like C2-type (immunoglobulin-like) domains, 15 LRR (leucine-rich) repeats, 1 LRRCT domain, and 1 LRRNT domain.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=30991"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/224">
    <ns1:Alias>carcinoembryonic antigen-related cell adhesion molecule 5</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Liu University of Washington</ns1:AccessGrantedTo>
    <ns1:Title>CEACAM5</ns1:Title>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:Type>Protein</ns1:Type>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1076"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:224</ns1:URN>
    <ns1:Description>From NCBI Gene: CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family, which belongs to the immunoglobulin superfamily. Two subgroups of the CEA family, the CEA cell adhesion molecules and the pregnancy-specific glycoproteins, are located within a 1.2 Mb cluster on the long arm of chromosome 19. Eleven pseudogenes of the CEA cell adhesion molecule subgroup are also found in the cluster.  CEACAM5 is a cell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. It is a receptor for E.coli Dr adhesins.</ns1:Description>
    <ns1:Alias>CEACAM5</ns1:Alias>
    <ns1:AccessGrantedTo>Marks Duke University Medical Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/236"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=1817"/>
    <ns1:Alias>Meconium antigen 100</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/244"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P06731"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/123"/>
    <ns1:Alias>Carcinoembryonic antigen</ns1:Alias>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:Alias>CEA</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_004354.2"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:1048"/>
    <ns1:HgncName>CEACAM5</ns1:HgncName>
    <ns1:Alias>CD66e Antigen</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Lokshin University of Pittsburgh Cancer Instititute</ns1:AccessGrantedTo>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>DKFZp781M2392</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Lung and Upper Aerodigestive</ns1:AccessGrantedTo>
    <ns1:Alias>CD66e</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/99"/>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/427">
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:URN>urn:edrn:bmdb:biomarker:427</ns1:URN>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>des-Gly-Gly-ubiquitin</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Type>Proteomic</ns1:Type>
    <ns1:Description>Des-ubiquitin is formed when a cysteine protease cleaves two carboxy-terminal glycine residues from ubiquitin.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>Des-ubiquitin</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/241"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/504"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Title>Des-ubiquitin</ns1:Title>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/114"/>
    <ns1:HgncName></ns1:HgncName>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/50">
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/91"/>
    <ns1:Alias>Hyperplastic polyposis protein 1</ns1:Alias>
    <ns1:Alias>HPP1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000144339"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/58"/>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:23671"/>
    <ns1:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/70"/>
    <ns1:Alias>tomoregulin</ns1:Alias>
    <ns1:Alias>TR-2</ns1:Alias>
    <ns1:Alias>TR</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9UIK5"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>cancer/testis antigen family 120, member 2</ns1:Alias>
    <ns1:Type>Genomic</ns1:Type>
    <ns1:Title>TMEFF2</ns1:Title>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>TMEFF2</ns1:Alias>
    <ns1:hasBiomarkerStudyDatas>
      <rdf:Bag rdf:nodeID="Nbdaea7ac3aa0459387e6c2cd7801beeb">
        <rdf:_1 rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/50/49"/>
      </rdf:Bag>
    </ns1:hasBiomarkerStudyDatas>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/54"/>
    <ns1:Alias>Tomoregulin-2</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/57"/>
    <ns1:HgncName>TMEFF2</ns1:HgncName>
    <ns1:Alias>TENB2</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <ns1:Alias>transmembrane protein TENB2</ns1:Alias>
    <ns1:QAState>Accepted</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/53"/>
    <ns1:AccessGrantedTo>Meltzer Johns Hopkins University</ns1:AccessGrantedTo>
    <ns1:Alias>CT120.2</ns1:Alias>
    <ns1:Alias>TPEF</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/90"/>
    <ns1:Description>HPP1 (also called TMEFF2) may be a survival factor for hippocampal and mesencephalic neurons. The shedded form (generated by proteolytic shedding) up-regulates cancer cell proliferation, probably by promoting ERK1/2 phosphorylation. HPP1 is down-regulated in tumor cell lines in response to a high level of methylation in the 5' region. The CpG island methylation correlates with HPP1 silencing in tumor cell lines.</ns1:Description>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/49"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11867"/>
    <ns1:Alias>transmembrane protein with EGF-like and two follistatin-like domains 2</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:50</ns1:URN>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:HopkinsMeltzerBarrettMethylationProfiles"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/223">
    <ns1:Title>APOA1</ns1:Title>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>Apo-AI</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=600"/>
    <ns1:Alias>apolipoprotein A-I</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:335"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>ApoA-I</ns1:Alias>
    <ns1:Alias>APOA1</ns1:Alias>
    <ns1:AccessGrantedTo>Bast MD Anderson</ns1:AccessGrantedTo>
    <ns1:HgncName>APOA1</ns1:HgncName>
    <ns1:Alias>Apolipoprotein A-I</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>Apolipoprotein A1</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/94"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/93"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:223</ns1:URN>
    <ns1:Description>APOA1, a secreted protein belonging to the apolipoprotein A1/A4/E family, participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, APOA1 activates spermatozoa motility. This protein is a major protein of plasma HDL and is also found in chylomicrons. It is synthesized in the liver and small intestine.  Defects in APOA1 are a cause of several diseases: 1) high density lipoprotein deficiency type 2 (HDLD2), also known as familial hypoalphalipoproteinemia, for which inheritance is autosomal dominant; 2) the low HDL levels observed in high density lipoprotein deficiency type 1 (HDLD1), also known as analphalipoproteinemia or Tangier disease (TGD), a recessive disorder characterized by the absence of plasma HDL, accumulation of cholesteryl esters, premature coronary artery disease, hepatosplenomegaly, recurrent peripheral neuropathy and progressive muscle wasting and weakness; 3) amyloid polyneuropathy-nephropathy Iowa type (AMYLIOWA), also known as amyloidosis van Allen type or familial amyloid polyneuropathy type III, a hereditary generalized amyloidosis due to deposition of amyloid mainly constituted by apolipoprotein A1; 4) amyloidosis type 8 (AMYL8), also known as systemic non-neuropathic amyloidosis or Ostertag-type amyloidosis, a hereditary generalized amyloidosis due to deposition of apolipoprotein A1, fibrinogen and lysozyme amyloids.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_000030.1"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Alias>MGC117399</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P02647"/>
    <ns1:Phase></ns1:Phase>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/547"/>
    <ns1:AccessGrantedTo>Breast and Gynecologic</ns1:AccessGrantedTo>
    <ns1:IsPanel>0</ns1:IsPanel>
  </ns1:Biomarker>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/39/1000">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/138"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/57/1035">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/286"/>
  </ns1:BiomarkerStudyData>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/413">
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11938"/>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P32971"/>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/184"/>
    <ns1:Title>TNFSF8</ns1:Title>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972"/>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>CD153 antigen</ns1:Alias>
    <ns1:Alias>TNFSF8</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>CD30 antigen ligand</ns1:Alias>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>tumor necrosis factor (ligand) superfamily, member 8</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>CD30LG</ns1:Alias>
    <ns1:Alias>CD30-L</ns1:Alias>
    <ns1:Description>TNFSF8, also known as CD30 ligand, is a cytokine belonging to the tumor necrosis factor (TNF) ligand family.  TNFSF8 binds to TNFRSF8/CD30, a cell surface antigen and a marker for Hodgkin lymphoma and related hematologic malignancies.  TNFSF8 has been shown to induce proliferation of T-cells.  It also enhances cell proliferation of some lymphoma cell lines, and induces cell death and reduces cell proliferation of other lymphoma cell lines.  There are two different isoforms encoded by two transcript variants.</ns1:Description>
    <ns1:Alias>CD30L</ns1:Alias>
    <ns1:Alias>CD30 ligand</ns1:Alias>
    <ns1:HgncName>TNFSF8</ns1:HgncName>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_001235.1"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:URN>urn:edrn:bmdb:biomarker:413</ns1:URN>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>tumor necrosis factor ligand  superfamily member 8</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
    <ns1:Alias>CD153</ns1:Alias>
    <ns1:Type>Protein</ns1:Type>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF8&amp;search=cd30+ligand"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/48">
    <ns1:Title>p16</ns1:Title>
    <ns1:HgncName>CDKN2A</ns1:HgncName>
    <ns1:Alias>CDK4I</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/64"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/91"/>
    <ns1:Type>Genomic</ns1:Type>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/164"/>
    <ns1:AccessGrantedTo>GI and Other Associated</ns1:AccessGrantedTo>
    <ns1:Alias>CMM2</ns1:Alias>
    <ns1:Alias>CDKN2A</ns1:Alias>
    <ns1:URN>urn:edrn:bmdb:biomarker:48</ns1:URN>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/1029"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/165"/>
    <ns1:referencesResource rdf:resource="http://http://www.genecards.org/cgi-bin/carddisp.pl?gene=CDKN2A&amp;search=p16"/>
    <ns1:Alias>INK4</ns1:Alias>
    <ns1:AssociatedDataset rdf:resource="https://edrn.jpl.nasa.gov/ecas/data/dataset/urn:edrn:HopkinsMeltzerBarrettMethylationProfiles"/>
    <ns1:Alias>MTS1</ns1:Alias>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Alias>INK4a</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/163"/>
    <ns1:Alias>CDKN2</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=1787"/>
    <ns1:Alias>p16INK4a</ns1:Alias>
    <ns1:Alias>Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P42771"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <ns1:Phase></ns1:Phase>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:Alias>p19</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/54"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/53"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/65"/>
    <ns1:Alias>Multiple tumor suppressor 1</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:referencesResource rdf:resource="http://www.proteinatlas.org/ENSG00000147889"/>
    <ns1:Alias>Cyclin-dependent kinase 4 inhibitor A</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/137"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/90"/>
    <ns1:Description>The CDKN2A locus generates several transcript variants which differ in their first exons. Two distinct transcripts are produced from different promoters: p16 (INK4A) and p14 (ARF). At least three alternatively spliced variants encoding distinct proteins have been reported, two of which (p16 and p14) encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, MDM1, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene.</ns1:Description>
    <ns1:Alias>p16</ns1:Alias>
    <ns1:Alias>p16-INK4a</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
  </ns1:Biomarker>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/22/32">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/916">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/350"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/54/22">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/127"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/50/49">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/26/37">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
  </ns1:BiomarkerStudyData>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/483">
    <ns1:Alias>JH</ns1:Alias>
    <ns1:Alias>hemojuvelin</ns1:Alias>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/100"/>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=4887"/>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:Alias>RGMC</ns1:Alias>
    <ns1:Security>Public</ns1:Security>
    <ns1:Alias>HFE2A</ns1:Alias>
    <ns1:Description>HFE2, also known as RGM-C, is a member of the repulsive guidance molecule (RGM) family and is involved in iron metabolism.  HFE2 may act as a bone morphogenetic protein (BMP) coreceptor.  It is also thought to be a component of the signaling pathway which activates hepcidin or it may act as a modulator of hepcidin expression. It could also represent the cellular receptor for hepcidin. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene.  Mutations in the HFE2 gene cause hemochromatosis type 2A, also called juvenile hemochromatosis (JH), an early-onset autosomal recessive disorder due to severe iron overload resulting in hypogonadotrophic hypogonadism, hepatic fibrosis or cirrhosis and cardiomyopathy, occurring typically before age of 30.</ns1:Description>
    <ns1:Alias>haemojuvelin</ns1:Alias>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:Alias>HFE2</ns1:Alias>
    <ns1:Alias>RGM-C</ns1:Alias>
    <ns1:Alias>hemochromatosis type 2 (juvenile)</ns1:Alias>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=HFE2&amp;search=rgm-c"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/126"/>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972"/>
    <ns1:HgncName>HFE2</ns1:HgncName>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:Title>HFE2</ns1:Title>
    <ns1:Type>Protein</ns1:Type>
    <ns1:Alias>HJV</ns1:Alias>
    <ns1:Alias>Hemochromatosis type 2 protein</ns1:Alias>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Phase></ns1:Phase>
    <ns1:Alias>RGM domain family member C</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:Alias>repulsive guidance molecule c</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.uniprot.org/uniprot/q6zvn8"/>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/protein/NP_998818.1"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:483</ns1:URN>
  </ns1:Biomarker>
  <ns1:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/63">
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/129"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/247"/>
    <ns1:URN>urn:edrn:bmdb:biomarker:63</ns1:URN>
    <ns1:Alias>prostate cancer associated transcript 3 (non-protein coding)</ns1:Alias>
    <ns1:Alias>DD3</ns1:Alias>
    <ns1:Alias>PCA3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.omim.org/entry/604845"/>
    <ns1:AccessGrantedTo>Lin UW University of Washington</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/188"/>
    <ns1:AccessGrantedTo>National Cancer Institute</ns1:AccessGrantedTo>
    <ns1:Description>The prostate cancer antigen 3 (PCA3) gene is a highly specific biomarker upregulated in prostate cancer.  Because there is no extensive open reading frame, the gene is thought to express a noncoding RNA.	
The FDA has approved an assay for prostate cancer that uses the ratio of PCA3 RNA to PSA RNA in urine.  The assay is used to help physicians determine the need for repeat prostate biopsies in men 50 years of age or older who have had a previous negative biopsy.  When used in conjunction with other clinical information, the use of this test can reduce the need for unnecessary prostate biopsies.</ns1:Description>
    <ns1:referencesResource rdf:resource="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PCA3&amp;search=pca3"/>
    <ns1:AccessGrantedTo>Crichton JPL</ns1:AccessGrantedTo>
    <ns1:Alias>PCAT3</ns1:Alias>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1075"/>
    <ns1:Alias>NCRNA00019</ns1:Alias>
    <ns1:Alias>non-protein coding RNA 19</ns1:Alias>
    <ns1:QAState>Curated</ns1:QAState>
    <ns1:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=8637"/>
    <ns1:AccessGrantedTo>Wei University of Michigan</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/95"/>
    <ns1:Type>Gene</ns1:Type>
    <ns1:Alias>prostate cancer antigen 3 (non-protein coding)</ns1:Alias>
    <ns1:AccessGrantedTo>Feng Fred Hutchinson Cancer Research Center</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/140"/>
    <ns1:Title>PCA3</ns1:Title>
    <ns1:Alias>prostate cancer antigen 3</ns1:Alias>
    <ns1:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/gene/50652"/>
    <ns1:HgncName>PCA3</ns1:HgncName>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/130"/>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/142"/>
    <ns1:Security>Public</ns1:Security>
    <ns1:AccessGrantedTo>Prostate and Urologic</ns1:AccessGrantedTo>
    <ns1:AccessGrantedTo>Curators</ns1:AccessGrantedTo>
    <ns1:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/141"/>
    <ns1:Phase></ns1:Phase>
    <ns1:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/970"/>
    <ns1:IsPanel>0</ns1:IsPanel>
    <ns1:referencesResource rdf:resource="http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm294907.htm"/>
  </ns1:Biomarker>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/62/29">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/287"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/57/26">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/127"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/26/38">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/30">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/41/998">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/138"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/23/40">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/52/51">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/1010">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/244"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/24/41">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/51/50">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/1016">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/352"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/21/15">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/35">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/55">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/152">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/330"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/959">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/367"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/24/155">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/330"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/34/19">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/138"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/46/45">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/53/52">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/56/59">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/287"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/26/960">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/367"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/47/46">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/917">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/350"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/22/33">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/49/48">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/35/20">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/138"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/57/925">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/193"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/56/24">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/127"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/21/1006">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/405"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/32/914">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/350"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/45/44">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/57/27">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/287"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/961">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/367"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/26/915">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/350"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/34">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/24/42">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
  </ns1:BiomarkerStudyData>
  <ns1:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/26/1021">
    <ns1:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/281"/>
  </ns1:BiomarkerStudyData>
</rdf:RDF>

